data_1e2b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e2b _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.595 0 CA-C-O 120.977 0.418 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 52.8 m170 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.565 ' CG ' ' HB3' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.758 HD22 ' OG1' ' A' ' 16' ' ' THR . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.52 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.758 ' OG1' HD22 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.802 HD21 ' O ' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' N ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 17' ' ' SER . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' N ' HD11 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 1.004 ' OE1' HD11 ' A' ' 90' ' ' LEU 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 30' ' ' TYR . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.717 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.845 ' OE2' ' HG3' ' A' ' 63' ' ' MET . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.724 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.711 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.667 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 53' ' ' VAL . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 52' ' ' ASP . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 ' HA2' ' A' ' 48' ' ' GLY . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.709 ' N ' HD12 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' HG ' ' A' ' 11' ' ' SER . 5.4 mt-30 -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.845 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.531 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.956 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HG2' HG21 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 67' ' ' ILE . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 80' ' ' ASP . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.999 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.999 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.778 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.736 ' O ' HG22 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.922 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 1.004 HD11 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 1.012 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 88' ' ' ASP 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 1.012 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' LYS . 11.7 tptm . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.746 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.583 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.871 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.711 HD22 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 44' ' ' ALA . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.965 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.91 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.91 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.675 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.884 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.645 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG22 ' CB ' ' A' ' 30' ' ' TYR . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' HG11 ' A' ' 32' ' ' VAL 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.508 HD11 ' NE2' ' A' ' 5' ' ' HIS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HG21 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.793 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.577 HG21 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 9' ' ' PHE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.804 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.746 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.971 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.8 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.488 HG13 ' CD1' ' A' ' 56' ' ' LEU . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.557 ' NE2' ' CG1' ' A' ' 76' ' ' VAL . 3.9 mm-40 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.971 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 1.032 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.592 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.824 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 1.032 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.87 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.447 ' O ' ' OE1' ' A' ' 26' ' ' GLN . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 88' ' ' ASP 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 30' ' ' TYR . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 93' ' ' LEU . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.751 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm . . . . . 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 122.302 1.048 . . . . 0.0 112.325 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 m80 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.826 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 44' ' ' ALA . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.477 ' HB2' ' CG2' ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.477 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.875 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' HG23 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.737 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 23' ' ' MET . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.49 ' O ' HG11 ' A' ' 32' ' ' VAL . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.778 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.826 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.573 ' HZ ' ' OE1' ' A' ' 37' ' ' GLU . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.88 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.88 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.823 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.823 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.712 ' N ' HD23 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 52' ' ' ASP . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 56' ' ' LEU . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.008 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.869 ' O ' HG21 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.911 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.869 HG21 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.49 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.464 ' N ' ' HD1' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.045 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.528 ' CG1' HD11 ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 1.045 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB3' ' HA2' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 49' ' ' GLN . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.813 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.656 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.008 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 58' ' ' PRO . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.911 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.84 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.544 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.84 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.838 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.576 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.872 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.436 ' HB ' ' SD ' ' A' ' 23' ' ' MET . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.513 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 10.7 tttm . . . . . 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 32.6 m170 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.778 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 16' ' ' THR . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.907 ' O ' HG21 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.907 HG21 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 16' ' ' THR . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.788 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.807 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD11 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.923 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.974 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.923 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.492 ' C ' ' CG1' ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.784 HG23 ' OE2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.545 HD11 ' N ' ' A' ' 24' ' ' ARG . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 35' ' ' ILE . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.605 ' O ' ' HA ' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 1.078 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA2' HD21 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' O ' ' A' ' 75' ' ' PRO . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.537 ' O ' HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.016 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.964 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.646 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.564 ' OE1' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.894 HD12 ' N ' ' A' ' 61' ' ' ALA 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.894 ' N ' HD12 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.443 ' CG1' HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.61 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG11 ' N ' ' A' ' 77' ' ' GLU . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.016 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.964 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.865 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.865 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.701 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 84' ' ' TYR . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.454 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.974 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 83' ' ' LEU 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.538 ' N ' ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.456 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 101' ' ' LYS . 1.1 tmmt? . . . . . 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 122.559 1.171 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.848 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.966 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.818 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.818 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.462 HG23 HD22 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' HG12 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.888 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.81 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.972 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.81 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.972 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.592 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.848 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.823 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.966 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 1.02 ' O ' HG21 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 1.02 HG21 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.872 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.659 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.872 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.659 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.926 ' O ' HG21 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.926 HG21 ' O ' ' A' ' 52' ' ' ASP . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 60' ' ' ILE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 11' ' ' SER 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.783 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.5 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.964 ' O ' HD22 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.712 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.867 ' OE2' HD11 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.867 HD11 ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.66 ' O ' HG12 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.604 ' CG2' ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.651 HG21 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.893 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.893 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 1.008 ' O ' HG22 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.523 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 88' ' ' ASP . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.823 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.761 ' HD3' ' O ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.637 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 19' ' ' LEU . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.863 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.717 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.511 ' OG ' ' CD2' ' A' ' 84' ' ' TYR . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.648 ' HB3' ' O ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG11 ' N ' ' A' ' 21' ' ' SER . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.809 ' N ' HG11 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.964 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.913 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.852 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.913 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.831 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 31' ' ' GLU 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 35' ' ' ILE 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.651 ' N ' HG13 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.869 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' HG23 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.749 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.91 ' O ' HG21 ' A' ' 42' ' ' THR . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE2' ' SD ' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.91 HG21 ' O ' ' A' ' 40' ' ' PRO 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.734 HD11 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 51' ' ' ALA . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.637 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 51' ' ' ALA . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.821 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.697 ' O ' HG13 ' A' ' 67' ' ' ILE . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.876 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.985 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.952 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.876 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.985 ' HB2' ' O ' ' A' ' 67' ' ' ILE 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.741 ' O ' HG21 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.438 HG12 HG23 ' A' ' 67' ' ' ILE . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.821 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 56' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.997 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.833 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.402 ' HA ' HD21 ' A' ' 83' ' ' LEU . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.997 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.833 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.964 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 22' ' ' LYS . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.852 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.693 ' N ' HD22 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.545 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.526 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' OE2' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? . . . . . 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.946 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CE2' ' CB ' ' A' ' 5' ' ' HIS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.824 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' N ' ' HH ' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.664 ' O ' HD21 ' A' ' 19' ' ' LEU . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.769 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.917 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.804 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.799 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.629 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.799 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CB ' HG22 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.946 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' CB ' HG23 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.824 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 39' ' ' PHE . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' HB1' ' A' ' 44' ' ' ALA 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 47' ' ' LYS 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.839 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.554 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.719 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 53' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.859 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.655 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.668 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.709 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 67' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.762 ' HB ' ' OE1' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.762 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.508 ' CG1' HG13 ' A' ' 54' ' ' VAL . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.977 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.977 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.804 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.413 ' O ' ' CG2' ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.716 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.731 ' O ' ' HE2' ' A' ' 23' ' ' MET 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.869 ' O ' HG21 ' A' ' 100' ' ' ILE . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.869 HG21 ' O ' ' A' ' 96' ' ' ALA 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.718 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.702 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.779 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.987 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.981 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.714 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 1.439 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.432 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.847 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.669 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.847 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.669 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.927 ' OE1' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.815 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE2' ' HE3' ' A' ' 29' ' ' LYS . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.807 ' O ' HG21 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB3' ' CE ' ' A' ' 63' ' ' MET . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.807 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.939 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.939 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG22 ' OD2' ' A' ' 52' ' ' ASP . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.987 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.981 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.714 ' N ' ' HB2' ' A' ' 10' ' ' SER . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.883 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.883 ' HB1' ' O ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.653 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.468 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.938 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.858 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.797 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.797 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.679 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.664 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.688 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.927 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.564 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.533 HD21 ' CG ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.861 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.551 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.5 m80 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.684 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 8' ' ' LEU 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 44' ' ' ALA . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 16' ' ' THR . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.776 ' O ' ' HG3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.822 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.572 ' CG2' ' CD2' ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.768 HD13 ' O ' ' A' ' 84' ' ' TYR 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.745 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.971 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.745 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.971 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.594 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.642 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' CA ' ' CG2' ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB1' ' HA2' ' A' ' 48' ' ' GLY . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.901 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.768 HG21 ' O ' ' A' ' 52' ' ' ASP . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.896 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' CG ' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.642 ' HB ' ' OE1' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.411 ' O ' ' CG1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' MET . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.428 ' C ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.463 HD22 ' HD3' ' A' ' 74' ' ' LYS . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' HD22 ' A' ' 71' ' ' LEU . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.901 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.896 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.625 HD21 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.768 ' O ' HD13 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.822 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.631 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.625 ' OD2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.762 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.581 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.702 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 92' ' ' VAL . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.638 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 100' ' ' ILE . 9.0 ttpt . . . . . 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' CB ' ' A' ' 52' ' ' ASP 0.342 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 . . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 5' ' ' HIS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.782 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.819 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 14' ' ' MET . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.563 HG21 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.595 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.649 ' CD2' ' CD1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.503 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.762 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.57 ' N ' HD11 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.762 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 26' ' ' GLN . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 4' ' ' LYS 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.682 ' O ' HG13 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 35' ' ' ILE . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 1.048 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.048 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.741 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.838 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' N ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.018 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 60' ' ' ILE . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.708 ' O ' HG21 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 11' ' ' SER 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.864 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.805 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.864 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.595 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.921 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.495 ' CG1' HD23 ' A' ' 56' ' ' LEU . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.817 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.921 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.659 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.879 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.838 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.018 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.729 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA2' ' CG2' ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 88' ' ' ASP . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.741 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.426 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.934 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 122.22 1.01 . . . . 0.0 113.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.807 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.795 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.811 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' ' HB2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.634 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.811 ' HD2' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 1.014 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.797 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.0 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 1.0 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.556 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.807 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.815 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 1.01 ' O ' HG21 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.587 ' OE1' HG21 ' A' ' 42' ' ' THR 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 1.01 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.514 HD23 ' CD2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.881 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.881 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.971 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.934 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.441 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.733 ' O ' HD22 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.972 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.822 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.795 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.647 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.794 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.001 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 1.001 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.821 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HG2' ' ND2' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.665 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.971 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.568 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.972 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 1.055 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.888 HD11 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 1.055 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.524 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.888 ' OD2' HD11 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 1.014 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.693 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.611 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.633 ' O ' HG21 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.477 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.801 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.671 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.733 HG22 ' OH ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CB ' HG23 ' A' ' 87' ' ' VAL . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' O ' ' A' ' 88' ' ' ASP 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.749 ' N ' HG21 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.722 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.605 ' SD ' ' CG1' ' A' ' 92' ' ' VAL . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.661 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.884 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 5.1 pp0? -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.759 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.801 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.624 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.54 ' CG ' ' CG2' ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.796 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.54 ' CG2' ' CG ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.92 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.92 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.959 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.908 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.5 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.959 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.648 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG2' ' CA ' ' A' ' 48' ' ' GLY . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.849 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 60' ' ' ILE 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.499 ' CA ' HG21 ' A' ' 60' ' ' ILE . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 81' ' ' SER . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.912 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.518 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.697 ' NE2' ' HB ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 74' ' ' LYS 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.849 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.607 HG21 ' O ' ' A' ' 80' ' ' ASP . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.864 HD11 ' O ' ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.841 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 87' ' ' VAL . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.783 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.674 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.884 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.883 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.772 ' HE2' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 93' ' ' LEU . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? . . . . . 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.825 0.345 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.613 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 14.7 m170 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.833 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.591 ' O ' ' HD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.959 ' O ' HD21 ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.616 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.752 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.867 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.484 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.994 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.782 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.666 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.994 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.792 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.75 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.75 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' N ' HG21 ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.833 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 37' ' ' GLU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.876 ' O ' HG21 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.876 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.625 ' CB ' ' CE2' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.89 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.902 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 44' ' ' ALA . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.89 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 52' ' ' ASP . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.732 ' O ' HD22 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.817 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.685 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.81 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.571 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.498 ' CB ' ' HD3' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.771 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.835 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.593 ' O ' ' HB2' ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.838 ' OE1' HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.835 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.618 ' N ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' O ' HG11 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG12 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.685 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.827 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.752 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.831 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.893 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.799 HG22 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' N ' ' HE1' ' A' ' 23' ' ' MET . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tttm . . . . . 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.758 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm . . . . . 0 CA--C 1.551 1.009 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 8' ' ' LEU 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CD1' ' CB ' ' A' ' 39' ' ' PHE . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.672 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.831 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.529 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.723 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 20' ' ' VAL . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.831 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.899 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 1.042 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.734 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.854 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.854 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.764 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.813 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.775 ' O ' HG21 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.724 ' OE2' HD13 ' A' ' 60' ' ' ILE . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.775 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 39' ' ' PHE . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.82 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.512 ' CA ' HG23 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.82 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.2 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 99' ' ' ALA . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG23 ' CA ' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.003 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.838 ' N ' HG21 ' A' ' 60' ' ' ILE . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 57' ' ' GLY 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.533 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.751 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.732 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' OE2' ' HE3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.763 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.602 ' CD2' ' CA ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.003 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG1' ' HA2' ' A' ' 57' ' ' GLY . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 1.05 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.496 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 1.05 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.665 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.849 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' N ' ' SD ' ' A' ' 23' ' ' MET . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.467 ' HB2' HG23 ' A' ' 53' ' ' VAL . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm . . . . . 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.885 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 8' ' ' LEU 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 7' ' ' TYR . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.632 ' HB1' ' OE1' ' A' ' 59' ' ' GLN . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.872 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.772 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 1.003 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 1.003 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.759 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.779 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.636 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG22 ' CB ' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.499 ' O ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.885 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.622 ' CE2' ' CG ' ' A' ' 47' ' ' LYS . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.71 ' O ' HG21 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.945 ' OE1' HD12 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.71 HG21 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.831 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.963 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.892 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.854 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.948 ' OD1' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.948 HG13 ' OD1' ' A' ' 52' ' ' ASP 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.781 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.632 ' OE1' ' HB1' ' A' ' 12' ' ' ALA . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.945 HD12 ' OE1' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.796 ' OH ' HD13 ' A' ' 60' ' ' ILE . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.837 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.864 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.963 HD21 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.852 ' O ' HG21 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.892 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.781 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 1.105 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 58' ' ' PRO 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.806 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 1.105 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 15' ' ' SER . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.759 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.843 ' O ' HG22 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.783 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 88' ' ' ASP . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.915 ' O ' HG12 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.77 ' O ' HG21 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.915 HG12 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.689 HG21 ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.689 ' N ' HG21 ' A' ' 100' ' ' ILE . 11.4 tttt . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.629 ' HB3' ' OD2' ' A' ' 52' ' ' ASP 0.294 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 . . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.566 ' CD2' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.845 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.898 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.679 ' O ' HD11 ' A' ' 56' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.869 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 23' ' ' MET 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.64 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.926 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.789 ' N ' HD11 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.926 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.781 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.996 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 5' ' ' HIS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' N ' HG13 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.789 HD11 ' N ' ' A' ' 24' ' ' ARG . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.845 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.898 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.64 ' CE2' ' CG ' ' A' ' 47' ' ' LYS . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.712 ' O ' HG21 ' A' ' 42' ' ' THR 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.747 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.993 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.528 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.747 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.804 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG2' HG12 ' A' ' 100' ' ' ILE . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.823 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 2.8 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CD1' ' C ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.643 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.662 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.475 ' CG2' HG13 ' A' ' 76' ' ' VAL . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HG2' ' ND2' ' A' ' 73' ' ' ASN . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.507 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 2.3 p30 -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.804 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.572 ' CG2' ' CG1' ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.882 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.823 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.668 HG21 ' O ' ' A' ' 80' ' ' ASP 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.889 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.816 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.884 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' N ' HD11 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.889 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.884 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.442 ' C ' HD11 ' A' ' 93' ' ' LEU . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.662 HG21 ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.662 ' N ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.795 ' H ' ' N ' ' A' ' 34' ' ' VAL . 9.6 mttp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.553 ' CG ' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.924 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.778 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.468 ' HB2' HG22 ' A' ' 16' ' ' THR . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.462 ' CB ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.694 ' HB1' ' NE2' ' A' ' 59' ' ' GLN . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.772 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 1.062 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.922 ' O ' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HE2' ' A' ' 22' ' ' LYS 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 1.062 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.767 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.671 ' N ' HG12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.783 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 23' ' ' MET . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.75 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.75 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.795 ' N ' ' H ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 1.572 HG23 ' CG2' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.671 HG12 ' N ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.924 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.843 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 42' ' ' THR . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 1.062 ' OE1' HG21 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 1.062 HG21 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 ' CD1' ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.681 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.9 m120 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.835 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 52' ' ' ASP . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.896 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.894 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.506 ' N ' HG21 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.694 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 2.7 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG12 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' GLY . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.701 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.792 ' N ' HD11 ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.894 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.596 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.498 ' CB ' HG12 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 3.2 tmtt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 121.982 0.896 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 1' ' ' MET . 1.9 mt-10 82.68 3.17 1.11 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.243 -0.911 . . . . 0.0 109.729 174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.03 149.03 2.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 123.278 1.513 . . . . 0.0 112.203 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.855 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.84 -177.11 3.82 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.105 -176.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 52.8 m170 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.565 ' CG ' ' HB3' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.758 HD22 ' OG1' ' A' ' 16' ' ' THR . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.52 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.758 ' OG1' HD22 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.802 HD21 ' O ' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' N ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 17' ' ' SER . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' N ' HD11 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 1.004 ' OE1' HD11 ' A' ' 90' ' ' LEU 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 30' ' ' TYR . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.717 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.845 ' OE2' ' HG3' ' A' ' 63' ' ' MET . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.724 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.711 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.667 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.588 ' O ' HG21 ' A' ' 53' ' ' VAL . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 52' ' ' ASP . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 ' HA2' ' A' ' 48' ' ' GLY . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.709 ' N ' HD12 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' HG ' ' A' ' 11' ' ' SER . 5.4 mt-30 -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.845 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.531 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.956 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.956 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HG2' HG21 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 67' ' ' ILE . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 80' ' ' ASP . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.999 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.999 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.778 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.736 ' O ' HG22 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.922 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 1.004 HD11 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 1.012 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 88' ' ' ASP 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 1.012 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' LYS . 11.7 tptm -101.33 -28.26 12.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.3 2.72 14.86 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 125.108 1.505 . . . . 0.0 112.848 165.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.14 -68.11 0.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.476 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.83 155.39 27.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.995 1.718 . . . . 0.0 111.693 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 153.81 71.64 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.732 1.613 . . . . 0.0 110.24 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.266 1.964 0 C-N-CA 124.561 1.144 . . . . 0.0 108.468 167.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -139.42 118.33 12.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.85 1.26 . . . . 0.0 111.631 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 2.2 mmpt? -102.1 165.63 11.05 Favored 'General case' 0 C--N 1.382 2.0 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -166.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.746 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -150.13 161.98 41.33 Favored 'General case' 0 C--N 1.37 1.469 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.426 -168.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.583 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.871 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.711 HD22 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 44' ' ' ALA . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.965 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.91 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.91 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.675 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.884 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.645 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG22 ' CB ' ' A' ' 30' ' ' TYR . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' HG11 ' A' ' 32' ' ' VAL 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.508 HD11 ' NE2' ' A' ' 5' ' ' HIS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HG21 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.793 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.577 HG21 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 9' ' ' PHE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.804 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.746 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.971 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.8 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 HG13 ' CD1' ' A' ' 56' ' ' LEU . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.557 ' NE2' ' CG1' ' A' ' 76' ' ' VAL . 3.9 mm-40 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.971 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 1.032 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.592 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.824 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 1.032 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.87 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.447 ' O ' ' OE1' ' A' ' 26' ' ' GLN . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 88' ' ' ASP 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 30' ' ' TYR . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 93' ' ' LEU . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.751 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 102' ' ' LYS . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.798 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -97.59 -0.88 45.0 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 2.8 tttp -91.66 -9.75 42.81 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.552 0.741 . . . . 0.0 111.397 158.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -45.77 -35.02 4.02 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 125.082 1.489 . . . . 0.0 111.566 172.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.788 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -166.4 -165.26 0.75 Allowed 'General case' 0 C--N 1.368 1.406 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.804 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . 106.41 -62.76 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 126.743 2.017 . . . . 0.0 111.121 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.377 1.762 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.186 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 CA-C-O 122.049 0.928 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -140.96 -64.76 0.45 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.538 170.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER 168.44 141.02 0.02 OUTLIER 'General case' 0 C--N 1.364 1.227 0 CA-C-O 122.697 1.237 . . . . 0.0 111.877 -169.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -96.51 175.39 6.42 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.325 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 m80 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.826 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 44' ' ' ALA . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.477 ' HB2' ' CG2' ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.477 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.875 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' HG23 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.737 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 23' ' ' MET . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.49 ' O ' HG11 ' A' ' 32' ' ' VAL . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.778 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.826 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.573 ' HZ ' ' OE1' ' A' ' 37' ' ' GLU . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.88 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.88 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.823 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.823 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.712 ' N ' HD23 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.589 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 52' ' ' ASP . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 56' ' ' LEU . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.008 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.869 ' O ' HG21 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.911 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.869 HG21 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.49 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.464 ' N ' ' HD1' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.045 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.528 ' CG1' HD11 ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 1.045 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB3' ' HA2' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 49' ' ' GLN . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.813 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.656 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.008 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 58' ' ' PRO . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.911 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.84 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.544 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.84 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.838 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.576 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.872 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.436 ' HB ' ' SD ' ' A' ' 23' ' ' MET . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.513 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.872 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.916 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.56 ' O ' ' HB1' ' A' ' 103' ' ' ALA . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 10.7 tttm -54.28 -50.95 66.08 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.916 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -66.92 -23.1 65.94 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 99' ' ' ALA . . . -89.45 -11.59 42.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.125 1.77 . . . . 0.0 112.597 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 103' ' ' ALA . . . 176.12 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.365 1.466 . . . . 0.0 111.317 168.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 106' ' ' ASN . . . -98.28 143.87 28.31 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.45 174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.865 161.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 77.9 91.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.301 1.84 . . . . 0.0 112.495 171.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.88 143.66 20.72 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 163.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -109.44 174.49 5.84 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.809 170.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 32.6 m170 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.778 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 16' ' ' THR . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.907 ' O ' HG21 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.907 HG21 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.788 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.54 HG22 ' OG1' ' A' ' 16' ' ' THR . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.788 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.807 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD11 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.923 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.974 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.923 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.492 ' C ' ' CG1' ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.784 HG23 ' OE2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.545 HD11 ' N ' ' A' ' 24' ' ' ARG . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE2' HG23 ' A' ' 35' ' ' ILE . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.605 ' O ' ' HA ' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.456 HG21 ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 1.078 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA2' HD21 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG11 ' O ' ' A' ' 75' ' ' PRO . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.537 ' O ' HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.016 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.964 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.646 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.564 ' OE1' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.894 HD12 ' N ' ' A' ' 61' ' ' ALA 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.894 ' N ' HD12 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.643 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.443 ' CG1' HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.61 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG11 ' N ' ' A' ' 77' ' ' GLU . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.016 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.964 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.632 ' CD1' ' CE1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.865 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.865 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.701 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 84' ' ' TYR . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.454 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.974 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 83' ' ' LEU 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.538 ' N ' ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.456 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 101' ' ' LYS . 1.1 tmmt? -77.2 -55.86 5.06 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -48.6 -33.3 9.55 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.375 1.047 . . . . 0.0 111.108 173.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' A' ' 102' ' ' LYS . . . -41.51 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.205 1.802 . . . . 0.0 113.0 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' ASN . . . -92.85 131.43 37.89 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.839 2.056 . . . . 0.0 113.278 -166.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.23 -80.24 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.658 1.583 . . . . 0.0 110.623 160.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 104' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.631 1.573 . . . . 0.0 110.091 -166.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.912 0.863 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.718 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 2.2 mt-10 -107.7 -16.33 14.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.597 1.559 . . . . 0.0 111.345 -167.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 10.2 mttp 88.61 163.11 0.06 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.541 1.136 . . . . 0.0 113.627 -159.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt -154.61 153.53 31.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 126.459 2.35 . . . . 0.0 110.478 -165.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.848 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.966 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.818 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.818 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.462 HG23 HD22 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' HG12 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.888 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.81 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.972 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.81 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.972 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.592 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.848 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.823 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.966 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 1.02 ' O ' HG21 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 1.02 HG21 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.872 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.659 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.872 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.659 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.926 ' O ' HG21 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.926 HG21 ' O ' ' A' ' 52' ' ' ASP . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 60' ' ' ILE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 11' ' ' SER 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.783 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.5 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.964 ' O ' HD22 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.712 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.867 ' OE2' HD11 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.867 HD11 ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.66 ' O ' HG12 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 ' CG2' ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.651 HG21 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.893 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.893 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 19' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 1.008 ' O ' HG22 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.523 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 88' ' ' ASP . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.823 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.761 ' HD3' ' O ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -49.97 -45.46 51.5 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 -12.38 59.82 Favored 'General case' 0 C--O 1.259 1.563 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.132 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.65 57.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.987 1.715 . . . . 0.0 110.935 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.659 ' HB1' ' O ' ' A' ' 101' ' ' LYS . . . -50.28 175.66 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.265 170.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.27 -53.12 2.36 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 125.19 1.556 . . . . 0.0 111.08 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.378 1.824 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.454 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.19 -2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.712 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -93.64 85.85 5.0 Favored 'General case' 0 CA--C 1.573 1.85 0 CA-C-N 111.868 -2.424 . . . . 0.0 109.849 -166.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' HG3' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 178.5 110.15 0.03 OUTLIER 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 123.921 1.819 . . . . 0.0 111.765 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.637 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER -174.86 141.47 0.61 Allowed 'General case' 0 C--N 1.386 2.158 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -161.896 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 19' ' ' LEU . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.863 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.717 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.511 ' OG ' ' CD2' ' A' ' 84' ' ' TYR . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.648 ' HB3' ' O ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG11 ' N ' ' A' ' 21' ' ' SER . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.809 ' N ' HG11 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.964 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.913 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.852 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.913 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.831 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 3' ' ' LYS 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 35' ' ' ILE 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.651 ' N ' HG13 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.869 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' HG23 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.749 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.91 ' O ' HG21 ' A' ' 42' ' ' THR . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE2' ' SD ' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.91 HG21 ' O ' ' A' ' 40' ' ' PRO 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.734 HD11 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 51' ' ' ALA . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.637 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' CB ' ' A' ' 51' ' ' ALA . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.821 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.697 ' O ' HG13 ' A' ' 67' ' ' ILE . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.876 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.985 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.952 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.876 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.985 ' HB2' ' O ' ' A' ' 67' ' ' ILE 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.741 ' O ' HG21 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.438 HG12 HG23 ' A' ' 67' ' ' ILE . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.821 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 56' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.997 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.833 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.402 ' HA ' HD21 ' A' ' 83' ' ' LEU . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.997 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.833 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.964 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 22' ' ' LYS . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.852 ' HB3' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.693 ' N ' HD22 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.545 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.526 ' N ' ' SD ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' OE2' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? -59.09 -66.53 0.49 Allowed 'General case' 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -27.51 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.773 . . . . 0.0 112.324 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -49.91 -49.28 50.35 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.234 1.013 . . . . 0.0 112.403 -174.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.837 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -41.87 144.2 0.45 Allowed 'General case' 0 C--N 1.352 0.712 0 CA-C-O 123.584 1.659 . . . . 0.0 112.738 -161.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . 118.31 152.53 0.0 OUTLIER 'General case' 0 C--N 1.381 1.968 0 C-N-CA 124.897 1.279 . . . . 0.0 113.418 161.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 125.07 1.348 . . . . 0.0 110.089 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 122.144 0.973 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 25.74 -107.56 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.043 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 2.4 ptpt -174.81 138.1 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.953 1.301 . . . . 0.0 111.051 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp -130.89 -177.24 4.28 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.514 1.133 . . . . 0.0 112.612 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.946 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CE2' ' CB ' ' A' ' 5' ' ' HIS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.522 ' CD2' ' HG ' ' A' ' 19' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.824 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.668 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' N ' ' HH ' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.664 ' O ' HD21 ' A' ' 19' ' ' LEU . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.769 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.917 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.804 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.799 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.629 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.799 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CB ' HG22 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.946 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' CB ' HG23 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.824 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 39' ' ' PHE . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' HB1' ' A' ' 44' ' ' ALA 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 47' ' ' LYS 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.839 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.839 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.554 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.719 ' O ' HG21 ' A' ' 54' ' ' VAL . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.719 HG21 ' O ' ' A' ' 53' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.859 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.655 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.668 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.709 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.709 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 67' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.762 ' HB ' ' OE1' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.762 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.508 ' CG1' HG13 ' A' ' 54' ' ' VAL . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.977 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.977 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.804 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.413 ' O ' ' CG2' ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.629 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.716 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.731 ' O ' ' HE2' ' A' ' 23' ' ' MET 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.495 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.869 ' O ' HG21 ' A' ' 100' ' ' ILE . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.869 HG21 ' O ' ' A' ' 96' ' ' ALA 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.718 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -102.19 -22.47 14.18 Favored 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 3.56 29.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 160.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . . . -83.47 -44.12 15.08 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.611 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . 66.86 -161.25 0.24 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.864 1.666 . . . . 0.0 111.076 -165.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 179.23 -54.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.302 1.441 . . . . 0.0 110.744 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 6.2 t-20 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 125.555 1.542 . . . . 0.0 109.953 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.801 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 1.2 tp10 61.58 52.02 3.8 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.224 2.21 . . . . 0.0 111.569 160.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.481 ' O ' HD11 ' A' ' 35' ' ' ILE . 12.5 mmmt -96.77 159.7 14.78 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.774 ' O ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -42.59 136.69 2.4 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.906 1.682 . . . . 0.0 114.905 -163.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.702 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.779 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.987 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.981 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.714 ' HB2' ' N ' ' A' ' 57' ' ' GLY . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 1.439 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.432 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.847 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.669 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.593 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.847 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.664 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.669 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.927 ' OE1' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.815 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE2' ' HE3' ' A' ' 29' ' ' LYS . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.445 ' CA ' ' HB3' ' A' ' 3' ' ' LYS . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.481 HD11 ' O ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.807 ' O ' HG21 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB3' ' CE ' ' A' ' 63' ' ' MET . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.807 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.939 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.939 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG22 ' OD2' ' A' ' 52' ' ' ASP . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.987 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.981 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.714 ' N ' ' HB2' ' A' ' 10' ' ' SER . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.883 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.883 ' HB1' ' O ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.653 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.938 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.858 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.797 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.797 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.679 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.664 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.688 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.927 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.564 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.533 HD21 ' CG ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.861 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.773 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.661 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 0.3 OUTLIER -41.93 -41.53 2.5 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -48.69 78.41 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.773 0.829 . . . . 0.0 111.45 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -37.23 -39.8 0.29 Allowed 'General case' 0 C--N 1.357 0.927 0 C-N-CA 125.66 1.584 . . . . 0.0 111.386 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 101' ' ' LYS . . . -39.55 150.24 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.172 0.989 . . . . 0.0 111.659 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 163.05 -59.21 0.0 OUTLIER 'General case' 0 C--O 1.247 0.947 0 C-N-CA 125.299 1.44 . . . . 0.0 110.792 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.269 2.131 0 C-N-CA 124.518 1.127 . . . . 0.0 110.262 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.512 2.646 0 CA-C-O 123.138 1.447 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 1.9 mt-10 162.18 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.408 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 13.0 mmtm 96.7 123.15 0.02 OUTLIER 'General case' 0 C--O 1.254 1.316 0 C-N-CA 124.232 1.013 . . . . 0.0 113.029 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -85.21 165.91 16.99 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.729 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.551 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.5 m80 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.684 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 8' ' ' LEU 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 44' ' ' ALA . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 16' ' ' THR . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.776 ' O ' ' HG3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.822 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.572 ' CG2' ' CD2' ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.768 HD13 ' O ' ' A' ' 84' ' ' TYR 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.745 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.971 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.745 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.971 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.594 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.642 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' CA ' ' CG2' ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.762 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB1' ' HA2' ' A' ' 48' ' ' GLY . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.901 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.768 HG21 ' O ' ' A' ' 52' ' ' ASP . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.896 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.523 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' CG ' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.642 ' HB ' ' OE1' ' A' ' 41' ' ' GLU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.411 ' O ' ' CG1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 63' ' ' MET . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.428 ' C ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.463 HD22 ' HD3' ' A' ' 74' ' ' LYS . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' HD22 ' A' ' 71' ' ' LEU . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.901 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.896 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.625 HD21 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.768 ' O ' HD13 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.822 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.631 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.625 ' OD2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.762 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.581 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.702 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 92' ' ' VAL . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.638 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.896 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 100' ' ' ILE . 9.0 ttpt -39.0 -53.31 1.77 Allowed 'General case' 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.896 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -58.5 -25.4 62.33 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.222 -169.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.34 -20.51 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.603 1.561 . . . . 0.0 110.302 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.28 87.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.41 1.484 . . . . 0.0 110.988 168.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.42 107.54 5.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.884 1.674 . . . . 0.0 112.159 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 126.638 1.975 . . . . 0.0 111.011 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtm . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 122.072 0.939 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 1.4 tt0 75.91 46.37 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.562 1.145 . . . . 0.0 110.494 -171.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' CB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER 60.77 117.07 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.37 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' CB ' ' A' ' 52' ' ' ASP 0.342 0.0 OUTLIER -165.07 132.8 3.12 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 -164.527 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 5' ' ' HIS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 55' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.782 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.819 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 14' ' ' MET . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.563 HG21 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.595 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.649 ' CD2' ' CD1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.503 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 19' ' ' LEU . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.762 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.57 ' N ' HD11 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.762 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 26' ' ' GLN . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 4' ' ' LYS 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.682 ' O ' HG13 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 35' ' ' ILE . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.782 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 1.048 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.048 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.741 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.838 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' N ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.018 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 60' ' ' ILE . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.708 ' O ' HG21 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 11' ' ' SER 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.864 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.805 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.864 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.595 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.805 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.921 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.495 ' CG1' HD23 ' A' ' 56' ' ' LEU . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.817 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.921 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.659 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.879 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.838 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.018 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.729 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.482 ' HA2' ' CG2' ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 88' ' ' ASP . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.741 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.426 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.717 ' HZ2' ' N ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -67.02 -21.36 65.94 Favored 'General case' 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.717 ' N ' ' HZ2' ' A' ' 101' ' ' LYS . 4.5 tttt -69.24 -31.94 70.82 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.021 167.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.07 -2.86 39.35 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 126.704 2.001 . . . . 0.0 111.455 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -25.62 -92.49 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.644 1.577 . . . . 0.0 111.47 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.13 -177.95 0.95 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 113.235 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 C--N 1.375 1.706 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 -175.259 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 11.0 ptm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 121.213 0.53 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 1' ' ' MET . 4.5 mt-10 -141.6 66.39 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.077 0.951 . . . . 0.0 110.689 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 66.32 116.76 0.03 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.207 1.003 . . . . 0.0 113.591 162.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.934 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm -92.16 174.95 7.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 113.441 168.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.807 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.655 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.795 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.811 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.859 ' O ' ' HB2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.634 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.811 ' HD2' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 1.014 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.797 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.0 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.693 ' OE1' ' HB2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 1.0 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.556 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.807 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.815 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 1.01 ' O ' HG21 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.587 ' OE1' HG21 ' A' ' 42' ' ' THR 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 1.01 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.514 HD23 ' CD2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.881 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.881 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.971 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.934 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.733 ' O ' HD22 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.972 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.822 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.795 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.647 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.794 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.001 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 1.001 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.821 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HG2' ' ND2' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.665 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.971 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.568 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.972 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 1.055 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.888 HD11 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 1.055 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.524 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.888 ' OD2' HD11 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 1.014 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.693 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.611 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.633 ' O ' HG21 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.477 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -44.08 12.13 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.61 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.49 -17.3 53.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.88 1.53 48.24 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.901 2.08 . . . . 0.0 114.513 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 93.0 127.94 0.02 OUTLIER 'General case' 0 C--O 1.253 1.251 0 C-N-CA 126.149 1.78 . . . . 0.0 112.004 168.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' O ' ' ND2' ' A' ' 106' ' ' ASN . . . 177.33 155.95 0.31 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.14 1.776 . . . . 0.0 111.874 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.377 2.271 . . . . 0.0 110.476 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.978 0.418 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -150.9 51.34 0.86 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 125.379 1.471 . . . . 0.0 113.252 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.805 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 93.12 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.434 1.112 . . . . 0.0 112.138 160.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.801 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm -130.48 174.79 9.54 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.036 1.335 . . . . 0.0 111.785 172.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.691 ' O ' HD23 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.671 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.733 HG22 ' OH ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' CB ' HG23 ' A' ' 87' ' ' VAL . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' O ' ' A' ' 88' ' ' ASP 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.749 ' N ' HG21 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.722 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.605 ' SD ' ' CG1' ' A' ' 92' ' ' VAL . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.661 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.884 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 5.1 pp0? -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' CG ' ' CE1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.759 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.805 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.801 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.624 ' HD1' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.54 ' CG ' ' CG2' ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.796 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.54 ' CG2' ' CG ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.92 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.92 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.959 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.908 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.5 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.959 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.648 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG2' ' CA ' ' A' ' 48' ' ' GLY . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.849 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 60' ' ' ILE 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.499 ' CA ' HG21 ' A' ' 60' ' ' ILE . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 81' ' ' SER . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.912 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.518 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.697 ' NE2' ' HB ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 74' ' ' LYS 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.849 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.607 HG21 ' O ' ' A' ' 80' ' ' ASP . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.529 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.864 ' O ' HD11 ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.841 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 87' ' ' VAL . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.783 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.674 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.884 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.883 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.772 ' HE2' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 93' ' ' LEU . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.844 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.619 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 2.7 ttpm? -23.85 -86.85 0.0 OUTLIER 'General case' 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -21.63 65.99 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.794 -1.191 . . . . 0.0 114.079 -172.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.844 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -49.87 -34.27 19.6 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 124.299 1.04 . . . . 0.0 111.325 161.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 101' ' ' LYS . . . -60.7 81.71 0.01 OUTLIER 'General case' 0 C--N 1.352 0.68 0 C-N-CA 126.26 1.824 . . . . 0.0 112.546 171.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 65.38 -174.75 0.18 Allowed 'General case' 0 C--O 1.249 1.042 0 C-N-CA 125.124 1.37 . . . . 0.0 111.902 164.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 127.074 2.15 . . . . 0.0 110.518 175.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 123.197 1.475 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' PRO . 21.2 mt-10 81.79 12.64 0.64 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.306 1.442 . . . . 0.0 112.621 -173.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -102.07 135.03 44.35 Favored 'General case' 0 C--N 1.368 1.392 0 CA-C-O 122.797 1.284 . . . . 0.0 112.685 -175.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm -127.49 165.56 19.63 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.174 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.613 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 14.7 m170 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.833 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' O ' ' HD1' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.959 ' O ' HD21 ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.616 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.752 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.691 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.867 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.994 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.782 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.666 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.994 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.792 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.75 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.75 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.488 ' HB2' ' O ' ' A' ' 2' ' ' GLU 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' N ' HG21 ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.833 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 37' ' ' GLU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.876 ' O ' HG21 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.876 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.625 ' CB ' ' CE2' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.89 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.902 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 44' ' ' ALA . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.89 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 52' ' ' ASP . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.732 ' O ' HD22 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.817 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.685 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.81 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.571 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' CB ' ' HD3' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.771 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.835 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.593 ' O ' ' HB2' ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.838 ' OE1' HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.835 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.618 ' N ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' O ' HG11 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG12 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.685 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.827 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.752 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.831 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.893 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.799 HG22 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' N ' ' HE1' ' A' ' 23' ' ' MET . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' O ' ' HB1' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.705 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tttm -63.36 -20.99 66.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' CG ' ' O ' ' A' ' 102' ' ' LYS . 4.7 tttp -91.67 -6.04 52.76 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -62.93 -34.39 77.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 111.245 166.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 103' ' ' ALA . . . 104.21 74.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.926 1.69 . . . . 0.0 112.248 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.17 -157.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.648 1.179 . . . . 0.0 111.098 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 124.373 1.069 . . . . 0.0 110.557 167.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 1.5 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.649 0.261 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 73.8 136.81 0.05 Allowed 'General case' 0 C--O 1.253 1.286 0 C-N-CA 124.642 1.177 . . . . 0.0 110.869 161.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -123.65 111.23 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.758 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm -123.9 149.99 45.2 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 -159.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.764 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 8' ' ' LEU 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.587 ' CD1' ' CB ' ' A' ' 39' ' ' PHE . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.672 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' N ' ' HG ' ' A' ' 10' ' ' SER . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.831 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.529 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.723 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 20' ' ' VAL . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.831 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.899 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 1.042 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.734 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.854 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.854 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.758 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.764 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.813 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.59 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.775 ' O ' HG21 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.724 ' OE2' HD13 ' A' ' 60' ' ' ILE . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.775 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 39' ' ' PHE . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.82 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.512 ' CA ' HG23 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.82 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.2 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 99' ' ' ALA . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG23 ' CA ' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.003 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.838 ' N ' HG21 ' A' ' 60' ' ' ILE . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 57' ' ' GLY 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.533 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.751 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.732 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' OE2' ' HE3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.763 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.602 ' CD2' ' CA ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.003 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG1' ' HA2' ' A' ' 57' ' ' GLY . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 1.05 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.496 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 1.05 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.665 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.849 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.572 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.481 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' N ' ' SD ' ' A' ' 23' ' ' MET . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.467 ' HB2' HG23 ' A' ' 53' ' ' VAL . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.774 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -56.62 -44.83 81.57 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -57.73 -30.73 65.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.035 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -59.43 -75.27 0.06 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.597 1.559 . . . . 0.0 112.353 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -130.09 -75.89 0.54 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.651 1.58 . . . . 0.0 111.632 -169.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 104' ' ' ALA . . . 99.84 149.27 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.981 1.712 . . . . 0.0 110.792 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.174 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 122.816 1.293 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.95 -161.52 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.218 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.799 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 53.81 111.56 0.01 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.329 1.052 . . . . 0.0 113.108 -154.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm -114.27 160.15 19.37 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -161.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.885 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 8' ' ' LEU 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 7' ' ' TYR . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.58 ' N ' HG23 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.632 ' HB1' ' OE1' ' A' ' 59' ' ' GLN . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.872 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.772 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 1.003 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 1.003 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.759 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.779 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.636 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG22 ' CB ' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.799 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.885 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.814 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.622 ' CE2' ' CG ' ' A' ' 47' ' ' LYS . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.71 ' O ' HG21 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.945 ' OE1' HD12 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.71 HG21 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.831 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.963 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.831 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.892 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.854 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.948 ' OD1' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.948 HG13 ' OD1' ' A' ' 52' ' ' ASP 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.892 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.781 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.632 ' OE1' ' HB1' ' A' ' 12' ' ' ALA . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.945 HD12 ' OE1' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.796 ' OH ' HD13 ' A' ' 60' ' ' ILE . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.837 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.864 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.963 HD21 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.852 ' O ' HG21 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.892 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.781 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 1.105 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 58' ' ' PRO 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.806 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.573 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 1.105 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 15' ' ' SER . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.759 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.843 ' O ' HG22 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.653 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.783 ' O ' ' HB1' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 88' ' ' ASP . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.915 ' O ' HG12 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.77 ' O ' HG21 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.915 HG12 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.764 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.689 ' N ' HG21 ' A' ' 100' ' ' ILE . 11.4 tttt -81.68 -14.3 56.78 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.59 ' HD3' ' O ' ' A' ' 102' ' ' LYS . 13.0 tmtt? -89.72 8.42 31.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 125.101 1.501 . . . . 0.0 112.036 167.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -96.73 -45.21 6.77 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.938 1.295 . . . . 0.0 111.412 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.736 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -142.41 102.44 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.955 2.102 . . . . 0.0 113.143 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . 158.64 -169.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.291 1.436 . . . . 0.0 112.12 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 C-N-CA 125.459 1.504 . . . . 0.0 110.105 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.478 1.132 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.807 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 7.4 mm-40 -57.9 139.92 53.17 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.492 1.117 . . . . 0.0 110.551 159.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 12.2 mttt 108.11 128.84 0.0 OUTLIER 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.933 1.293 . . . . 0.0 114.463 -164.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.789 ' HB2' ' O ' ' A' ' 3' ' ' LYS 0.294 0.0 OUTLIER 163.81 157.38 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 173.33 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.566 ' CD2' HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.845 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.898 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.679 ' O ' HD11 ' A' ' 56' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.869 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.905 ' O ' ' HB2' ' A' ' 23' ' ' MET 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.64 ' O ' ' HD2' ' A' ' 24' ' ' ARG . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 87' ' ' VAL . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.926 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.789 ' N ' HD11 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.926 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.781 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.996 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.871 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.608 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' N ' HG13 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.789 HD11 ' N ' ' A' ' 24' ' ' ARG . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.845 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.898 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.64 ' CE2' ' CG ' ' A' ' 47' ' ' LYS . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.712 ' O ' HG21 ' A' ' 42' ' ' THR 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.993 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.747 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.993 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.528 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.747 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.804 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG2' HG12 ' A' ' 100' ' ' ILE . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.823 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 2.8 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CD1' ' C ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.643 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.475 ' CG2' HG13 ' A' ' 76' ' ' VAL . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.507 ' HG2' ' ND2' ' A' ' 73' ' ' ASN . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.507 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 2.3 p30 -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.804 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.572 ' CG2' ' CG1' ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.882 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.823 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.668 HG21 ' O ' ' A' ' 80' ' ' ASP 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.889 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.816 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.884 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' N ' HD11 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.889 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.884 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.442 ' C ' HD11 ' A' ' 93' ' ' LEU . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.487 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.918 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.662 ' N ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.71 -45.37 78.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -67.73 -4.1 11.26 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.921 178.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.918 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -54.22 -39.38 66.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.019 1.727 . . . . 0.0 112.112 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 103' ' ' ALA . . . 157.94 150.34 0.01 OUTLIER 'General case' 0 C--N 1.374 1.633 0 C-N-CA 125.401 1.48 . . . . 0.0 112.458 167.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 -168.45 1.65 Allowed 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 125.69 1.596 . . . . 0.0 110.296 171.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.262 1.741 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.861 168.211 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.812 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 3.2 tpt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.589 0.233 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 5.0 mm-40 -55.75 -74.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.385 1.474 . . . . 0.0 108.917 -166.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.812 ' HG2' ' O ' ' A' ' 1' ' ' MET . 14.5 mmmt 85.62 122.06 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.197 0 O-C-N 125.812 1.945 . . . . 0.0 111.465 170.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.795 ' H ' ' N ' ' A' ' 34' ' ' VAL . 9.6 mttp -150.86 137.75 19.06 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 -174.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.553 ' CG ' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.924 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.778 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.468 ' HB2' HG22 ' A' ' 16' ' ' THR . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.462 ' CB ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.694 ' HB1' ' NE2' ' A' ' 59' ' ' GLN . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.772 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 1.062 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.922 ' O ' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HE2' ' A' ' 22' ' ' LYS 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 1.062 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.767 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.671 ' N ' HG12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB1' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.783 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 23' ' ' MET . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.963 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.75 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.75 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 27' ' ' ALA . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.795 ' N ' ' H ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 1.572 HG23 ' CG2' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.671 HG12 ' N ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.924 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.843 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 42' ' ' THR . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.062 ' OE1' HG21 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 1.062 HG21 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' CD1' ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.681 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.9 m120 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.578 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.835 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 52' ' ' ASP . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.896 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.894 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.506 ' N ' HG21 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.694 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 2.7 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG12 ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' GLY . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.701 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.792 ' N ' HD11 ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.775 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.894 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.596 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CB ' ' HE1' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.498 ' CB ' HG12 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.55 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.73 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 3.2 tmtt? -68.2 -4.02 12.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 19.1 ttpt -86.63 -31.46 21.11 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.481 1.113 . . . . 0.0 112.693 168.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 100' ' ' ILE . . . -47.84 -49.45 29.27 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.744 1.618 . . . . 0.0 112.158 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . 155.27 162.4 0.01 OUTLIER 'General case' 0 C--N 1.367 1.368 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.455 -175.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . 82.49 90.74 0.04 OUTLIER 'General case' 0 C--N 1.37 1.483 0 C-N-CA 125.162 1.385 . . . . 0.0 112.29 165.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 126.224 1.809 . . . . 0.0 110.49 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.886 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.595 0 CA-C-O 120.977 0.418 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 2.1 m-70 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.742 ' CD2' ' HB2' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.016 HD13 HG12 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.832 ' O ' HD13 ' A' ' 60' ' ' ILE . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.827 ' OG1' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.044 HD11 HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.016 HG12 HD13 ' A' ' 8' ' ' LEU . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.888 ' SD ' HG12 ' A' ' 92' ' ' VAL . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.601 ' N ' HD13 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLY 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.728 HG12 HG12 ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.826 HG23 HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' HG2' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.895 ' OE1' HD12 ' A' ' 60' ' ' ILE . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 39' ' ' PHE 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' LYS . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 75' ' ' PRO . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 76' ' ' VAL . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.958 HD13 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.958 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.669 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 ' OE1' ' A' ' 41' ' ' GLU . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.844 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.933 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.546 HD21 ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.933 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.619 ' HG2' HG22 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 54' ' ' VAL . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.99 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.99 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.779 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 1.041 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.759 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD12 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.044 HG11 HD11 ' A' ' 19' ' ' LEU 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 11.7 tptm . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.69 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 34' ' ' VAL . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.862 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.916 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.861 ' OG ' HG22 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.96 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' CB ' HG21 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG21 ' A' ' 92' ' ' VAL 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.759 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.914 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.907 ' CE2' HD21 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 34' ' ' VAL . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 32' ' ' VAL . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 23' ' ' MET . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.862 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.848 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 67' ' ' ILE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.676 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.786 ' CG1' HD21 ' A' ' 56' ' ' LEU . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 11' ' ' SER . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.861 HG22 ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' ALA . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' OE1' ' CG1' ' A' ' 76' ' ' VAL . 4.1 mm100 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 66' ' ' GLU 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.828 HG21 HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.03 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.833 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.03 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.904 ' OD2' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 23' ' ' MET . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.978 HG21 HD13 ' A' ' 19' ' ' LEU 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 26' ' ' GLN . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm . . . . . 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 122.302 1.048 . . . . 0.0 112.325 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 9.6 m-70 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.812 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.866 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' HG21 ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.864 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.731 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 30' ' ' TYR . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.915 HG22 HG13 ' A' ' 20' ' ' VAL . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.842 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.913 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.913 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' HD22 ' A' ' 70' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' H ' HD21 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.577 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 75' ' ' PRO . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 ' HE2' ' A' ' 9' ' ' PHE . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.002 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.784 ' CD1' HG21 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.947 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.901 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG3' HG12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.974 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.784 HG21 ' CD1' ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.974 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.497 HD22 ' HA3' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HA3' ' A' ' 48' ' ' GLY . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.002 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 79' ' ' ILE . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.901 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 82' ' ' LEU 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.881 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.864 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.617 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.869 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.661 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 100' ' ' ILE . 10.7 tttm . . . . . 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 5.5 m-70 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.723 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.874 ' O ' HG22 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.772 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.725 HG22 HD13 ' A' ' 8' ' ' LEU . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.975 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.774 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.975 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.934 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.917 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 93' ' ' LEU . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.693 ' O ' HG12 ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.628 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.756 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.709 ' HB2' ' CD1' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.717 ' HA2' HD22 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.411 ' O ' ' HD2' ' A' ' 5' ' ' HIS . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 100' ' ' ILE . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.896 HG12 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.969 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.956 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' CE2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.956 HG23 ' O ' ' A' ' 57' ' ' GLY 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.938 ' N ' HD13 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.614 ' CG1' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD22 ' HA2' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.72 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.896 HG13 HG12 ' A' ' 54' ' ' VAL . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.969 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.805 HD13 ' CD1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.718 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.934 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.934 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' CE ' ' A' ' 23' ' ' MET 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD13 ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? . . . . . 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 122.559 1.171 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.825 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.074 HD22 ' CG2' ' A' ' 20' ' ' VAL 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.865 ' HB2' HD12 ' A' ' 56' ' ' LEU . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.692 ' O ' HG21 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.703 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.826 HG22 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.926 ' HG ' HG11 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.074 ' CG2' HD22 ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.927 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.959 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.524 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.959 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.575 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.581 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.832 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.967 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 56' ' ' LEU . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.903 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 75' ' ' PRO . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.001 ' CG1' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.79 HD22 HG12 ' A' ' 79' ' ' ILE . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 9' ' ' PHE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 79' ' ' ILE 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.771 ' HB2' ' O ' ' A' ' 11' ' ' SER . 9.9 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.852 ' O ' HD23 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.675 ' O ' HG12 ' A' ' 67' ' ' ILE . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.731 ' OE2' HD13 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.841 ' CG2' HG11 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.473 ' OE1' HG22 ' A' ' 67' ' ' ILE . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.844 HD23 ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.626 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.82 ' O ' HG13 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.001 HG22 ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.814 HG22 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.93 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.926 HG11 ' HG ' ' A' ' 18' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 19' ' ' LEU . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.746 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.73 ' CD2' HG11 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.961 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.969 HD12 HG23 ' A' ' 20' ' ' VAL . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.501 ' O ' HD23 ' A' ' 19' ' ' LEU . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.677 HG22 ' HB1' ' A' ' 38' ' ' ALA . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.889 ' CD1' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD12 ' A' ' 8' ' ' LEU . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.947 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.891 ' CE ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.817 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.912 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.845 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.651 ' HB2' HG23 ' A' ' 32' ' ' VAL . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.753 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 31' ' ' GLU 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 5' ' ' HIS 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.655 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.961 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.677 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.868 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 39' ' ' PHE . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.594 ' CD ' ' HG3' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.936 ' OG1' HD13 ' A' ' 43' ' ' LEU 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.609 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.733 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 67' ' ' ILE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.842 HD13 HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.672 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.852 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.911 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.021 HD23 HD13 ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD13 HD23 ' A' ' 70' ' ' LEU 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' LYS 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.566 ' O ' HG22 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' VAL . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.878 ' OE1' ' HB2' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.81 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.013 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.013 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.947 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 23' ' ' MET . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.858 ' N ' HD23 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.891 HG12 ' CE ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.691 HD13 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.878 ' HB2' ' OE1' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? . . . . . 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.995 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 47' ' ' LYS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.829 ' CD1' HD23 ' A' ' 55' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.917 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.955 ' HA ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.654 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB3' ' CE2' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.026 HG22 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.852 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.033 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' CG2' ' A' ' 36' ' ' ILE . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.852 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.876 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.823 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CB ' HG23 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 32' ' ' VAL . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.995 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.026 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.917 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG2' ' SD ' ' A' ' 63' ' ' MET 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 39' ' ' PHE 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.873 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.704 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.867 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 76' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.734 HD23 HD11 ' A' ' 67' ' ' ILE . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 60' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.699 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.072 HG21 HG11 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 67' ' ' ILE . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.981 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.981 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 87' ' ' VAL 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.935 ' O ' HG23 ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.033 HG11 HD11 ' A' ' 19' ' ' LEU 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 94' ' ' LYS . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.867 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 100' ' ' ILE . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 53' ' ' VAL . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.86 HG22 HG21 ' A' ' 53' ' ' VAL 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.939 HG22 HG23 ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.107 HD12 HG22 ' A' ' 20' ' ' VAL . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.982 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.85 ' HA ' HG21 ' A' ' 60' ' ' ILE . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.572 ' CB ' ' OH ' ' A' ' 84' ' ' TYR . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.879 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.107 HG22 HD12 ' A' ' 8' ' ' LEU . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.879 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.871 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.848 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.848 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' C ' HG12 ' A' ' 34' ' ' VAL . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.939 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.713 ' O ' HG23 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.958 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 1.2 m-20 -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 75' ' ' PRO . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.993 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.99 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.909 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.88 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.662 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.738 ' CE ' HD11 ' A' ' 60' ' ' ILE . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.782 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 62' ' ' TYR 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.871 HG21 HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 76' ' ' VAL . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' HG13 ' A' ' 53' ' ' VAL 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.871 HG21 HG21 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.993 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.99 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.909 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.828 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.828 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.557 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.787 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.679 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.679 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.575 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 mttp . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 10.8 m-70 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.951 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.775 ' HB2' HD22 ' A' ' 56' ' ' LEU . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.886 ' O ' ' HG3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.989 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.852 HG22 HD21 ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.989 HD12 ' O ' ' A' ' 15' ' ' SER 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.92 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.999 ' HE3' HG21 ' A' ' 36' ' ' ILE . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.727 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 22' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.973 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' HD11 ' A' ' 93' ' ' LEU . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.618 ' HB2' HG23 ' A' ' 32' ' ' VAL . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' TYR . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.636 HG11 HG13 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.999 HG21 ' HE3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.951 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.643 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.995 ' O ' HG22 ' A' ' 42' ' ' THR . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.637 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.641 ' CA ' HG22 ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.866 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 75' ' ' PRO . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.641 HG22 ' CA ' ' A' ' 48' ' ' GLY . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.955 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.661 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.482 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.479 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 49' ' ' GLN . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.866 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.955 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD12 HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD22 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.736 ' HA ' HD11 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.799 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.532 ' C ' HG22 ' A' ' 87' ' ' VAL . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 18' ' ' LEU . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.648 ' OD2' HD22 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.959 HG11 HD22 ' A' ' 19' ' ' LEU . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.913 HD22 ' HG3' ' A' ' 26' ' ' GLN . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.94 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.692 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 100' ' ' ILE . 9.0 ttpt . . . . . 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 34' ' ' VAL 0.342 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 . . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 2.7 m-70 -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.807 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' HB3' ' A' ' 47' ' ' LYS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.727 HD11 HD11 ' A' ' 19' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.847 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.643 ' OG ' ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.884 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.884 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.928 ' O ' HG22 ' A' ' 87' ' ' VAL . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.893 HG23 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.759 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.51 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.815 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' N ' HD13 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.624 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.789 HG12 ' N ' ' A' ' 35' ' ' ILE 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.789 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 35' ' ' ILE . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' N ' HG21 ' A' ' 20' ' ' VAL . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.847 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.892 ' O ' HG23 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 1.036 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.775 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.775 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.83 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.964 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.619 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 12' ' ' ALA 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.819 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.803 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.819 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.94 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.489 HG21 HG11 ' A' ' 76' ' ' VAL . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.94 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.876 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.83 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.968 HG13 HG12 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.964 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.619 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.893 ' OH ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.656 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 19' ' ' LEU . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.821 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.93 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 122.22 1.01 . . . . 0.0 113.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.604 ' CA ' HG23 ' A' ' 34' ' ' VAL . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.903 HG22 HG23 ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.967 HD12 HD12 ' A' ' 55' ' ' LEU 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.844 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.56 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.72 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.056 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.979 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.997 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.01 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.904 ' HG3' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' MET . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.815 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 1.01 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.979 HG22 ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.987 ' O ' HG23 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.712 ' HB2' HD21 ' A' ' 56' ' ' LEU 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HD2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.909 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.909 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.967 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.941 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.976 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.85 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.844 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG1' HD22 ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.99 ' CB ' HG21 ' A' ' 78' ' ' VAL . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 60' ' ' ILE . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.064 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.064 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.882 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.519 ' HG2' ' OD1' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.967 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HB2' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG22 HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.99 HG21 ' CB ' ' A' ' 61' ' ' ALA . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.75 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.034 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.034 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.896 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.997 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.685 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.056 HG11 HD11 ' A' ' 19' ' ' LEU . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.904 HD12 ' HG3' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 92' ' ' VAL . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.867 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 79' ' ' ILE 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.787 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.659 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.98 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.998 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.98 HD12 ' HA ' ' A' ' 16' ' ' THR 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.998 HG22 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.59 ' H ' HG22 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.771 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.844 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.961 ' NE2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.572 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.695 ' CD1' ' HG2' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.792 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG11 HD21 ' A' ' 93' ' ' LEU . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.867 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 23' ' ' MET . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.682 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' HG23 ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.873 HG23 ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 71' ' ' LEU . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.943 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.923 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 21.4 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.684 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' HE2' ' A' ' 9' ' ' PHE . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' VAL 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.713 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.744 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.619 ' O ' HG12 ' A' ' 67' ' ' ILE . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' LEU . 1.9 mt-30 -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HG2' ' HB ' ' A' ' 53' ' ' VAL 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 54' ' ' VAL . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.92 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 8' ' ' LEU . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.98 ' O ' HD12 ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.758 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.961 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.789 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 ttpm? . . . . . 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.825 0.345 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.518 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 8.0 m-70 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.84 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.76 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.891 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.947 ' O ' HG12 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.909 HD22 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.947 HG12 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.913 ' HB3' HD13 ' A' ' 36' ' ' ILE . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.956 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 26' ' ' GLN . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 32' ' ' VAL 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.869 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 23' ' ' MET . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.8 ' O ' HG23 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.807 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.69 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.836 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.463 ' O ' ' HD2' ' A' ' 5' ' ' HIS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 4' ' ' LYS . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 75' ' ' PRO . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.887 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 54' ' ' VAL . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.654 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.814 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.716 HG23 HD12 ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.688 ' OE1' HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' O ' HG13 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.623 HD11 HD23 ' A' ' 8' ' ' LEU . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.805 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.798 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.909 ' OD2' HD22 ' A' ' 19' ' ' LEU . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.728 HG21 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 93' ' ' LEU . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.0 tttm . . . . . 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.72 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm . . . . . 0 CA--C 1.551 1.009 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.963 ' NE2' HD12 ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.079 ' CD2' HG22 ' A' ' 16' ' ' THR 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.797 ' HB2' HD13 ' A' ' 56' ' ' LEU . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.079 HG22 ' CD2' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.123 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.865 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 1.008 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.744 ' HB2' HG23 ' A' ' 32' ' ' VAL . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 30' ' ' TYR . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.963 HD12 ' NE2' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.123 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.738 ' O ' HG22 ' A' ' 42' ' ' THR . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' PRO . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.984 ' HA3' HD21 ' A' ' 70' ' ' LEU . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.662 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.839 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 2.7 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' PRO . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.839 HG22 ' HA2' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.037 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.826 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.497 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.765 ' O ' ' HB3' ' A' ' 56' ' ' LEU 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' HD13 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.88 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.984 HD21 ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.88 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 54' ' ' VAL . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.037 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 61' ' ' ALA . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.035 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.035 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 92' ' ' VAL . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 19' ' ' LEU . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 97' ' ' VAL . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.739 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm . . . . . 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.943 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.933 ' HB2' HD12 ' A' ' 56' ' ' LEU . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.925 ' HB3' HG22 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.854 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 8' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.97 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 38' ' ' ALA . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.97 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.898 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 1.083 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 36' ' ' ILE . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.782 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG23 HG22 ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 37' ' ' GLU . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.842 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.911 ' OD1' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 75' ' ' PRO 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.811 HG13 ' CE1' ' A' ' 9' ' ' PHE . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.947 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.777 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.429 ' OE1' ' C ' ' A' ' 11' ' ' SER . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HB3' ' A' ' 11' ' ' SER . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.575 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.881 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 76' ' ' VAL . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.845 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.475 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.57 ' CG ' HD11 ' A' ' 71' ' ' LEU . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 67' ' ' ILE . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.947 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.777 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 1.033 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.805 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.033 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.677 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.083 HG12 ' SD ' ' A' ' 23' ' ' MET . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.995 ' O ' HG13 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.624 HD11 ' OD1' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 100' ' ' ILE . 11.4 tttt . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.598 ' HA ' HG21 ' A' ' 34' ' ' VAL 0.294 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 . . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.817 ' CD2' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.752 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.977 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.726 ' N ' HD23 ' A' ' 8' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 60' ' ' ILE . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.864 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.738 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 92' ' ' VAL 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 HG22 ' A' ' 36' ' ' ILE . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.881 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.816 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.908 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.017 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.771 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.954 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.017 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 5' ' ' HIS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' N ' HG12 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG22 HG22 ' A' ' 20' ' ' VAL . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.977 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 43' ' ' LEU 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.955 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.801 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.76 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.955 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.76 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' CG ' ' A' ' 75' ' ' PRO . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.974 HG11 HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.985 HD12 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 2.0 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.985 HD13 HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.497 HD12 HD21 ' A' ' 56' ' ' LEU . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.769 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.974 HG22 HG11 ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.921 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 8' ' ' LEU 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.854 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.809 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.886 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.852 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.854 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.886 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 26' ' ' GLN . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.741 ' CG1' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.888 ' N ' HG23 ' A' ' 34' ' ' VAL . 9.6 mttp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.905 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 11' ' ' SER . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.806 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.04 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' CG2' ' A' ' 87' ' ' VAL 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.04 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.77 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 36' ' ' ILE . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.925 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.789 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 30' ' ' TYR . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 ' N ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.903 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HD2' HD13 ' A' ' 43' ' ' LEU . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.882 ' OE1' HG23 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.882 HG23 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.7 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 47.2 m-20 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' HG23 ' A' ' 54' ' ' VAL . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.62 ' OD2' ' HD3' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.081 HG11 ' HB1' ' A' ' 96' ' ' ALA . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.817 ' HA3' HG22 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 5.2 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.817 HG22 ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.622 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 53' ' ' VAL 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.805 HG13 HG12 ' A' ' 54' ' ' VAL . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.756 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.752 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HB2' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 1.081 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 3.2 tmtt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 121.982 0.896 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 1.9 mt-10 82.68 3.17 1.11 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.243 -0.911 . . . . 0.0 109.729 174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -171.03 149.03 2.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 123.278 1.513 . . . . 0.0 112.203 170.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.886 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.84 -177.11 3.82 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.105 -176.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 2.1 m-70 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.742 ' CD2' ' HB2' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.016 HD13 HG12 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.832 ' O ' HD13 ' A' ' 60' ' ' ILE . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.827 ' OG1' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.044 HD11 HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.016 HG12 HD13 ' A' ' 8' ' ' LEU . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.888 ' SD ' HG12 ' A' ' 92' ' ' VAL . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.601 ' N ' HD13 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLY 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.728 HG12 HG12 ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.826 HG23 HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' HG2' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.895 ' OE1' HD12 ' A' ' 60' ' ' ILE . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 39' ' ' PHE 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' LYS . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 75' ' ' PRO . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 76' ' ' VAL . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.958 HD13 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.958 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.669 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 ' OE1' ' A' ' 41' ' ' GLU . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.844 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.933 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.546 HD21 ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.933 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.619 ' HG2' HG22 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 54' ' ' VAL . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.99 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.99 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.779 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 1.041 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.759 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD12 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.044 HG11 HD11 ' A' ' 19' ' ' LEU 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 11.7 tptm -101.33 -28.26 12.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.3 2.72 14.86 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 125.108 1.505 . . . . 0.0 112.848 165.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.14 -68.11 0.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.476 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -62.83 155.39 27.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.995 1.718 . . . . 0.0 111.693 -169.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . 153.81 71.64 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.732 1.613 . . . . 0.0 110.24 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.266 1.964 0 C-N-CA 124.561 1.144 . . . . 0.0 108.468 167.112 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -139.42 118.33 12.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.85 1.26 . . . . 0.0 111.631 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 2.2 mmpt? -102.1 165.63 11.05 Favored 'General case' 0 C--N 1.382 2.0 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -166.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.69 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -150.13 161.98 41.33 Favored 'General case' 0 C--N 1.37 1.469 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.426 -168.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 34' ' ' VAL . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.862 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.916 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.861 ' OG ' HG22 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.96 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' CB ' HG21 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG21 ' A' ' 92' ' ' VAL 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.759 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.914 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.907 ' CE2' HD21 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 34' ' ' VAL . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 32' ' ' VAL . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 3' ' ' LYS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 23' ' ' MET . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.862 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.848 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 67' ' ' ILE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.676 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.786 ' CG1' HD21 ' A' ' 56' ' ' LEU . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 11' ' ' SER . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.861 HG22 ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' ALA . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' OE1' ' CG1' ' A' ' 76' ' ' VAL . 4.1 mm100 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 66' ' ' GLU 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.828 HG21 HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.03 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.833 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.03 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.904 ' OD2' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 23' ' ' MET . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.978 HG21 HD13 ' A' ' 19' ' ' LEU 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 26' ' ' GLN . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -97.59 -0.88 45.0 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 2.8 tttp -91.66 -9.75 42.81 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.552 0.741 . . . . 0.0 111.397 158.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.77 -35.02 4.02 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 125.082 1.489 . . . . 0.0 111.566 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -166.4 -165.26 0.75 Allowed 'General case' 0 C--N 1.368 1.406 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.804 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' ALA . . . 106.41 -62.76 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 126.743 2.017 . . . . 0.0 111.121 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.377 1.762 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.186 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 CA-C-O 122.049 0.928 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -140.96 -64.76 0.45 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.538 170.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER 168.44 141.02 0.02 OUTLIER 'General case' 0 C--N 1.364 1.227 0 CA-C-O 122.697 1.237 . . . . 0.0 111.877 -169.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -96.51 175.39 6.42 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.325 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 9.6 m-70 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.812 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.866 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' HG21 ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.864 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.731 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 30' ' ' TYR . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.915 HG22 HG13 ' A' ' 20' ' ' VAL . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.842 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.913 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.913 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' HD22 ' A' ' 70' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' H ' HD21 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.577 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 75' ' ' PRO . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 ' HE2' ' A' ' 9' ' ' PHE . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.002 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.784 ' CD1' HG21 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.947 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.901 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG3' HG12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.974 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.784 HG21 ' CD1' ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.974 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD22 ' HA3' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HA3' ' A' ' 48' ' ' GLY . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.002 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 79' ' ' ILE . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.901 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 82' ' ' LEU 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.881 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.864 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.617 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.869 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.661 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.937 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 100' ' ' ILE . 10.7 tttm -54.28 -50.95 66.08 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.937 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -66.92 -23.1 65.94 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.45 -11.59 42.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.125 1.77 . . . . 0.0 112.597 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 176.12 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.365 1.466 . . . . 0.0 111.317 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 106' ' ' ASN . . . -98.28 143.87 28.31 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.45 174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.865 161.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 77.9 91.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.301 1.84 . . . . 0.0 112.495 171.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -53.88 143.66 20.72 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 163.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -109.44 174.49 5.84 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.809 170.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 5.5 m-70 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.723 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.874 ' O ' HG22 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.772 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.725 HG22 HD13 ' A' ' 8' ' ' LEU . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.975 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.774 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.975 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.934 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.917 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 93' ' ' LEU . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' O ' HG12 ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.628 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.756 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.709 ' HB2' ' CD1' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.717 ' HA2' HD22 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.411 ' O ' ' HD2' ' A' ' 5' ' ' HIS . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 100' ' ' ILE . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.896 HG12 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.969 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.956 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' CE2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.956 HG23 ' O ' ' A' ' 57' ' ' GLY 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.938 ' N ' HD13 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.614 ' CG1' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD22 ' HA2' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.72 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.896 HG13 HG12 ' A' ' 54' ' ' VAL . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.969 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD13 ' CD1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.718 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.934 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.934 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' CE ' ' A' ' 23' ' ' MET 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD13 ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -77.2 -55.86 5.06 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -48.6 -33.3 9.55 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.375 1.047 . . . . 0.0 111.108 173.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' A' ' 102' ' ' LYS . . . -41.51 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.205 1.802 . . . . 0.0 113.0 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' ASN . . . -92.85 131.43 37.89 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.839 2.056 . . . . 0.0 113.278 -166.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.23 -80.24 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.658 1.583 . . . . 0.0 110.623 160.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 104' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.631 1.573 . . . . 0.0 110.091 -166.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.912 0.863 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 2.2 mt-10 -107.7 -16.33 14.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.597 1.559 . . . . 0.0 111.345 -167.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 10.2 mttp 88.61 163.11 0.06 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.541 1.136 . . . . 0.0 113.627 -159.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt -154.61 153.53 31.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 126.459 2.35 . . . . 0.0 110.478 -165.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.825 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.074 HD22 ' CG2' ' A' ' 20' ' ' VAL 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.865 ' HB2' HD12 ' A' ' 56' ' ' LEU . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.692 ' O ' HG21 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.703 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.826 HG22 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.926 ' HG ' HG11 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.074 ' CG2' HD22 ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.927 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.959 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.524 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.959 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.575 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.581 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.832 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.967 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 56' ' ' LEU . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.903 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 75' ' ' PRO . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.001 ' CG1' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.79 HD22 HG12 ' A' ' 79' ' ' ILE . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 9' ' ' PHE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 79' ' ' ILE 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.771 ' HB2' ' O ' ' A' ' 11' ' ' SER . 9.9 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.852 ' O ' HD23 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.675 ' O ' HG12 ' A' ' 67' ' ' ILE . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.731 ' OE2' HD13 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.841 ' CG2' HG11 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.473 ' OE1' HG22 ' A' ' 67' ' ' ILE . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.844 HD23 ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.626 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.82 ' O ' HG13 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.001 HG22 ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.814 HG22 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.93 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.926 HG11 ' HG ' ' A' ' 18' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 19' ' ' LEU . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' ALA . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.746 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -49.97 -45.46 51.5 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 -12.38 59.82 Favored 'General case' 0 C--O 1.259 1.563 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.132 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -75.09 -8.65 57.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.987 1.715 . . . . 0.0 110.935 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.28 175.66 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.265 170.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.27 -53.12 2.36 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 125.19 1.556 . . . . 0.0 111.08 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.378 1.824 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.454 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.19 -2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.73 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -93.64 85.85 5.0 Favored 'General case' 0 CA--C 1.573 1.85 0 CA-C-N 111.868 -2.424 . . . . 0.0 109.849 -166.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER 178.5 110.15 0.03 OUTLIER 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 123.921 1.819 . . . . 0.0 111.765 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER -174.86 141.47 0.61 Allowed 'General case' 0 C--N 1.386 2.158 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -161.896 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.73 ' CD2' HG11 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.961 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.969 HD12 HG23 ' A' ' 20' ' ' VAL . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.501 ' O ' HD23 ' A' ' 19' ' ' LEU . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.677 HG22 ' HB1' ' A' ' 38' ' ' ALA . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.889 ' CD1' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD12 ' A' ' 8' ' ' LEU . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.947 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.891 ' CE ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.817 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.912 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.845 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.651 ' HB2' HG23 ' A' ' 32' ' ' VAL . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.753 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 31' ' ' GLU 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.813 HG23 ' C ' ' A' ' 3' ' ' LYS 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.655 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.961 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.677 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.868 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 39' ' ' PHE . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.594 ' CD ' ' HG3' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.936 ' OG1' HD13 ' A' ' 43' ' ' LEU 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.609 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.733 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 67' ' ' ILE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.842 HD13 HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.672 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.852 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.911 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.021 HD23 HD13 ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD13 HD23 ' A' ' 70' ' ' LEU 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' LYS 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.566 ' O ' HG22 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' VAL . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.878 ' OE1' ' HB2' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.81 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.013 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.013 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.947 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 23' ' ' MET . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.858 ' N ' HD23 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.891 HG12 ' CE ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.691 HD13 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.878 ' HB2' ' OE1' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? -59.09 -66.53 0.49 Allowed 'General case' 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -27.51 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.773 . . . . 0.0 112.324 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.91 -49.28 50.35 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.234 1.013 . . . . 0.0 112.403 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -41.87 144.2 0.45 Allowed 'General case' 0 C--N 1.352 0.712 0 CA-C-O 123.584 1.659 . . . . 0.0 112.738 -161.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ALA . . . 118.31 152.53 0.0 OUTLIER 'General case' 0 C--N 1.381 1.968 0 C-N-CA 124.897 1.279 . . . . 0.0 113.418 161.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 125.07 1.348 . . . . 0.0 110.089 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' HG2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 122.144 0.973 . . . . 0.0 110.693 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 25.74 -107.56 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.043 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 2.4 ptpt -174.81 138.1 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.953 1.301 . . . . 0.0 111.051 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp -130.89 -177.24 4.28 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.514 1.133 . . . . 0.0 112.612 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.995 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 47' ' ' LYS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.829 ' CD1' HD23 ' A' ' 55' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.917 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.955 ' HA ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.654 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB3' ' CE2' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.026 HG22 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.852 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.033 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' CG2' ' A' ' 36' ' ' ILE . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.852 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.876 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.823 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CB ' HG23 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.995 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.026 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.917 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG2' ' SD ' ' A' ' 63' ' ' MET 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 39' ' ' PHE 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.873 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.704 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.867 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 76' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.734 HD23 HD11 ' A' ' 67' ' ' ILE . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 60' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.699 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.072 HG21 HG11 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 67' ' ' ILE . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.981 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.981 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 87' ' ' VAL 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.935 ' O ' HG23 ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.033 HG11 HD11 ' A' ' 19' ' ' LEU 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 94' ' ' LYS . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.867 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 100' ' ' ILE . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 53' ' ' VAL . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.86 HG22 HG21 ' A' ' 53' ' ' VAL 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -102.19 -22.47 14.18 Favored 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 3.56 29.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 160.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.12 15.08 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.611 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 66.86 -161.25 0.24 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.864 1.666 . . . . 0.0 111.076 -165.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 179.23 -54.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.302 1.441 . . . . 0.0 110.744 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 6.2 t-20 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 125.555 1.542 . . . . 0.0 109.953 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.806 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 1.2 tp10 61.58 52.02 3.8 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.224 2.21 . . . . 0.0 111.569 160.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HB3' ' C ' ' A' ' 33' ' ' PRO . 12.5 mmmt -96.77 159.7 14.78 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -42.59 136.69 2.4 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.906 1.682 . . . . 0.0 114.905 -163.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.939 HG22 HG23 ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.107 HD12 HG22 ' A' ' 20' ' ' VAL . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.982 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.85 ' HA ' HG21 ' A' ' 60' ' ' ILE . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.572 ' CB ' ' OH ' ' A' ' 84' ' ' TYR . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.879 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.107 HG22 HD12 ' A' ' 8' ' ' LEU . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.879 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.871 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.848 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.848 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' C ' ' HB3' ' A' ' 3' ' ' LYS . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.939 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.713 ' O ' HG23 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.958 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 1.2 m-20 -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 75' ' ' PRO . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.993 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.99 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.909 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.88 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.662 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.738 ' CE ' HD11 ' A' ' 60' ' ' ILE . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.782 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 62' ' ' TYR 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.871 HG21 HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 76' ' ' VAL . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' HG13 ' A' ' 53' ' ' VAL 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.871 HG21 HG21 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.993 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.99 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.909 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.828 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.828 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.787 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.679 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.679 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -41.93 -41.53 2.5 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -48.69 78.41 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.773 0.829 . . . . 0.0 111.45 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -37.23 -39.8 0.29 Allowed 'General case' 0 C--N 1.357 0.927 0 C-N-CA 125.66 1.584 . . . . 0.0 111.386 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -39.55 150.24 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.172 0.989 . . . . 0.0 111.659 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 163.05 -59.21 0.0 OUTLIER 'General case' 0 C--O 1.247 0.947 0 C-N-CA 125.299 1.44 . . . . 0.0 110.792 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.269 2.131 0 C-N-CA 124.518 1.127 . . . . 0.0 110.262 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.512 2.646 0 CA-C-O 123.138 1.447 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.9 mt-10 162.18 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.408 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 13.0 mmtm 96.7 123.15 0.02 OUTLIER 'General case' 0 C--O 1.254 1.316 0 C-N-CA 124.232 1.013 . . . . 0.0 113.029 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.575 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 mttp -85.21 165.91 16.99 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.729 174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 10.8 m-70 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.951 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.775 ' HB2' HD22 ' A' ' 56' ' ' LEU . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.886 ' HG3' ' O ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.989 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.852 HG22 HD21 ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.9 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.989 HD12 ' O ' ' A' ' 15' ' ' SER 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.92 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.999 ' HE3' HG21 ' A' ' 36' ' ' ILE . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.727 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 22' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.973 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' HD11 ' A' ' 93' ' ' LEU . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.618 ' HB2' HG23 ' A' ' 32' ' ' VAL . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' TYR . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.636 HG11 HG13 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.999 HG21 ' HE3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.951 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.643 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.995 ' O ' HG22 ' A' ' 42' ' ' THR . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.637 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.641 ' CA ' HG22 ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.866 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 75' ' ' PRO . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.641 HG22 ' CA ' ' A' ' 48' ' ' GLY . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.955 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.661 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.482 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.479 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 49' ' ' GLN . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.866 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.955 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD12 HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD22 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.736 ' HA ' HD11 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.799 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.532 ' C ' HG22 ' A' ' 87' ' ' VAL . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 18' ' ' LEU . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.648 ' OD2' HD22 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.959 HG11 HD22 ' A' ' 19' ' ' LEU . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.913 HD22 ' HG3' ' A' ' 26' ' ' GLN . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.94 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.692 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 100' ' ' ILE . 9.0 ttpt -39.0 -53.31 1.77 Allowed 'General case' 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.872 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -58.5 -25.4 62.33 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.222 -169.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.34 -20.51 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.603 1.561 . . . . 0.0 110.302 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.28 87.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.41 1.484 . . . . 0.0 110.988 168.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.42 107.54 5.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.884 1.674 . . . . 0.0 112.159 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 126.638 1.975 . . . . 0.0 111.011 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtm . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 122.072 0.939 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 1.4 tt0 75.91 46.37 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.562 1.145 . . . . 0.0 110.494 -171.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.836 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER 60.77 117.07 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.37 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 34' ' ' VAL 0.342 0.0 OUTLIER -165.07 132.8 3.12 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 -164.527 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 2.7 m-70 -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.807 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' HB3' ' A' ' 47' ' ' LYS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD11 HD11 ' A' ' 19' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.847 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.643 ' OG ' ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.884 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.884 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.928 ' O ' HG22 ' A' ' 87' ' ' VAL . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.893 HG23 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.759 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.51 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.815 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' N ' HD13 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.624 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 3' ' ' LYS 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.789 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 35' ' ' ILE . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' N ' HG21 ' A' ' 20' ' ' VAL . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.847 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.892 ' O ' HG23 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 1.036 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.775 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.775 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.83 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.964 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.619 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 12' ' ' ALA 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.819 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.803 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.819 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.94 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.489 HG21 HG11 ' A' ' 76' ' ' VAL . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.94 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.876 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.83 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.968 HG13 HG12 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.964 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.619 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.893 ' OH ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.656 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 19' ' ' LEU . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.821 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.633 ' HZ3' ' N ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -67.02 -21.36 65.94 Favored 'General case' 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.633 ' N ' ' HZ3' ' A' ' 101' ' ' LYS . 4.5 tttt -69.24 -31.94 70.82 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.021 167.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.07 -2.86 39.35 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 126.704 2.001 . . . . 0.0 111.455 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' LYS . . . -25.62 -92.49 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.644 1.577 . . . . 0.0 111.47 -170.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.13 -177.95 0.95 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 113.235 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 C--N 1.375 1.706 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 -175.259 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 11.0 ptm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 121.213 0.53 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 1' ' ' MET . 4.5 mt-10 -141.6 66.39 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.077 0.951 . . . . 0.0 110.689 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 66.32 116.76 0.03 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.207 1.003 . . . . 0.0 113.591 162.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.93 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm -92.16 174.95 7.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 113.441 168.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.604 ' CA ' HG23 ' A' ' 34' ' ' VAL . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.903 HG22 HG23 ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.967 HD12 HD12 ' A' ' 55' ' ' LEU 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.844 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.56 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.72 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.056 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.979 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.997 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.01 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.904 ' HG3' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' MET . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.815 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.01 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.979 HG22 ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.987 ' O ' HG23 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.712 ' HB2' HD21 ' A' ' 56' ' ' LEU 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HD2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.909 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.909 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.967 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.941 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.976 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.85 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.844 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG1' HD22 ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.99 ' CB ' HG21 ' A' ' 78' ' ' VAL . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 60' ' ' ILE . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.064 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.064 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.882 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.519 ' HG2' ' OD1' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.967 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HB2' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG22 HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.99 HG21 ' CB ' ' A' ' 61' ' ' ALA . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.75 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.034 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.034 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.896 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.997 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.685 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.056 HG11 HD11 ' A' ' 19' ' ' LEU . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.904 HD12 ' HG3' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 92' ' ' VAL . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -44.08 12.13 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.595 ' HD2' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.49 -17.3 53.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -97.88 1.53 48.24 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.901 2.08 . . . . 0.0 114.513 -173.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . 93.0 127.94 0.02 OUTLIER 'General case' 0 C--O 1.253 1.251 0 C-N-CA 126.149 1.78 . . . . 0.0 112.004 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' O ' ' ND2' ' A' ' 106' ' ' ASN . . . 177.33 155.95 0.31 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.14 1.776 . . . . 0.0 111.874 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.377 2.271 . . . . 0.0 110.476 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.978 0.418 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -150.9 51.34 0.86 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 125.379 1.471 . . . . 0.0 113.252 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 93.12 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.434 1.112 . . . . 0.0 112.138 160.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.867 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm -130.48 174.79 9.54 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.036 1.335 . . . . 0.0 111.785 172.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 79' ' ' ILE 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.787 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.659 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.98 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.998 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.98 HD12 ' HA ' ' A' ' 16' ' ' THR 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.998 HG22 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.59 ' H ' HG22 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.771 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.844 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.961 ' NE2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.572 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.695 ' CD1' ' HG2' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.792 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG11 HD21 ' A' ' 93' ' ' LEU . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.792 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.867 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 23' ' ' MET . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.682 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' HG23 ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.873 HG23 ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 71' ' ' LEU . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.943 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.923 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 21.4 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.684 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' HE2' ' A' ' 9' ' ' PHE . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' VAL 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.713 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.744 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.619 ' O ' HG12 ' A' ' 67' ' ' ILE . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' LEU . 1.9 mt-30 -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HG2' ' HB ' ' A' ' 53' ' ' VAL 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 54' ' ' VAL . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.92 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 8' ' ' LEU . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.98 ' O ' HD12 ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.758 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.961 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.789 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.808 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 2.7 ttpm? -23.85 -86.85 0.0 OUTLIER 'General case' 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -21.63 65.99 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.794 -1.191 . . . . 0.0 114.079 -172.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -49.87 -34.27 19.6 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 124.299 1.04 . . . . 0.0 111.325 161.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' LYS . . . -60.7 81.71 0.01 OUTLIER 'General case' 0 C--N 1.352 0.68 0 C-N-CA 126.26 1.824 . . . . 0.0 112.546 171.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 65.38 -174.75 0.18 Allowed 'General case' 0 C--O 1.249 1.042 0 C-N-CA 125.124 1.37 . . . . 0.0 111.902 164.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 127.074 2.15 . . . . 0.0 110.518 175.447 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 123.197 1.475 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 33' ' ' PRO . 21.2 mt-10 81.79 12.64 0.64 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.306 1.442 . . . . 0.0 112.621 -173.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -102.07 135.03 44.35 Favored 'General case' 0 C--N 1.368 1.392 0 CA-C-O 122.797 1.284 . . . . 0.0 112.685 -175.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm -127.49 165.56 19.63 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.174 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.518 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 8.0 m-70 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.84 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.76 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.891 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.947 ' O ' HG12 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.909 HD22 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.947 HG12 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.913 ' HB3' HD13 ' A' ' 36' ' ' ILE . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.956 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 26' ' ' GLN . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 32' ' ' VAL 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.869 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 23' ' ' MET . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.8 ' O ' HG23 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.807 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.69 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.836 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.463 ' O ' ' HD2' ' A' ' 5' ' ' HIS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 4' ' ' LYS . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 75' ' ' PRO . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.887 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 54' ' ' VAL . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.654 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.814 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.716 HG23 HD12 ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.688 ' OE1' HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' O ' HG13 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.623 HD11 HD23 ' A' ' 8' ' ' LEU . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.798 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.909 ' OD2' HD22 ' A' ' 19' ' ' LEU . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.728 HG21 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 93' ' ' LEU . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.0 tttm -63.36 -20.99 66.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 4.7 tttp -91.67 -6.04 52.76 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -62.93 -34.39 77.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 111.245 166.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . 104.21 74.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.926 1.69 . . . . 0.0 112.248 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.17 -157.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.648 1.179 . . . . 0.0 111.098 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 124.373 1.069 . . . . 0.0 110.557 167.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' C ' ' HG2' ' A' ' 2' ' ' GLU . 1.5 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.649 0.261 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 1' ' ' MET . 4.8 mm-40 73.8 136.81 0.05 Allowed 'General case' 0 C--O 1.253 1.286 0 C-N-CA 124.642 1.177 . . . . 0.0 110.869 161.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -123.65 111.23 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.72 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm -123.9 149.99 45.2 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 -159.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.963 ' NE2' HD12 ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.079 ' CD2' HG22 ' A' ' 16' ' ' THR 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.797 ' HB2' HD13 ' A' ' 56' ' ' LEU . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.079 HG22 ' CD2' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.123 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.865 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 1.008 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.744 ' HB2' HG23 ' A' ' 32' ' ' VAL . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 30' ' ' TYR . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.963 HD12 ' NE2' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.123 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.738 ' O ' HG22 ' A' ' 42' ' ' THR . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' PRO . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.984 ' HA3' HD21 ' A' ' 70' ' ' LEU . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.839 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 2.7 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' PRO . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.839 HG22 ' HA2' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.037 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.826 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.497 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.765 ' O ' ' HB3' ' A' ' 56' ' ' LEU 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' HD13 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.88 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.984 HD21 ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.88 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 54' ' ' VAL . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.037 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 61' ' ' ALA . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.035 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.035 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 92' ' ' VAL . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 19' ' ' LEU . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 97' ' ' VAL . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.69 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -56.62 -44.83 81.57 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -57.73 -30.73 65.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.035 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -59.43 -75.27 0.06 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.597 1.559 . . . . 0.0 112.353 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -130.09 -75.89 0.54 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.651 1.58 . . . . 0.0 111.632 -169.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . 99.84 149.27 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.981 1.712 . . . . 0.0 110.792 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.174 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 122.816 1.293 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.95 -161.52 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.218 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 53.81 111.56 0.01 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.329 1.052 . . . . 0.0 113.108 -154.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.739 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm -114.27 160.15 19.37 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -161.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.943 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.933 ' HB2' HD12 ' A' ' 56' ' ' LEU . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.925 ' HB3' HG22 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.854 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 8' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.97 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 38' ' ' ALA . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.97 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.898 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 1.083 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 36' ' ' ILE . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.782 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG23 HG22 ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 37' ' ' GLU . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.842 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.911 ' OD1' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 75' ' ' PRO 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.811 HG13 ' CE1' ' A' ' 9' ' ' PHE . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.947 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.777 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.429 ' OE1' ' C ' ' A' ' 11' ' ' SER . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HB3' ' A' ' 11' ' ' SER . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.575 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.881 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 76' ' ' VAL . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.845 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.57 ' CG ' HD11 ' A' ' 71' ' ' LEU . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 67' ' ' ILE . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.947 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.777 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 1.033 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.805 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.033 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.677 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.083 HG12 ' SD ' ' A' ' 23' ' ' MET . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.995 ' O ' HG13 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.624 HD11 ' OD1' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 100' ' ' ILE . 11.4 tttt -81.68 -14.3 56.78 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 102' ' ' LYS . 13.0 tmtt? -89.72 8.42 31.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 125.101 1.501 . . . . 0.0 112.036 167.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -96.73 -45.21 6.77 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.938 1.295 . . . . 0.0 111.412 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -142.41 102.44 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.955 2.102 . . . . 0.0 113.143 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . 158.64 -169.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.291 1.436 . . . . 0.0 112.12 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 C-N-CA 125.459 1.504 . . . . 0.0 110.105 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.478 1.132 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.893 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 7.4 mm-40 -57.9 139.92 53.17 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.492 1.117 . . . . 0.0 110.551 159.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.893 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 12.2 mttt 108.11 128.84 0.0 OUTLIER 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.933 1.293 . . . . 0.0 114.463 -164.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 3' ' ' LYS 0.294 0.0 OUTLIER 163.81 157.38 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 173.33 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.817 ' CD2' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.752 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.977 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.726 ' N ' HD23 ' A' ' 8' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 60' ' ' ILE . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.864 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 92' ' ' VAL 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 HG22 ' A' ' 36' ' ' ILE . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.881 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.816 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.908 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.017 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.771 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.954 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.017 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 5' ' ' HIS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' N ' HG12 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG22 HG22 ' A' ' 20' ' ' VAL . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.977 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 43' ' ' LEU 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.955 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.801 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.76 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.955 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.76 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' CG ' ' A' ' 75' ' ' PRO . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.974 HG11 HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.985 HD12 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 2.0 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.985 HD13 HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.497 HD12 HD21 ' A' ' 56' ' ' LEU . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.769 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.974 HG22 HG11 ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.921 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 8' ' ' LEU 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.854 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.809 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.886 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.852 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.854 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.886 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 26' ' ' GLN . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.741 ' CG1' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.71 -45.37 78.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -67.73 -4.1 11.26 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.921 178.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -54.22 -39.38 66.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.019 1.727 . . . . 0.0 112.112 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' ALA . . . 157.94 150.34 0.01 OUTLIER 'General case' 0 C--N 1.374 1.633 0 C-N-CA 125.401 1.48 . . . . 0.0 112.458 167.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 -168.45 1.65 Allowed 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 125.69 1.596 . . . . 0.0 110.296 171.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.262 1.741 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.861 168.211 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.814 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 3.2 tpt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.589 0.233 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.536 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 5.0 mm-40 -55.75 -74.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.385 1.474 . . . . 0.0 108.917 -166.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.856 ' C ' HG23 ' A' ' 34' ' ' VAL . 14.5 mmmt 85.62 122.06 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.197 0 O-C-N 125.812 1.945 . . . . 0.0 111.465 170.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.888 ' N ' HG23 ' A' ' 34' ' ' VAL . 9.6 mttp -150.86 137.75 19.06 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 -174.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.905 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 11' ' ' SER . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.806 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.04 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' CG2' ' A' ' 87' ' ' VAL 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.04 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.77 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 36' ' ' ILE . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.925 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.789 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 30' ' ' TYR . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 ' N ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.903 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HD2' HD13 ' A' ' 43' ' ' LEU . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.882 ' OE1' HG23 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.882 HG23 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.7 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 47.2 m-20 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' HG23 ' A' ' 54' ' ' VAL . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.62 ' OD2' ' HD3' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.081 HG11 ' HB1' ' A' ' 96' ' ' ALA . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.817 ' HA3' HG22 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 5.2 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.817 HG22 ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.622 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 53' ' ' VAL 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.805 HG13 HG12 ' A' ' 54' ' ' VAL . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.756 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.752 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HB2' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 1.081 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 3.2 tmtt? -68.2 -4.02 12.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 19.1 ttpt -86.63 -31.46 21.11 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.481 1.113 . . . . 0.0 112.693 168.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . -47.84 -49.45 29.27 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.744 1.618 . . . . 0.0 112.158 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 103' ' ' ALA . . . 155.27 162.4 0.01 OUTLIER 'General case' 0 C--N 1.367 1.368 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.455 -175.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 82.49 90.74 0.04 OUTLIER 'General case' 0 C--N 1.37 1.483 0 C-N-CA 125.162 1.385 . . . . 0.0 112.29 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 126.224 1.809 . . . . 0.0 110.49 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.886 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.566 1.595 0 CA-C-O 120.977 0.418 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 52.8 m170 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.742 ' CD2' ' HB2' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.016 HD13 HG12 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.832 ' O ' HD13 ' A' ' 60' ' ' ILE . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.827 ' OG1' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.044 HD11 HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.016 HG12 HD13 ' A' ' 8' ' ' LEU . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.888 ' SD ' HG12 ' A' ' 92' ' ' VAL . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.601 ' N ' HD13 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLY 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.728 HG12 HG12 ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.826 HG23 HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' HG2' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.895 ' OE1' HD12 ' A' ' 60' ' ' ILE . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 39' ' ' PHE 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' LYS . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 75' ' ' PRO . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 76' ' ' VAL . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.958 HD13 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.958 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.669 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 ' OE1' ' A' ' 41' ' ' GLU . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.844 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.933 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.546 HD21 ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.933 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.619 ' HG2' HG22 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 54' ' ' VAL . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.99 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.99 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.779 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 1.041 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.759 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD12 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.044 HG11 HD11 ' A' ' 19' ' ' LEU 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 11.7 tptm . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.69 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 34' ' ' VAL . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.862 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.916 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.861 ' OG ' HG22 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.96 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' CB ' HG21 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG21 ' A' ' 92' ' ' VAL 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.759 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.914 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.907 ' CE2' HD21 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 34' ' ' VAL . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 32' ' ' VAL . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 23' ' ' MET . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.862 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.848 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 67' ' ' ILE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.676 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.786 ' CG1' HD21 ' A' ' 56' ' ' LEU . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 11' ' ' SER . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.861 HG22 ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' ALA . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.557 ' NE2' ' CG1' ' A' ' 76' ' ' VAL . 3.9 mm-40 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 66' ' ' GLU 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.828 HG21 HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.03 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.833 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.03 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.904 ' OD2' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 23' ' ' MET . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.978 HG21 HD13 ' A' ' 19' ' ' LEU 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 26' ' ' GLN . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm . . . . . 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 122.302 1.048 . . . . 0.0 112.325 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 m80 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.812 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.866 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' HG21 ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.864 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.731 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 30' ' ' TYR . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.915 HG22 HG13 ' A' ' 20' ' ' VAL . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.842 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.913 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.913 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' HD22 ' A' ' 70' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' H ' HD21 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.577 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 75' ' ' PRO . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 ' HE2' ' A' ' 9' ' ' PHE . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.002 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.784 ' CD1' HG21 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.947 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.901 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG3' HG12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.974 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.784 HG21 ' CD1' ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.974 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.497 HD22 ' HA3' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HA3' ' A' ' 48' ' ' GLY . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.002 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 79' ' ' ILE . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.901 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 82' ' ' LEU 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.881 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.864 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.617 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.869 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.661 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 100' ' ' ILE . 10.7 tttm . . . . . 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 32.6 m170 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.723 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.874 ' O ' HG22 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.772 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.725 HG22 HD13 ' A' ' 8' ' ' LEU . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.975 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.774 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.975 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.934 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.917 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 93' ' ' LEU . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.693 ' O ' HG12 ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.628 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.756 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.709 ' HB2' ' CD1' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.717 ' HA2' HD22 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 100' ' ' ILE . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.896 HG12 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.969 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.956 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' CE2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.956 HG23 ' O ' ' A' ' 57' ' ' GLY 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.938 ' N ' HD13 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.614 ' CG1' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD22 ' HA2' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.72 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.896 HG13 HG12 ' A' ' 54' ' ' VAL . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.969 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.805 HD13 ' CD1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.718 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.934 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.934 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' CE ' ' A' ' 23' ' ' MET 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD13 ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? . . . . . 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 122.559 1.171 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.825 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.074 HD22 ' CG2' ' A' ' 20' ' ' VAL 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.865 ' HB2' HD12 ' A' ' 56' ' ' LEU . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.692 ' O ' HG21 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.703 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.826 HG22 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.926 ' HG ' HG11 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.074 ' CG2' HD22 ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.927 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.959 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.524 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.959 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.575 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.581 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.832 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.967 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 56' ' ' LEU . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.903 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 75' ' ' PRO . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.001 ' CG1' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.79 HD22 HG12 ' A' ' 79' ' ' ILE . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 9' ' ' PHE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 79' ' ' ILE 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.771 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.5 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.852 ' O ' HD23 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.675 ' O ' HG12 ' A' ' 67' ' ' ILE . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.731 ' OE2' HD13 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.841 ' CG2' HG11 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.473 ' OE1' HG22 ' A' ' 67' ' ' ILE . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.844 HD23 ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.626 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.82 ' O ' HG13 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.001 HG22 ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.814 HG22 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.93 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.926 HG11 ' HG ' ' A' ' 18' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 19' ' ' LEU . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.746 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.73 ' CD2' HG11 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.961 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.969 HD12 HG23 ' A' ' 20' ' ' VAL . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.501 ' O ' HD23 ' A' ' 19' ' ' LEU . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.677 HG22 ' HB1' ' A' ' 38' ' ' ALA . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.889 ' CD1' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD12 ' A' ' 8' ' ' LEU . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.947 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.891 ' CE ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.817 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.912 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.845 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.651 ' HB2' HG23 ' A' ' 32' ' ' VAL . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.753 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 31' ' ' GLU 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 5' ' ' HIS 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.655 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.961 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.677 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.868 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 39' ' ' PHE . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.594 ' CD ' ' HG3' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.936 ' OG1' HD13 ' A' ' 43' ' ' LEU 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.609 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.733 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 67' ' ' ILE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.842 HD13 HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.672 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.852 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.911 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.021 HD23 HD13 ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD13 HD23 ' A' ' 70' ' ' LEU 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' LYS 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.566 ' O ' HG22 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' VAL . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.878 ' OE1' ' HB2' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.81 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.013 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.013 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.947 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 23' ' ' MET . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.858 ' N ' HD23 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.891 HG12 ' CE ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.691 HD13 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.878 ' HB2' ' OE1' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? . . . . . 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.995 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 47' ' ' LYS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.829 ' CD1' HD23 ' A' ' 55' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.917 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.955 ' HA ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.654 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB3' ' CE2' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.026 HG22 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.852 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.033 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' CG2' ' A' ' 36' ' ' ILE . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.852 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.876 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.823 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CB ' HG23 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 32' ' ' VAL . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.995 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.026 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.917 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG2' ' SD ' ' A' ' 63' ' ' MET 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 39' ' ' PHE 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.873 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.704 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.867 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 76' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.734 HD23 HD11 ' A' ' 67' ' ' ILE . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 60' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.699 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.072 HG21 HG11 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 67' ' ' ILE . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.981 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.981 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 87' ' ' VAL 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.935 ' O ' HG23 ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.033 HG11 HD11 ' A' ' 19' ' ' LEU 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 94' ' ' LYS . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.867 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 100' ' ' ILE . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 53' ' ' VAL . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.86 HG22 HG21 ' A' ' 53' ' ' VAL 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.939 HG22 HG23 ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.107 HD12 HG22 ' A' ' 20' ' ' VAL . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.982 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.85 ' HA ' HG21 ' A' ' 60' ' ' ILE . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.572 ' CB ' ' OH ' ' A' ' 84' ' ' TYR . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.879 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.107 HG22 HD12 ' A' ' 8' ' ' LEU . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.879 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.871 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.848 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.848 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' C ' HG12 ' A' ' 34' ' ' VAL . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.939 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.713 ' O ' HG23 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.958 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 75' ' ' PRO . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.993 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.99 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.909 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.88 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.662 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.738 ' CE ' HD11 ' A' ' 60' ' ' ILE . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.782 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 62' ' ' TYR 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.871 HG21 HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' H ' ' ND2' ' A' ' 73' ' ' ASN . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' HG13 ' A' ' 53' ' ' VAL 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.871 HG21 HG21 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.993 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.99 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.909 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.828 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.828 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.557 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.787 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.679 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.679 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.575 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 mttp . . . . . 0 N--CA 1.507 2.419 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 6.5 m80 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.951 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.775 ' HB2' HD22 ' A' ' 56' ' ' LEU . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.886 ' O ' ' HG3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.989 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.852 HG22 HD21 ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.989 HD12 ' O ' ' A' ' 15' ' ' SER 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.92 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.999 ' HE3' HG21 ' A' ' 36' ' ' ILE . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.727 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 22' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.973 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' HD11 ' A' ' 93' ' ' LEU . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.618 ' HB2' HG23 ' A' ' 32' ' ' VAL . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' TYR . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.636 HG11 HG13 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.999 HG21 ' HE3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.951 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.643 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.995 ' O ' HG22 ' A' ' 42' ' ' THR . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.637 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.641 ' CA ' HG22 ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.866 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 75' ' ' PRO . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.641 HG22 ' CA ' ' A' ' 48' ' ' GLY . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.955 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.661 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.482 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.479 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 49' ' ' GLN . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.866 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.955 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD12 HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD22 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.736 ' HA ' HD11 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.799 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.532 ' C ' HG22 ' A' ' 87' ' ' VAL . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 18' ' ' LEU . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.648 ' OD2' HD22 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.959 HG11 HD22 ' A' ' 19' ' ' LEU . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.913 HD22 ' HG3' ' A' ' 26' ' ' GLN . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.94 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.692 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 100' ' ' ILE . 9.0 ttpt . . . . . 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 34' ' ' VAL 0.342 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.807 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' HB3' ' A' ' 47' ' ' LYS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.727 HD11 HD11 ' A' ' 19' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.847 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.643 ' OG ' ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.884 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.884 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.928 ' O ' HG22 ' A' ' 87' ' ' VAL . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.893 HG23 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.759 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.51 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.815 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' N ' HD13 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.624 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.789 HG12 ' N ' ' A' ' 35' ' ' ILE 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.789 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 35' ' ' ILE . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' N ' HG21 ' A' ' 20' ' ' VAL . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.847 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.892 ' O ' HG23 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 1.036 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.775 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.775 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.83 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.964 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.619 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 12' ' ' ALA 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.819 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.803 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.819 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.94 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.489 HG21 HG11 ' A' ' 76' ' ' VAL . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.94 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.876 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.83 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.968 HG13 HG12 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.964 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.619 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.893 ' OH ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.651 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.656 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 19' ' ' LEU . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.821 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.93 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 122.22 1.01 . . . . 0.0 113.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.604 ' CA ' HG23 ' A' ' 34' ' ' VAL . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.903 HG22 HG23 ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.967 HD12 HD12 ' A' ' 55' ' ' LEU 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.844 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.56 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.72 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.056 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.979 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.997 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.01 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.904 ' HG3' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' MET . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.815 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 1.01 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.979 HG22 ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.987 ' O ' HG23 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.712 ' HB2' HD21 ' A' ' 56' ' ' LEU 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HD2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.909 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.909 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.967 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.941 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.976 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.85 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.844 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG1' HD22 ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.99 ' CB ' HG21 ' A' ' 78' ' ' VAL . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 60' ' ' ILE . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.064 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.064 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.882 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HG2' ' ND2' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.669 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.967 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HB2' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG22 HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.99 HG21 ' CB ' ' A' ' 61' ' ' ALA . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.75 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.034 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.034 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.896 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.997 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.685 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.056 HG11 HD11 ' A' ' 19' ' ' LEU . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.904 HD12 ' HG3' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 92' ' ' VAL . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.867 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 79' ' ' ILE 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.787 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.659 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.98 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.998 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.98 HD12 ' HA ' ' A' ' 16' ' ' THR 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.998 HG22 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.59 ' H ' HG22 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.771 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.844 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.824 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 5.1 pp0? -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.721 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.695 ' CD1' ' HG2' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.792 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG11 HD21 ' A' ' 93' ' ' LEU . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.867 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 23' ' ' MET . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.682 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' HG23 ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.873 HG23 ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 71' ' ' LEU . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.943 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.923 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.5 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.684 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' HE2' ' A' ' 9' ' ' PHE . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' VAL 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.713 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.744 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.619 ' O ' HG12 ' A' ' 67' ' ' ILE . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.606 ' NE2' ' HB ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HG2' ' HB ' ' A' ' 53' ' ' VAL 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 54' ' ' VAL . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.92 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 8' ' ' LEU . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.98 ' O ' HD12 ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.758 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.771 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.91 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.789 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 ttpm? . . . . . 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.825 0.345 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.573 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 14.7 m170 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.84 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.76 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.891 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.947 ' O ' HG12 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.909 HD22 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.947 HG12 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.913 ' HB3' HD13 ' A' ' 36' ' ' ILE . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.956 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 26' ' ' GLN . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 32' ' ' VAL 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.869 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 23' ' ' MET . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.8 ' O ' HG23 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.807 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.69 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.836 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 4' ' ' LYS . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 75' ' ' PRO . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.887 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 54' ' ' VAL . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.654 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.814 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.716 HG23 HD12 ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.688 ' OE1' HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' O ' HG13 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.623 HD11 HD23 ' A' ' 8' ' ' LEU . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.798 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.909 ' OD2' HD22 ' A' ' 19' ' ' LEU . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.728 HG21 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 93' ' ' LEU . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.0 tttm . . . . . 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.72 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm . . . . . 0 CA--C 1.551 1.009 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.963 ' NE2' HD12 ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.079 ' CD2' HG22 ' A' ' 16' ' ' THR 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.797 ' HB2' HD13 ' A' ' 56' ' ' LEU . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.079 HG22 ' CD2' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.123 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.865 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 1.008 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.744 ' HB2' HG23 ' A' ' 32' ' ' VAL . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 30' ' ' TYR . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.963 HD12 ' NE2' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.123 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.738 ' O ' HG22 ' A' ' 42' ' ' THR . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' PRO . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.984 ' HA3' HD21 ' A' ' 70' ' ' LEU . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.662 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.839 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.2 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' PRO . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.839 HG22 ' HA2' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.037 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.826 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.497 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.765 ' O ' ' HB3' ' A' ' 56' ' ' LEU 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' HD13 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.88 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.984 HD21 ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.88 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 54' ' ' VAL . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.037 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 61' ' ' ALA . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.035 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.035 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 92' ' ' VAL . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 19' ' ' LEU . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 97' ' ' VAL . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.739 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm . . . . . 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.943 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.933 ' HB2' HD12 ' A' ' 56' ' ' LEU . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.925 ' HB3' HG22 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.854 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 8' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.97 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 38' ' ' ALA . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.97 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.898 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 1.083 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 36' ' ' ILE . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.782 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG23 HG22 ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 37' ' ' GLU . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.842 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.911 ' OD1' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 75' ' ' PRO 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.811 HG13 ' CE1' ' A' ' 9' ' ' PHE . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.947 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.777 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.429 ' OE1' ' C ' ' A' ' 11' ' ' SER . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HB3' ' A' ' 11' ' ' SER . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.575 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.881 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 76' ' ' VAL . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.845 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.475 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.57 ' CG ' HD11 ' A' ' 71' ' ' LEU . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 67' ' ' ILE . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.947 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.777 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 1.033 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.805 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.033 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.677 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.083 HG12 ' SD ' ' A' ' 23' ' ' MET . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.995 ' O ' HG13 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.624 HD11 ' OD1' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 100' ' ' ILE . 11.4 tttt . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.598 ' HA ' HG21 ' A' ' 34' ' ' VAL 0.294 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.817 ' CD2' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.752 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.977 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.726 ' N ' HD23 ' A' ' 8' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 60' ' ' ILE . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.864 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.738 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 92' ' ' VAL 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 HG22 ' A' ' 36' ' ' ILE . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.881 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.816 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.908 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.017 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.771 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.954 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.017 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 5' ' ' HIS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' N ' HG12 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG22 HG22 ' A' ' 20' ' ' VAL . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.977 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 43' ' ' LEU 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.955 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.801 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.76 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.955 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.76 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' CG ' ' A' ' 75' ' ' PRO . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.974 HG11 HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.985 HD12 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 2.8 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.985 HD13 HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.497 HD12 HD21 ' A' ' 56' ' ' LEU . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' HG2' ' ND2' ' A' ' 73' ' ' ASN . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.558 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 2.3 p30 -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.769 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.974 HG22 HG11 ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.921 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 8' ' ' LEU 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.854 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.809 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.886 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.852 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.854 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.886 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 26' ' ' GLN . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.741 ' CG1' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.888 ' N ' HG23 ' A' ' 34' ' ' VAL . 9.6 mttp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.905 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 11' ' ' SER . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.806 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.04 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' CG2' ' A' ' 87' ' ' VAL 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.04 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.77 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 36' ' ' ILE . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.925 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.789 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 30' ' ' TYR . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 ' N ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.903 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HD2' HD13 ' A' ' 43' ' ' LEU . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.882 ' OE1' HG23 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.882 HG23 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.7 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.9 m120 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' HG23 ' A' ' 54' ' ' VAL . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.62 ' OD2' ' HD3' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.081 HG11 ' HB1' ' A' ' 96' ' ' ALA . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.817 ' HA3' HG22 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 2.7 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.817 HG22 ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.622 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 53' ' ' VAL 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.805 HG13 HG12 ' A' ' 54' ' ' VAL . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.756 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.752 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HB2' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 1.081 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 3.2 tmtt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 121.982 0.896 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 1.9 mt-10 82.68 3.17 1.11 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.243 -0.911 . . . . 0.0 109.729 174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -171.03 149.03 2.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 123.278 1.513 . . . . 0.0 112.203 170.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.886 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.84 -177.11 3.82 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.105 -176.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 52.8 m170 -129.76 96.02 4.12 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 125.708 1.88 . . . . 0.0 109.601 -156.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.826 HG22 HG23 ' A' ' 36' ' ' ILE . 46.2 mt -76.8 98.69 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.594 0 C-N-CA 126.847 2.059 . . . . 0.0 109.908 166.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.742 ' CD2' ' HB2' ' A' ' 51' ' ' ALA . 5.8 m-30 -104.29 138.31 40.92 Favored 'General case' 0 C--N 1.387 2.201 0 C-N-CA 127.452 2.301 . . . . 0.0 112.329 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.016 HD13 HG12 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -129.52 130.54 45.92 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 125.792 1.637 . . . . 0.0 109.847 -169.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 39' ' ' PHE . 48.4 m-85 -124.62 104.41 8.68 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.085 2.154 . . . . 0.0 109.708 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.832 ' O ' HD13 ' A' ' 60' ' ' ILE . 5.2 t -79.44 135.4 36.66 Favored 'General case' 0 C--O 1.269 2.102 0 O-C-N 116.832 -3.667 . . . . 0.0 118.381 -146.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -76.47 -55.2 5.75 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 129.372 3.069 . . . . 0.0 112.279 -174.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . . . -118.83 -22.09 7.51 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 126.461 1.904 . . . . 0.0 113.106 174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.04 -84.75 0.35 Allowed Glycine 0 C--O 1.262 1.855 0 C-N-CA 125.471 1.51 . . . . 0.0 116.492 -163.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.1 mtt -112.67 49.46 0.93 Allowed 'General case' 0 C--O 1.199 -1.591 0 CA-C-O 124.613 2.149 . . . . 0.0 110.98 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 16.0 m -118.67 17.47 13.57 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 112.497 -2.138 . . . . 0.0 111.44 154.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.827 ' OG1' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -136.69 -59.33 0.72 Allowed 'General case' 0 C--N 1.377 1.784 0 C-N-CA 128.769 2.828 . . . . 0.0 112.83 -171.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.0 t -50.04 -33.97 19.93 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.494 1.918 . . . . 0.0 112.399 -167.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -95.32 -15.76 22.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.972 2.109 . . . . 0.0 110.101 177.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.044 HD11 HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -82.15 -31.99 30.27 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.64 2.376 . . . . 0.0 108.738 178.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.016 HG12 HD13 ' A' ' 8' ' ' LEU . 4.3 m -67.51 -49.61 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 126.517 1.927 . . . . 0.0 110.612 163.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 3.2 m -71.48 -5.58 34.04 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.975 1.31 . . . . 0.0 113.879 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' HE2' ' O ' ' A' ' 87' ' ' VAL . 1.9 ttpt -102.96 -51.43 3.27 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 122.815 1.293 . . . . 0.0 108.131 166.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.888 ' SD ' HG12 ' A' ' 92' ' ' VAL . 2.2 mtp -40.05 -34.37 0.29 Allowed 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 112.255 -2.248 . . . . 0.0 109.133 168.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.601 ' N ' HD13 ' A' ' 36' ' ' ILE . 46.6 mtt180 -66.22 -55.65 15.17 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.306 -2.225 . . . . 0.0 112.746 168.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.81 -73.22 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.893 164.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.759 ' HG2' ' O ' ' A' ' 89' ' ' GLY 0.264 0.0 OUTLIER -18.59 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 161.689 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.59 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.14 2.176 . . . . 0.0 113.032 -160.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.2 -17.89 9.45 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.454 1.597 . . . . 0.0 112.279 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 14.4 ttpt -62.7 -12.47 23.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 117.894 -3.004 . . . . 0.0 111.688 148.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 29' ' ' LYS 0.36 6.8 m-30 -123.48 -137.48 0.3 Allowed 'General case' 0 N--CA 1.518 2.933 0 CA-C-N 111.972 -2.376 . . . . 0.0 108.255 160.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.81 1.49 2.09 Favored 'General case' 0 C--O 1.253 1.277 0 C-N-CA 124.912 1.285 . . . . 0.0 111.716 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.728 HG12 HG12 ' A' ' 34' ' ' VAL . 81.9 t -34.4 117.37 0.52 Allowed Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 125.615 1.566 . . . . 0.0 108.239 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 80.8 Cg_endo -79.54 74.89 5.34 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 125.158 3.906 . . . . 0.0 117.618 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -162.88 125.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.729 0 CA-C-N 111.355 -2.657 . . . . 0.0 109.909 -170.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 3.5 mm -72.09 126.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.933 1.693 . . . . 0.0 110.576 154.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.826 HG23 HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.92 109.24 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 128.366 2.666 . . . . 0.0 110.39 161.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 18.1 mt-10 -111.29 147.11 35.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.892 1.677 . . . . 0.0 111.897 164.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . -131.93 132.58 43.68 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.347 1.459 . . . . 0.0 109.551 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 9' ' ' PHE . 1.2 m-85 -118.92 -178.37 0.55 Allowed Pre-proline 0 C--O 1.256 1.44 0 C-N-CA 125.797 1.639 . . . . 0.0 112.161 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' HG2' HG23 ' A' ' 42' ' ' THR 0.299 50.0 Cg_endo -88.95 52.84 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.873 2 C-N-CA 127.52 5.48 . . . . 0.0 122.587 170.697 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.895 ' OE1' HD12 ' A' ' 60' ' ' ILE . 7.0 pt-20 27.37 19.84 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.785 -2.461 . . . . 0.0 116.031 -161.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -91.49 -24.27 19.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.44 2.296 . . . . 0.0 111.357 -174.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 39' ' ' PHE 0.275 0.0 OUTLIER -99.82 -28.72 12.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.225 2.61 . . . . 0.0 107.642 -166.312 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -55.41 -34.87 64.78 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-O 123.058 1.409 . . . . 0.0 110.707 -156.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . -44.49 -60.58 3.64 Favored Glycine 0 C--N 1.377 2.809 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.495 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -82.29 -48.98 10.57 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 126.383 1.873 . . . . 0.0 111.587 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -70.46 -49.06 52.58 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.89 1.994 . . . . 0.0 109.934 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -31.66 -63.87 0.23 Allowed Glycine 0 N--CA 1.51 3.606 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.069 165.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 3.5 mt-30 -33.85 -65.62 0.18 Allowed 'General case' 0 C--N 1.375 1.7 0 C-N-CA 123.773 0.829 . . . . 0.0 112.627 164.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.0 -16.41 63.17 Favored 'General case' 0 C--O 1.253 1.257 0 C-N-CA 124.191 0.996 . . . . 0.0 109.24 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -74.54 162.03 29.18 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 124.796 1.238 . . . . 0.0 110.976 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' LYS . 7.8 t0 -107.68 -30.21 8.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.224 3.01 . . . . 0.0 112.854 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 75' ' ' PRO . 14.0 t -136.96 143.39 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 123.195 1.474 . . . . 0.0 111.497 161.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 76' ' ' VAL . 2.3 t -118.12 152.04 20.18 Favored 'Isoleucine or valine' 0 C--N 1.385 2.12 0 C-N-CA 126.368 1.867 . . . . 0.0 111.659 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.4 mp -138.94 152.05 47.4 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 129.667 3.187 . . . . 0.0 115.206 168.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.958 HD13 ' N ' ' A' ' 57' ' ' GLY . 1.4 tm? -142.61 146.03 34.11 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 126.744 2.018 . . . . 0.0 108.319 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.958 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -48.94 128.24 21.23 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 127.405 2.431 . . . . 0.0 114.3 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.669 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -36.24 -40.13 0.43 Allowed 'Trans proline' 0 CA--C 1.563 1.936 1 C-N-CA 125.818 4.345 . . . . 0.0 118.178 167.259 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -96.12 -21.87 17.67 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 110.787 -2.915 . . . . 0.0 113.66 -168.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 ' OE1' ' A' ' 41' ' ' GLU . 2.1 pt -102.26 9.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.235 1.414 . . . . 0.0 108.307 168.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.48 -44.38 0.01 OUTLIER 'General case' 0 C--O 1.255 1.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.97 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -47.87 -27.66 2.22 Favored 'General case' 0 C--O 1.273 2.307 0 C-N-CA 126.163 1.785 . . . . 0.0 111.763 -171.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.844 ' HG3' ' OE2' ' A' ' 41' ' ' GLU . 17.4 mmm -80.34 -13.4 59.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.022 1.729 . . . . 0.0 110.702 -165.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -36.95 16.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 126.054 1.742 . . . . 0.0 109.907 -168.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.912 ' O ' ' HD2' ' A' ' 69' ' ' ARG 0.255 32.6 Cg_exo -61.9 -42.39 31.33 Favored 'Trans proline' 0 CA--C 1.582 2.908 1 C-N-CA 125.579 4.186 . . . . 0.0 114.401 172.809 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 1.3 tt0 -56.79 -69.13 0.16 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 111.592 -2.549 . . . . 0.0 110.735 160.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 63' ' ' MET . 3.7 mm -41.43 -34.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 125.48 1.737 . . . . 0.0 107.68 -175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 2.5 mm-40 -85.72 -17.96 34.44 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.574 1.55 . . . . 0.0 113.166 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.933 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -72.13 -70.21 0.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.989 0.9 . . . . 0.0 109.885 163.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -27.79 -45.77 0.03 OUTLIER 'General case' 0 C--N 1.38 1.934 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.87 168.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.546 HD21 ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -140.12 96.73 8.01 Favored Pre-proline 0 C--N 1.361 1.108 0 C-N-CA 127.702 2.401 . . . . 0.0 108.644 172.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.933 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 24.6 Cg_endo -92.32 46.95 0.45 Allowed 'Trans proline' 0 C--N 1.365 1.405 1 C-N-CA 125.953 4.435 . . . . 0.0 120.492 171.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -161.21 -56.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.963 -2.381 . . . . 0.0 109.823 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 51' ' ' ALA . 9.2 mmtm -42.8 158.31 0.22 Allowed Pre-proline 0 N--CA 1.479 0.979 0 CA-C-O 123.616 1.674 . . . . 0.0 113.361 -171.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.619 ' HG2' HG22 ' A' ' 53' ' ' VAL . 61.8 Cg_endo -81.92 49.53 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 124.773 3.648 . . . . 0.0 119.117 166.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 54' ' ' VAL . 78.4 t -57.7 146.76 6.93 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 126.567 1.947 . . . . 0.0 110.336 166.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -163.93 114.41 1.3 Allowed 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.928 173.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 7.7 p -60.37 144.88 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.538 1.135 . . . . 0.0 108.724 164.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -73.69 -171.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 127.323 2.249 . . . . 0.0 109.138 -167.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.99 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -102.37 157.93 16.56 Favored 'General case' 0 CA--C 1.589 2.473 0 C-N-CA 128.929 2.891 . . . . 0.0 106.635 151.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.3 t -100.56 -16.46 17.48 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 127.381 2.926 . . . . 0.0 109.725 -156.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -103.58 -34.0 8.81 Favored 'General case' 0 C--O 1.284 2.884 0 C-N-CA 126.078 1.751 . . . . 0.0 113.495 173.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -62.34 -44.05 97.38 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 162.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.99 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.71 -83.39 0.01 OUTLIER 'General case' 0 C--N 1.379 1.855 0 O-C-N 125.99 2.056 . . . . 0.0 111.701 169.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.17 16.45 5.75 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 126.599 2.047 . . . . 0.0 111.903 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.4 mmmm -117.34 4.32 12.55 Favored 'General case' 0 C--O 1.259 1.575 0 CA-C-O 121.714 0.768 . . . . 0.0 112.107 156.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.779 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 4.4 t 51.07 58.53 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.087 0 C-N-CA 124.281 1.032 . . . . 0.0 110.528 161.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 1.041 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 t0 -101.99 65.36 0.98 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.476 3.11 . . . . 0.0 111.679 -171.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.759 ' O ' ' HG2' ' A' ' 26' ' ' GLN . . . -77.17 51.08 3.19 Favored Glycine 0 C--N 1.371 2.473 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.724 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD12 ' OE1' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -144.69 -36.19 0.32 Allowed 'General case' 0 C--N 1.376 1.757 0 C-N-CA 128.146 2.578 . . . . 0.0 110.374 174.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -70.07 -23.33 77.21 Favored Glycine 0 C--N 1.376 2.754 0 O-C-N 121.532 -0.73 . . . . 0.0 113.536 153.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.044 HG11 HD11 ' A' ' 19' ' ' LEU 0.323 3.9 t -87.92 -22.36 6.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 C-N-CA 127.035 2.134 . . . . 0.0 114.301 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -69.96 -55.85 8.54 Favored 'General case' 0 C--N 1.367 1.354 0 O-C-N 119.791 -1.818 . . . . 0.0 111.076 159.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 4.7 ttpt -52.77 -52.61 55.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -69.44 -32.26 71.1 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.879 1.672 . . . . 0.0 111.137 -165.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -50.38 -69.86 0.1 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.834 0.854 . . . . 0.0 110.687 161.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 51.8 t -33.56 -53.17 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 122.937 1.351 . . . . 0.0 109.672 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.79 -39.41 62.29 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.27 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -55.96 -53.44 56.82 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.373 1.469 . . . . 0.0 112.532 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -74.1 -8.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 126.79 2.036 . . . . 0.0 108.993 -169.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 11.7 tptm -101.33 -28.26 12.71 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.246 1.418 . . . . 0.0 112.573 170.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.3 2.72 14.86 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 125.108 1.505 . . . . 0.0 112.848 165.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.14 -68.11 0.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.476 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -62.83 155.39 27.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.995 1.718 . . . . 0.0 111.693 -169.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . 153.81 71.64 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.732 1.613 . . . . 0.0 110.24 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.0 m120 . . . . . 0 C--O 1.266 1.964 0 C-N-CA 124.561 1.144 . . . . 0.0 108.468 167.112 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -139.42 118.33 12.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.85 1.26 . . . . 0.0 111.631 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . 2.2 mmpt? -102.1 165.63 11.05 Favored 'General case' 0 C--N 1.382 2.0 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -166.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.69 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -150.13 161.98 41.33 Favored 'General case' 0 C--N 1.37 1.469 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.426 -168.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 34' ' ' VAL . 53.4 m170 -137.18 104.87 5.54 Favored 'General case' 0 C--O 1.254 1.328 0 O-C-N 125.286 1.616 . . . . 0.0 111.677 -153.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -87.06 102.61 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 124.783 1.233 . . . . 0.0 109.553 156.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.862 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 7.0 m-30 -100.04 140.3 34.47 Favored 'General case' 0 C--N 1.371 1.541 0 CA-C-O 124.507 2.098 . . . . 0.0 112.985 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' OG1' ' A' ' 16' ' ' THR . 0.0 OUTLIER -126.94 81.35 2.01 Favored 'General case' 0 C--N 1.401 2.823 0 C-N-CA 126.731 2.013 . . . . 0.0 111.6 -161.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 66.1 m-85 -88.92 63.51 6.8 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 129.245 3.018 . . . . 0.0 113.484 -154.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.916 ' HB2' ' O ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 40.91 -159.0 0.01 OUTLIER 'General case' 0 C--N 1.38 1.925 0 O-C-N 119.793 -1.817 . . . . 0.0 114.449 156.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.861 ' OG ' HG22 ' A' ' 60' ' ' ILE . 3.7 t 145.67 -54.75 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.243 -155.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.12 25.77 1.55 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 125.557 1.785 . . . . 0.0 110.525 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 30.6 92.06 0.01 OUTLIER Glycine 0 C--O 1.254 1.394 0 C-N-CA 126.08 1.8 . . . . 0.0 116.084 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 30.2 mtt 99.73 30.76 0.0 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 126.249 1.819 . . . . 0.0 113.565 154.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.487 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -92.21 21.54 5.07 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.709 144.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.96 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -129.21 -49.49 1.2 Allowed 'General case' 0 C--O 1.252 1.216 0 C-N-CA 129.113 2.965 . . . . 0.0 112.567 -165.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -52.7 -45.33 66.84 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.63 1.172 . . . . 0.0 111.712 -174.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' CB ' HG21 ' A' ' 87' ' ' VAL . 1.1 mt -77.18 -14.76 59.73 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 126.106 1.762 . . . . 0.0 108.327 -170.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.978 HD13 HG21 ' A' ' 92' ' ' VAL 0.282 0.1 OUTLIER -61.77 -57.71 10.83 Favored 'General case' 0 C--O 1.189 -2.13 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 164.768 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.759 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -34.91 -80.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.188 0 C-N-CA 124.855 1.262 . . . . 0.0 108.595 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.561 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.56 -29.86 4.68 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.992 1.377 . . . . 0.0 111.671 -167.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.897 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -75.12 -60.18 2.41 Favored 'General case' 0 CA--C 1.592 2.567 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -39.6 -74.2 0.04 OUTLIER 'General case' 0 C--N 1.371 1.505 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.062 175.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' VAL 0.32 0.1 OUTLIER -35.06 -36.95 0.06 Allowed 'General case' 0 C--N 1.365 1.28 0 CA-C-N 113.264 -1.789 . . . . 0.0 113.397 176.115 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.23 -69.32 0.14 Allowed 'General case' 0 C--N 1.352 0.695 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 162.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.914 ' HB3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -25.06 -66.89 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.986 0 CA-C-O 123.803 1.763 . . . . 0.0 108.558 164.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 32' ' ' VAL . . . -53.45 -54.07 42.31 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-N 113.128 -1.851 . . . . 0.0 112.656 -165.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 15.5 mt-10 -76.03 -36.74 58.98 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 125.961 1.704 . . . . 0.0 109.054 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 12.4 ttpt -52.01 -29.31 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.513 169.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.907 ' CE2' HD21 ' A' ' 93' ' ' LEU . 8.7 m-30 -102.36 -11.8 18.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 125.961 2.038 . . . . 0.0 109.932 -173.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 7.9 tm-20 82.84 10.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.723 1.725 . . . . 0.0 110.803 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 34' ' ' VAL . 4.8 t -69.82 145.93 95.01 Favored Pre-proline 0 C--N 1.379 1.863 0 CA-C-O 123.447 1.594 . . . . 0.0 110.83 -167.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . 0.372 66.2 Cg_endo -75.28 17.49 0.62 Allowed 'Trans proline' 0 C--N 1.378 2.1 2 N-CA-C 122.718 4.084 . . . . 0.0 122.718 176.504 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG12 HG12 ' A' ' 32' ' ' VAL . 6.4 p -109.21 129.69 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.638 1.975 . . . . 0.0 110.601 -174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 3' ' ' LYS . 3.4 mp -92.42 130.21 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 C-N-CA 126.145 1.778 . . . . 0.0 107.482 163.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 23' ' ' MET . 0.3 OUTLIER -95.98 108.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.26 1.647 0 C-N-CA 126.827 2.051 . . . . 0.0 111.547 173.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.862 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 75.0 mm-40 -122.15 131.54 54.01 Favored 'General case' 0 C--O 1.186 -2.269 0 C-N-CA 127.534 2.334 . . . . 0.0 111.826 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 16' ' ' THR . . . -103.96 124.85 49.74 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 126.429 2.33 . . . . 0.0 112.287 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 10' ' ' SER . 22.9 m-85 -123.85 162.4 41.23 Favored Pre-proline 0 C--O 1.208 -1.101 0 C-N-CA 127.827 2.451 . . . . 0.0 110.968 -159.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 42' ' ' THR . 61.3 Cg_endo -92.24 108.41 0.24 Allowed 'Trans proline' 0 C--N 1.373 1.841 1 C-N-CA 125.318 4.012 . . . . 0.0 117.152 162.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.848 ' OE1' HG13 ' A' ' 60' ' ' ILE . 6.9 pt-20 -19.25 -55.34 0.01 OUTLIER 'General case' 0 C--O 1.273 2.321 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.532 -164.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 40' ' ' PRO 0.335 0.4 OUTLIER -4.9 -53.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 129.629 3.171 . . . . 0.0 113.73 165.502 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -93.8 -23.12 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.542 2.737 . . . . 0.0 109.524 -155.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 67' ' ' ILE . . . -48.07 -35.67 11.67 Favored 'General case' 0 C--O 1.185 -2.338 0 CA-C-O 123.67 1.7 . . . . 0.0 109.641 -165.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -47.83 -64.07 3.17 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 112.796 -2.002 . . . . 0.0 110.946 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 3.1 mt-10 -87.77 -32.12 19.27 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 127.528 2.331 . . . . 0.0 111.689 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -88.73 -54.43 4.16 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.596 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.785 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -60.74 -18.79 53.84 Favored Glycine 0 C--N 1.369 2.377 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.437 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.0 tt0 -58.1 -56.37 22.94 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 126.508 1.923 . . . . 0.0 108.619 158.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -64.23 -8.45 12.65 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 123.095 1.426 . . . . 0.0 113.232 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -71.41 167.1 20.31 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-O 122.779 1.276 . . . . 0.0 111.239 159.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.676 ' OD2' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -118.83 -10.58 9.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.502 2.321 . . . . 0.0 112.067 160.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -167.5 89.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.653 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -161.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.786 ' CG1' HD21 ' A' ' 56' ' ' LEU . 42.0 t -97.14 133.03 40.26 Favored 'Isoleucine or valine' 0 C--O 1.254 1.321 0 C-N-CA 127.438 2.295 . . . . 0.0 110.234 -165.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 4.2 mt -119.09 133.85 55.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.104 2.962 . . . . 0.0 109.368 172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.828 HD11 HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -130.59 129.35 42.64 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 126.804 2.042 . . . . 0.0 110.111 -176.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 11' ' ' SER . . . -33.25 151.57 0.01 OUTLIER Glycine 0 C--O 1.255 1.46 0 C-N-CA 125.46 1.505 . . . . 0.0 114.791 -176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -99.28 13.52 0.6 Allowed 'Trans proline' 0 CA--C 1.553 1.442 1 C-N-CA 128.043 5.829 . . . . 0.0 118.858 -179.292 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -107.76 -15.57 14.53 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 112.185 -2.28 . . . . 0.0 110.028 155.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.861 HG22 ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -104.87 7.14 10.1 Favored 'Isoleucine or valine' 0 C--O 1.26 1.637 0 C-N-CA 125.602 1.561 . . . . 0.0 110.173 -175.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -20.04 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.195 1.798 . . . . 0.0 112.256 170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -55.89 -21.94 22.97 Favored 'General case' 0 C--O 1.257 1.472 0 C-N-CA 127.248 2.219 . . . . 0.0 113.276 -165.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.623 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 4.3 mmm -92.51 -32.45 14.86 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 127.071 2.148 . . . . 0.0 111.423 -162.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -43.49 -40.05 5.86 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 127.057 2.143 . . . . 0.0 108.661 175.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 64' ' ' LEU . 1.4 Cg_exo -51.45 -39.83 63.67 Favored 'Trans proline' 0 CA--C 1.594 3.489 0 C-N-CA 124.982 3.788 . . . . 0.0 114.22 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -88.19 -39.69 14.29 Favored 'General case' 0 C--N 1.37 1.459 1 CA-C-N 107.056 -4.611 . . . . 0.0 109.462 -176.775 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 44' ' ' ALA . 14.0 mm -39.2 -59.98 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 C-N-CA 124.754 1.222 . . . . 0.0 110.256 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.557 ' NE2' ' CG1' ' A' ' 76' ' ' VAL . 3.9 mm-40 -66.52 -31.99 73.06 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.121 1.768 . . . . 0.0 111.961 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -69.92 -25.61 63.75 Favored 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.9 1.28 . . . . 0.0 111.076 -174.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 66' ' ' GLU 0.266 3.8 mt -87.85 -54.31 4.31 Favored 'General case' 0 C--N 1.372 1.561 0 C-N-CA 125.321 1.448 . . . . 0.0 107.515 168.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -119.12 73.01 12.89 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.068 2.147 . . . . 0.0 107.993 -164.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 70' ' ' LEU 0.27 32.3 Cg_endo -78.58 -17.05 12.93 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.078 4.519 . . . . 0.0 120.489 -162.057 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -124.19 49.37 1.79 Allowed 'General case' 0 C--N 1.369 1.422 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.797 -161.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -145.95 168.7 11.12 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.432 1.493 . . . . 0.0 111.971 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.66 77.77 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 124.82 3.68 . . . . 0.0 118.4 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.828 HG21 HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.37 140.18 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.728 2.411 . . . . 0.0 110.525 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.5 mt-10 -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.23 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.58 142.18 14.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.279 164.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 80' ' ' ASP . 8.5 mt -72.44 -176.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.773 2.429 . . . . 0.0 108.349 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.03 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 m-20 -90.3 161.89 15.43 Favored 'General case' 0 CA--C 1.589 2.465 0 C-N-CA 126.433 1.893 . . . . 0.0 108.656 152.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 t -101.06 -30.65 11.48 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.657 -2.974 . . . . 0.0 110.626 -161.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -78.88 -56.77 4.15 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 127.087 2.155 . . . . 0.0 111.233 167.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.833 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.286 3.7 mm? -57.54 -38.72 75.21 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.318 1.847 . . . . 0.0 107.227 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.03 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 5.3 t80 -46.45 -79.26 0.02 OUTLIER 'General case' 0 C--O 1.271 2.228 0 C-N-CA 125.785 1.634 . . . . 0.0 111.305 170.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.74 14.78 63.23 Favored Glycine 0 C--O 1.264 2.023 0 C-N-CA 125.025 1.298 . . . . 0.0 113.713 -163.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 82' ' ' LEU 0.251 0.0 OUTLIER -113.61 1.71 15.04 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.274 1.035 . . . . 0.0 111.672 153.485 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 75.61 85.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.403 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.82 158.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.904 ' OD2' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -108.47 108.64 19.66 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 129.346 3.058 . . . . 0.0 113.91 164.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 23' ' ' MET . . . -109.56 99.64 1.25 Allowed Glycine 1 N--CA 1.535 5.241 0 N-CA-C 104.57 -3.412 . . . . 0.0 104.57 150.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER 176.99 -38.34 0.01 OUTLIER 'General case' 0 C--O 1.186 -2.254 0 C-N-CA 127.564 2.346 . . . . 0.0 107.023 165.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.73 -25.72 29.13 Favored Glycine 0 C--N 1.357 1.712 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.287 167.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.978 HG21 HD13 ' A' ' 19' ' ' LEU 0.291 55.7 t -65.8 -46.56 88.49 Favored 'Isoleucine or valine' 0 C--O 1.264 1.824 0 C-N-CA 127.871 2.468 . . . . 0.0 114.733 169.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 26' ' ' GLN . 36.9 tp -53.72 -69.73 0.11 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 126.207 1.803 . . . . 0.0 111.965 161.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.17 -45.62 0.3 Allowed 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.004 1.322 . . . . 0.0 113.285 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.26 83.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.646 1.579 . . . . 0.0 112.46 -176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -57.12 -54.7 43.83 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.226 167.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.719 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 22.6 t -51.26 -44.77 31.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 127.269 2.227 . . . . 0.0 110.17 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.66 67.59 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.301 1.841 . . . . 0.0 112.335 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -85.08 -17.57 36.97 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 125.189 1.555 . . . . 0.0 111.038 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -74.47 -33.46 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 125.615 1.566 . . . . 0.0 107.015 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -97.59 -0.88 45.0 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-N 111.31 -2.677 . . . . 0.0 112.509 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 2.8 tttp -91.66 -9.75 42.81 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.552 0.741 . . . . 0.0 111.397 158.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -45.77 -35.02 4.02 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 125.082 1.489 . . . . 0.0 111.566 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -166.4 -165.26 0.75 Allowed 'General case' 0 C--N 1.368 1.406 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.804 172.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 104' ' ' ALA . . . 106.41 -62.76 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 126.743 2.017 . . . . 0.0 111.121 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.377 1.762 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.186 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 CA-C-O 122.049 0.928 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -140.96 -64.76 0.45 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.608 1.163 . . . . 0.0 110.538 170.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER 168.44 141.02 0.02 OUTLIER 'General case' 0 C--N 1.364 1.227 0 CA-C-O 122.697 1.237 . . . . 0.0 111.877 -169.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -96.51 175.39 6.42 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.325 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 m80 -130.08 95.67 3.99 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.558 1.543 . . . . 0.0 112.423 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.812 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.277 18.8 mt -80.36 91.11 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 126.359 1.863 . . . . 0.0 107.985 171.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.593 ' CE1' ' HB3' ' A' ' 5' ' ' HIS . 12.4 m-30 -88.99 141.24 28.65 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 126.492 1.917 . . . . 0.0 113.694 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.866 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -127.48 149.97 49.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.378 2.271 . . . . 0.0 108.093 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 62.7 m-85 -139.08 102.71 4.59 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.654 1.582 . . . . 0.0 111.2 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' HG21 ' A' ' 16' ' ' THR . 0.1 OUTLIER -92.2 -177.81 4.77 Favored 'General case' 0 C--N 1.38 1.9 0 O-C-N 117.324 -3.36 . . . . 0.0 115.542 -152.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.85 -60.2 0.11 Allowed 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.022 1.329 . . . . 0.0 111.88 -166.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.9 88.53 2.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 125.34 1.65 . . . . 0.0 109.889 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.97 -127.21 0.48 Allowed Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 163.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.73 65.58 1.86 Allowed 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.88 1.8 . . . . 0.0 111.008 -157.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.864 ' OG ' ' HA2' ' A' ' 85' ' ' GLY . 3.1 m -99.92 -56.28 2.42 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-N 110.711 -2.949 . . . . 0.0 107.714 147.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 10' ' ' SER . 0.0 OUTLIER -44.48 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.376 1.727 0 C-N-CA 126.121 1.769 . . . . 0.0 112.171 -173.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.0 m -44.47 -55.62 4.92 Favored 'General case' 0 C--O 1.256 1.399 0 C-N-CA 125.612 1.565 . . . . 0.0 113.371 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.1 mt -71.43 -30.59 66.24 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 128.413 2.685 . . . . 0.0 107.031 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -78.63 -22.42 46.94 Favored 'General case' 0 C--O 1.278 2.601 0 C-N-CA 124.147 0.979 . . . . 0.0 110.895 -177.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 36' ' ' ILE . 99.1 t -73.54 -49.74 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.175 2.59 . . . . 0.0 109.851 161.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -2.51 44.57 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.629 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -78.96 -57.74 3.6 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 123.009 1.385 . . . . 0.0 108.363 155.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.731 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.25 -25.61 67.19 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-N 111.928 -2.397 . . . . 0.0 112.678 -172.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 94.6 mtt180 -70.82 -57.23 4.84 Favored 'General case' 0 C--O 1.204 -1.324 0 C-N-CA 125.17 1.388 . . . . 0.0 109.482 158.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -33.29 -59.87 0.36 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.73 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -52.61 -65.89 0.48 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.711 1.604 . . . . 0.0 108.908 169.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.78 -17.5 64.9 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.604 -164.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -93.43 -32.9 14.04 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 127.561 2.345 . . . . 0.0 108.919 172.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 6.6 ttpt -50.87 -50.45 57.0 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.045 1.466 . . . . 0.0 110.609 163.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.626 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m-85 -73.86 -52.72 12.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -170.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 27.2 mt-10 102.24 8.97 0.01 OUTLIER 'General case' 0 C--O 1.254 1.319 0 C-N-CA 128.507 2.723 . . . . 0.0 113.767 -154.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 30' ' ' TYR . 2.8 t -60.39 100.67 0.22 Allowed Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 127.682 2.393 . . . . 0.0 109.961 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.272 15.5 Cg_exo -63.16 93.89 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.879 1 C-N-CA 125.526 4.15 . . . . 0.0 118.218 -176.355 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -177.68 141.31 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.582 -173.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.7 mm -97.4 113.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 127.113 2.165 . . . . 0.0 110.639 167.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.915 HG22 HG13 ' A' ' 20' ' ' VAL . 1.5 mp -74.97 121.4 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 126.82 2.048 . . . . 0.0 110.737 155.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE1' ' HZ ' ' A' ' 39' ' ' PHE . 24.4 mt-10 -132.11 159.32 39.25 Favored 'General case' 0 C--O 1.267 2.016 0 C-N-CA 125.439 1.495 . . . . 0.0 110.299 164.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.842 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -142.6 142.3 32.12 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 127.328 2.251 . . . . 0.0 109.515 175.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 14.3 m-85 -145.11 165.46 21.93 Favored Pre-proline 0 N--CA 1.508 2.444 0 O-C-N 124.996 1.435 . . . . 0.0 108.373 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.913 ' O ' ' HG3' ' A' ' 41' ' ' GLU 0.313 73.5 Cg_endo -83.82 57.42 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.423 1 C-N-CA 127.536 5.491 . . . . 0.0 122.002 -172.472 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.913 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 2.2 pp20? 46.93 -50.68 0.0 OUTLIER 'General case' 0 C--O 1.257 1.498 0 C-N-CA 126.674 1.989 . . . . 0.0 114.508 -161.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -23.75 -37.37 0.0 OUTLIER 'General case' 0 C--O 1.271 2.203 0 C-N-CA 128.262 2.625 . . . . 0.0 114.259 172.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 13.8 mt -112.65 -9.31 13.75 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.063 2.545 . . . . 0.0 111.325 -169.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -45.92 -55.17 7.09 Favored 'General case' 0 C--N 1.378 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 111.574 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' HD22 ' A' ' 70' ' ' LEU . . . -33.01 -68.32 0.18 Allowed Glycine 0 CA--C 1.56 2.897 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.075 168.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.96 -63.56 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 125.659 1.447 . . . . 0.0 110.044 -167.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 11.9 mmtt -49.02 -59.76 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.369 0.668 . . . . 0.0 111.65 172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -29.75 -73.69 0.05 OUTLIER Glycine 0 C--N 1.36 1.914 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.622 168.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' H ' HD21 ' A' ' 71' ' ' LEU . 11.8 tt0 -46.23 -27.12 0.92 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.427 1.491 . . . . 0.0 109.943 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -99.88 7.87 44.57 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.613 1.565 . . . . 0.0 112.37 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.577 ' O ' ' HE3' ' A' ' 74' ' ' LYS . . . -93.28 163.55 13.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.432 1.493 . . . . 0.0 112.611 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 3.4 m-20 -84.44 -43.59 14.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 129.775 3.23 . . . . 0.0 111.415 163.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 75' ' ' PRO . 73.6 t -151.5 142.45 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 125.132 1.373 . . . . 0.0 107.306 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG22 ' HE2' ' A' ' 9' ' ' PHE . 1.2 t -128.95 136.67 59.17 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.689 -164.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.002 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.6 OUTLIER -137.51 120.02 16.0 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 127.787 2.435 . . . . 0.0 111.064 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.784 ' CD1' HG21 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -113.38 139.62 48.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 127.029 2.132 . . . . 0.0 106.718 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.947 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -34.53 143.99 0.06 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -171.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.901 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.287 25.9 Cg_endo -79.84 7.06 4.81 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.22 3.947 . . . . 0.0 117.06 178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.83 -7.26 19.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 111.433 -2.621 . . . . 0.0 108.945 159.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -106.25 28.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.111 1.364 . . . . 0.0 112.197 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.21 -37.29 10.06 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 123.166 1.46 . . . . 0.0 110.372 160.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.31 1.7 43.69 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 112.943 -1.935 . . . . 0.0 110.197 -162.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG3' HG12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -104.13 -13.94 16.06 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.515 -2.129 . . . . 0.0 110.913 173.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.974 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -54.73 -36.72 47.35 Favored Pre-proline 0 C--N 1.371 1.51 0 C-N-CA 127.061 2.144 . . . . 0.0 109.807 -167.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 20.4 Cg_endo -83.65 -25.68 2.37 Favored 'Trans proline' 0 N--CA 1.483 0.895 1 C-N-CA 126.29 4.66 . . . . 0.0 119.595 178.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 3.4 tt0 -77.26 -57.0 4.07 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.928 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.784 HG21 ' CD1' ' A' ' 56' ' ' LEU . 2.3 mm -40.79 -57.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 125.58 1.8 . . . . 0.0 110.178 170.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.974 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.92 -0.55 57.2 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 125.677 1.591 . . . . 0.0 111.083 -166.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.67 -45.38 79.1 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 124.187 1.946 . . . . 0.0 111.922 155.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD22 ' HA3' ' A' ' 45' ' ' GLY 0.256 0.2 OUTLIER -86.01 -39.33 16.96 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 128.629 2.772 . . . . 0.0 110.23 -171.934 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HA3' ' A' ' 48' ' ' GLY . 19.9 mt -105.82 81.58 0.74 Allowed Pre-proline 0 C--N 1.366 1.296 0 C-N-CA 126.365 1.866 . . . . 0.0 110.103 163.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -38.3 -62.29 0.32 Allowed 'Trans proline' 0 CA--C 1.57 2.277 1 C-N-CA 126.902 5.068 . . . . 0.0 119.612 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 25.4 t30 -148.24 77.04 1.39 Allowed 'General case' 0 C--O 1.271 2.2 0 CA-C-N 110.772 -2.922 . . . . 0.0 111.452 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -151.19 114.74 3.11 Favored Pre-proline 0 N--CA 1.491 1.619 0 CA-C-O 122.981 1.372 . . . . 0.0 110.793 169.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 39.6 Cg_exo -34.78 69.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.46 1 C-N-CA 125.613 4.208 . . . . 0.0 118.897 -150.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 74' ' ' LYS . 61.9 t -77.81 145.18 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.393 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.002 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.0 tp10 179.91 134.71 0.11 Allowed 'General case' 0 C--O 1.254 1.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.897 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 79' ' ' ILE . 10.3 t -36.67 134.56 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 125.566 1.546 . . . . 0.0 108.867 163.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.901 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 12.6 mt -64.11 173.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 161.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -95.25 144.92 25.44 Favored 'General case' 0 CA--C 1.59 2.511 0 C-N-CA 127.316 2.246 . . . . 0.0 106.98 173.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.49 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 8.2 t -87.78 -22.79 24.33 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 125.931 2.02 . . . . 0.0 107.91 -157.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 82' ' ' LEU 0.291 0.0 OUTLIER -91.34 -49.01 6.58 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 127.959 2.503 . . . . 0.0 108.562 176.58 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mt -65.74 -29.22 69.71 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 126.862 2.065 . . . . 0.0 107.999 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.881 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 14.3 t80 -62.53 -72.74 0.12 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 123.61 1.671 . . . . 0.0 110.434 177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.864 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.02 -10.59 86.18 Favored Glycine 0 C--N 1.364 2.084 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.869 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 8.6 mmpt? -93.97 -7.65 42.28 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.309 0.644 . . . . 0.0 110.434 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 15' ' ' SER . 1.5 t 45.94 63.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 164.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.34 98.61 7.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.806 2.043 . . . . 0.0 111.006 170.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.617 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -39.75 -75.35 0.11 Allowed Glycine 0 C--N 1.362 2.027 0 CA-C-N 113.963 -1.471 . . . . 0.0 114.737 172.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.869 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -50.12 -15.56 0.23 Allowed 'General case' 0 C--O 1.265 1.896 0 C-N-CA 127.422 2.289 . . . . 0.0 110.847 -165.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.661 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -96.48 -35.34 5.48 Favored Glycine 0 C--O 1.264 2.006 0 C-N-CA 125.569 1.557 . . . . 0.0 113.984 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 t -67.17 -66.91 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.373 0 C-N-CA 126.407 1.883 . . . . 0.0 112.751 158.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -36.37 -57.46 0.74 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 110.359 170.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 11.7 ttpt -48.6 -56.97 6.96 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -65.03 -20.81 66.68 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 112.698 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.99 -37.57 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.77 1.628 . . . . 0.0 111.761 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 93' ' ' LEU . 55.4 t -70.96 -41.82 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 126.184 1.793 . . . . 0.0 108.97 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.937 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -77.3 -26.22 52.08 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.862 1.265 . . . . 0.0 110.758 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -70.61 -29.1 65.4 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.821 1.648 . . . . 0.0 112.379 164.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -59.93 -64.38 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.19 0 C-N-CA 127.164 2.186 . . . . 0.0 109.696 176.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 100' ' ' ILE . 10.7 tttm -54.28 -50.95 66.08 Favored 'General case' 0 C--N 1.374 1.662 0 CA-C-N 112.284 -2.235 . . . . 0.0 111.847 168.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.937 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -66.92 -23.1 65.94 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.45 -11.59 42.61 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.125 1.77 . . . . 0.0 112.597 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 176.12 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.365 1.466 . . . . 0.0 111.317 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 106' ' ' ASN . . . -98.28 143.87 28.31 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.45 174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.261 1.702 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.865 161.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 77.9 91.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.301 1.84 . . . . 0.0 112.495 171.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -53.88 143.66 20.72 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 163.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -109.44 174.49 5.84 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.809 170.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 32.6 m170 -124.32 127.65 47.95 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 125.483 1.513 . . . . 0.0 113.77 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 36' ' ' ILE . 4.6 mt -108.01 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 127.198 2.199 . . . . 0.0 109.803 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.5 m-30 -91.93 130.06 37.76 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 127.297 2.239 . . . . 0.0 113.214 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.725 HD13 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -117.93 131.66 56.49 Favored 'General case' 0 C--N 1.368 1.4 0 C-N-CA 125.784 1.633 . . . . 0.0 108.379 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 39' ' ' PHE . 18.2 m-30 -119.53 95.68 4.89 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.972 2.109 . . . . 0.0 112.162 -160.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.723 ' O ' ' HB2' ' A' ' 11' ' ' SER . 13.0 t -22.07 -117.53 0.0 OUTLIER 'General case' 0 C--O 1.271 2.195 0 C-N-CA 128.025 2.53 . . . . 0.0 114.907 -154.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.3 t 133.59 -66.84 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 C-N-CA 128.221 2.608 . . . . 0.0 113.625 -161.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.07 -2.08 4.04 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-O 122.691 1.234 . . . . 0.0 111.911 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.44 163.1 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.656 -159.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 77.87 -13.92 0.9 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.546 1.938 . . . . 0.0 112.815 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.874 ' O ' HG22 ' A' ' 16' ' ' THR . 9.4 m -104.78 149.77 25.35 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.937 1.351 . . . . 0.0 111.422 148.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' SER 0.515 8.8 t 95.4 -48.32 0.01 OUTLIER 'General case' 1 N--CA 1.378 -4.072 1 C-N-CA 132.93 4.492 . . . . 0.0 117.456 -164.284 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -46.13 56.9 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.769 1.228 . . . . 0.0 110.88 -167.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -102.55 -0.34 32.29 Favored 'General case' 0 C--N 1.374 1.643 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.649 -175.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.772 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.274 0.5 OUTLIER -69.72 -61.63 1.71 Allowed 'General case' 0 C--O 1.193 -1.877 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 156.113 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.725 HG22 HD13 ' A' ' 8' ' ' LEU . 26.8 t -58.67 -36.4 60.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 126.335 1.854 . . . . 0.0 111.244 -172.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -90.96 -31.5 16.33 Favored 'General case' 0 C--N 1.38 1.899 0 C-N-CA 125.939 1.695 . . . . 0.0 113.77 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.975 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.4 ttmm -71.42 -37.7 71.47 Favored 'General case' 1 N--CA 1.547 4.395 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.774 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -57.17 -71.08 0.1 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.279 2.232 . . . . 0.0 115.0 174.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.545 ' N ' HD13 ' A' ' 36' ' ' ILE . 13.7 mtt-85 -28.61 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.824 1.25 . . . . 0.0 111.352 160.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.975 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -57.61 -48.74 78.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.597 1.959 . . . . 0.0 113.651 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.934 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -86.64 14.55 6.79 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.975 1.71 . . . . 0.0 111.44 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 31' ' ' GLU . . . -106.64 -29.03 9.85 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 124.271 1.028 . . . . 0.0 111.034 156.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.917 ' OE1' ' HA ' ' A' ' 25' ' ' ALA . 7.0 mt-10 -73.17 -55.71 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.441 1.496 . . . . 0.0 110.673 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -34.22 -72.12 0.06 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.015 1.326 . . . . 0.0 111.64 159.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' GLU . 34.4 m-85 -96.09 -27.28 15.15 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.741 -160.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 82.63 14.61 0.43 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.756 -1.215 . . . . 0.0 111.727 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG11 ' HG ' ' A' ' 93' ' ' LEU . 11.9 t -40.35 101.86 0.25 Allowed Pre-proline 0 C--N 1.363 1.17 0 C-N-CA 125.789 1.635 . . . . 0.0 111.531 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' O ' HG12 ' A' ' 34' ' ' VAL . 96.3 Cg_exo -52.49 71.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.573 2.443 1 C-N-CA 125.798 4.332 . . . . 0.0 118.298 -175.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -173.64 155.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.022 0 CA-C-N 111.311 -2.677 . . . . 0.0 110.736 170.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.628 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -94.89 118.38 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 125.401 1.48 . . . . 0.0 110.632 164.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.756 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mp -86.73 120.0 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 127.195 2.198 . . . . 0.0 107.756 172.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 13.8 mt-10 -134.96 119.31 17.85 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.455 1.502 . . . . 0.0 113.245 171.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -79.02 157.81 28.01 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 126.075 1.75 . . . . 0.0 112.986 170.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.709 ' HB2' ' CD1' ' A' ' 9' ' ' PHE 0.423 22.1 m-85 -169.69 161.05 7.18 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 128.361 2.665 . . . . 0.0 108.716 -167.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 42' ' ' THR . 75.4 Cg_endo -84.12 137.03 7.1 Favored 'Trans proline' 0 CA--C 1.598 3.688 0 C-N-CA 122.728 2.285 . . . . 0.0 114.369 156.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -21.82 -34.77 0.0 OUTLIER 'General case' 0 C--O 1.246 0.897 1 O-C-N 129.463 4.227 . . . . 0.0 116.069 171.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.525 HG23 ' HG2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -45.95 -29.87 1.58 Allowed 'General case' 0 C--O 1.259 1.588 0 C-N-CA 127.288 2.235 . . . . 0.0 112.454 166.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -119.62 29.37 7.63 Favored 'General case' 0 C--O 1.197 -1.659 0 C-N-CA 130.895 3.678 . . . . 0.0 109.33 -167.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -91.7 -36.06 13.81 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.713 156.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.717 ' HA2' HD22 ' A' ' 70' ' ' LEU . . . -36.41 -65.66 0.51 Allowed Glycine 0 CA--C 1.548 2.145 0 C-N-CA 125.254 1.407 . . . . 0.0 114.299 158.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 8.3 tp10 -83.15 -51.0 7.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.531 1.932 . . . . 0.0 111.276 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 5.0 mptt -77.78 -46.38 21.82 Favored 'General case' 0 C--O 1.191 -1.997 0 CA-C-O 122.794 1.283 . . . . 0.0 112.788 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -56.21 -25.74 48.32 Favored Glycine 0 C--N 1.367 2.252 0 CA-C-N 112.903 -1.953 . . . . 0.0 115.276 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 17.4 tt0 -62.3 -48.77 78.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.771 1.229 . . . . 0.0 109.897 157.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.84 20.92 14.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.159 2.183 . . . . 0.0 112.911 -170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -100.15 177.98 4.91 Favored 'General case' 0 C--N 1.384 2.071 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.38 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.72 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 t70 -114.09 -32.9 5.88 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.61 3.164 . . . . 0.0 112.287 160.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 100' ' ' ILE . 1.9 t -144.44 111.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.184 0 CA-C-O 122.531 1.158 . . . . 0.0 109.104 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.896 HG12 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -95.26 128.29 46.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.549 0 CA-C-N 114.194 -1.366 . . . . 0.0 109.414 -173.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.014 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -121.24 147.3 45.82 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.534 2.333 . . . . 0.0 109.65 170.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.969 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -159.03 100.45 1.56 Allowed 'General case' 1 N--CA 1.55 4.542 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -158.312 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.956 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -38.9 160.09 0.01 OUTLIER Glycine 0 C--O 1.261 1.809 0 C-N-CA 125.521 1.534 . . . . 0.0 115.031 -153.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 10.0 Cg_endo -61.69 -40.58 44.93 Favored 'Trans proline' 0 CA--C 1.602 3.905 1 C-N-CA 126.49 4.793 . . . . 0.0 113.579 -172.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' OE1' ' CE2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -72.97 -34.11 66.27 Favored 'General case' 0 C--N 1.375 1.688 1 O-C-N 129.346 4.154 . . . . 0.0 111.856 -175.023 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.956 HG23 ' O ' ' A' ' 57' ' ' GLY 0.383 0.0 OUTLIER -43.92 -61.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 C-N-CA 125.542 1.537 . . . . 0.0 108.818 164.697 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.938 ' N ' HD13 ' A' ' 60' ' ' ILE . . . 49.27 -59.25 0.0 OUTLIER 'General case' 0 C--O 1.245 0.84 0 C-N-CA 127.674 2.39 . . . . 0.0 115.514 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' CG ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -67.46 -23.41 65.5 Favored 'General case' 0 C--O 1.259 1.571 0 C-N-CA 130.002 3.321 . . . . 0.0 113.15 -167.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' GLU . 1.4 mmt -87.66 -14.77 39.07 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.601 1.56 . . . . 0.0 110.187 -165.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 tm? -50.59 -38.85 45.68 Favored Pre-proline 0 C--O 1.252 1.208 0 C-N-CA 129.229 3.012 . . . . 0.0 110.661 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.9 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 60.0 Cg_endo -78.25 -22.92 9.32 Favored 'Trans proline' 0 CA--C 1.559 1.753 1 C-N-CA 126.564 4.843 . . . . 0.0 116.814 172.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -65.15 -63.11 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.657 162.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.614 ' CG1' HD22 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -41.12 -68.45 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 C-N-CA 123.876 0.87 . . . . 0.0 110.335 171.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 72' ' ' PRO . 1.2 mp0 -37.03 -43.05 0.45 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 127.636 2.375 . . . . 0.0 114.54 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 2.2 mtt180 -78.52 -30.94 47.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.7 -0.625 . . . . 0.0 109.542 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD22 ' HA2' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -77.35 -28.15 52.93 Favored 'General case' 0 C--O 1.261 1.692 0 O-C-N 125.647 1.842 . . . . 0.0 112.227 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -153.58 69.87 6.59 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 127.137 2.175 . . . . 0.0 110.07 170.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 12.6 Cg_exo -43.12 -23.22 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.117 1 C-N-CA 127.433 5.422 . . . . 0.0 120.066 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 3.0 t-20 -126.52 56.23 1.48 Allowed 'General case' 0 C--N 1.376 1.758 0 CA-C-N 111.939 -2.391 . . . . 0.0 112.437 -168.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 73' ' ' ASN . 10.3 mmtt -142.46 157.77 61.9 Favored Pre-proline 0 C--N 1.368 1.404 0 CA-C-O 122.278 1.037 . . . . 0.0 112.818 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.72 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.316 47.1 Cg_endo -74.34 83.17 1.72 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.419 3.413 . . . . 0.0 118.415 174.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.896 HG13 HG12 ' A' ' 54' ' ' VAL . 63.3 t -100.0 159.68 3.63 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 111.932 -2.394 . . . . 0.0 111.911 -166.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.014 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER 172.54 141.18 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.785 2.434 . . . . 0.0 112.475 162.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.969 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 26.5 m -31.23 173.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 125.992 1.717 . . . . 0.0 111.671 164.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.805 HD13 ' CD1' ' A' ' 84' ' ' TYR 0.379 0.1 OUTLIER -84.18 158.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 122.282 1.039 . . . . 0.0 111.193 155.667 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -74.58 166.76 23.02 Favored 'General case' 0 CA--C 1.575 1.936 0 C-N-CA 128.118 2.567 . . . . 0.0 107.797 160.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.0 t -106.19 -30.54 9.15 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.48 -150.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.718 ' O ' ' HB2' ' A' ' 86' ' ' LYS 0.273 0.1 OUTLIER -107.08 -30.65 8.67 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 128.142 2.577 . . . . 0.0 110.035 174.031 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 3.9 mm? -65.46 -47.82 74.82 Favored 'General case' 0 N--CA 1.518 2.936 0 O-C-N 125.009 1.443 . . . . 0.0 107.518 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.934 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.7 t80 -53.05 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 125.741 1.617 . . . . 0.0 108.478 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 -7.14 82.8 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 125.595 1.569 . . . . 0.0 114.878 -161.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 6.8 mmtt -109.15 15.67 23.08 Favored 'General case' 0 C--N 1.387 2.206 0 CA-C-O 122.093 0.949 . . . . 0.0 112.683 157.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 69.6 t 49.44 66.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.382 1.979 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.059 154.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.06 129.09 56.02 Favored 'General case' 0 C--N 1.376 1.734 0 C-N-CA 126.157 1.783 . . . . 0.0 111.874 159.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.934 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -75.42 -47.21 13.02 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 125.51 1.528 . . . . 0.0 112.738 169.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 12.0 tp -64.85 -46.86 80.11 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 126.642 1.977 . . . . 0.0 109.96 -160.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -47.12 -54.55 9.61 Favored Glycine 0 C--N 1.361 1.937 0 O-C-N 123.462 0.476 . . . . 0.0 112.812 161.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' CE ' ' A' ' 23' ' ' MET 0.348 1.4 m -73.49 -27.69 23.93 Favored 'Isoleucine or valine' 0 C--O 1.285 2.928 0 C-N-CA 127.758 2.423 . . . . 0.0 115.966 -171.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD13 ' SD ' ' A' ' 23' ' ' MET . 7.2 tp -70.49 -52.13 24.19 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 117.599 -3.188 . . . . 0.0 111.256 164.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -82.81 -4.67 58.32 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.757 0.66 . . . . 0.0 112.61 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . -87.27 -45.56 10.5 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 125.402 1.481 . . . . 0.0 112.357 173.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -60.91 -52.32 65.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.668 172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -51.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 C-N-CA 123.731 0.813 . . . . 0.0 109.609 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -45.08 -42.97 9.2 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 126.54 1.936 . . . . 0.0 110.502 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.8 -47.94 82.85 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 123.689 1.709 . . . . 0.0 112.198 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.902 HG21 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -80.4 0.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 128.034 2.534 . . . . 0.0 111.216 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -77.2 -55.86 5.06 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.345 163.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -48.6 -33.3 9.55 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.375 1.047 . . . . 0.0 111.108 173.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' A' ' 102' ' ' LYS . . . -41.51 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.205 1.802 . . . . 0.0 113.0 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' ASN . . . -92.85 131.43 37.89 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.839 2.056 . . . . 0.0 113.278 -166.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.23 -80.24 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.658 1.583 . . . . 0.0 110.623 160.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 104' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.631 1.573 . . . . 0.0 110.091 -166.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.912 0.863 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 2.2 mt-10 -107.7 -16.33 14.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.597 1.559 . . . . 0.0 111.345 -167.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 10.2 mttp 88.61 163.11 0.06 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.541 1.136 . . . . 0.0 113.627 -159.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.805 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.1 mtmt -154.61 153.53 31.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 126.459 2.35 . . . . 0.0 110.478 -165.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 14.3 m170 -107.64 104.24 13.72 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.852 -158.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 36' ' ' ILE 0.253 3.0 mt -86.52 85.03 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 127.519 2.327 . . . . 0.0 109.017 167.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.825 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 16.7 m-30 -95.97 154.07 17.43 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.897 2.079 . . . . 0.0 108.93 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.074 HD22 ' CG2' ' A' ' 20' ' ' VAL 0.492 0.0 OUTLIER -158.52 104.0 1.79 Allowed 'General case' 1 N--CA 1.549 4.525 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 -155.872 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.865 ' HB2' HD12 ' A' ' 56' ' ' LEU . 28.8 m-85 -110.42 107.62 17.37 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 126.675 1.99 . . . . 0.0 109.155 -150.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.692 ' O ' HG21 ' A' ' 60' ' ' ILE . 11.7 t -52.09 145.02 11.06 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 130.746 3.619 . . . . 0.0 118.616 -148.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.771 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -88.36 -24.98 22.96 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 126.451 1.9 . . . . 0.0 112.104 -173.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . 150.46 -25.26 0.0 OUTLIER 'General case' 0 C--O 1.249 1.058 0 CA-C-N 112.496 -2.138 . . . . 0.0 113.335 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 14' ' ' MET . . . 176.9 138.67 3.0 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 126.032 1.777 . . . . 0.0 115.333 -160.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 13' ' ' GLY . 38.0 mmt 42.91 -170.67 0.01 OUTLIER 'General case' 0 C--O 1.256 1.446 0 C-N-CA 125.91 1.684 . . . . 0.0 111.613 169.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.703 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 31.03 24.33 0.0 OUTLIER 'General case' 0 C--O 1.263 1.815 0 C-N-CA 127.23 2.212 . . . . 0.0 115.61 -167.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.826 HG22 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -110.22 -90.53 0.47 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.042 2.537 . . . . 0.0 110.574 173.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 11.7 p -47.29 -39.36 14.41 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.098 -162.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.926 ' HG ' HG11 ' A' ' 87' ' ' VAL . 1.4 pt? -99.49 -0.22 41.11 Favored 'General case' 0 C--O 1.257 1.475 0 C-N-CA 125.97 1.708 . . . . 0.0 112.148 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -93.82 -31.17 14.47 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 128.929 2.892 . . . . 0.0 109.664 163.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.074 ' CG2' HD22 ' A' ' 8' ' ' LEU . 55.8 t -53.36 -57.2 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 CA-C-O 121.89 0.852 . . . . 0.0 109.326 157.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . 69.4 m -78.3 -9.23 59.15 Favored 'General case' 0 C--N 1.371 1.54 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.988 -170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.927 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 8.9 ttmm -84.66 -40.83 16.94 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.154 166.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.959 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 45.7 mtp -48.02 -58.56 4.29 Favored 'General case' 0 C--O 1.265 1.876 0 C-N-CA 127.153 2.181 . . . . 0.0 113.887 163.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.524 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -42.6 -39.61 2.4 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.897 1.679 . . . . 0.0 112.892 164.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -58.37 -61.19 2.76 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.467 1.107 . . . . 0.0 112.786 167.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.959 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -30.09 -67.22 0.09 Allowed 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.786 159.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -83.33 -21.58 33.13 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 125.957 1.703 . . . . 0.0 112.452 -162.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 30.0 mm-40 -86.89 -19.34 29.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.312 1.045 . . . . 0.0 109.252 165.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 4.5 ttpt -71.41 -52.47 18.37 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.133 164.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.575 ' CE2' ' HG2' ' A' ' 29' ' ' LYS . 92.9 m-85 -99.15 -15.44 18.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.872 1.269 . . . . 0.0 109.988 -169.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 22.4 tt0 79.89 7.39 1.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.439 1.496 . . . . 0.0 111.153 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.581 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t -46.91 106.17 0.56 Allowed Pre-proline 0 C--O 1.256 1.444 0 C-N-CA 124.672 1.189 . . . . 0.0 110.883 171.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 88.8 Cg_endo -78.52 39.59 0.81 Allowed 'Trans proline' 0 CA--C 1.574 2.476 1 C-N-CA 127.093 5.195 . . . . 0.0 117.062 -162.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 73.4 t -130.3 85.93 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.473 0 CA-C-N 109.956 -3.293 . . . . 0.0 111.378 -168.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -35.43 119.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 127.521 2.328 . . . . 0.0 109.823 164.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -78.85 155.15 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 127.652 2.381 . . . . 0.0 109.098 163.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.832 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 21.3 mm-40 -169.68 138.36 1.85 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 125.688 1.595 . . . . 0.0 112.392 164.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.967 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -81.93 156.86 24.54 Favored 'General case' 0 C--O 1.271 2.199 0 CA-C-N 114.032 -1.44 . . . . 0.0 112.04 169.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 61.8 m-85 -163.22 149.53 10.12 Favored Pre-proline 0 C--O 1.215 -0.734 0 C-N-CA 130.287 3.435 . . . . 0.0 111.396 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 42' ' ' THR . 47.6 Cg_endo -83.92 66.11 7.16 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 125.135 3.89 . . . . 0.0 118.338 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 56' ' ' LEU . 7.4 pt-20 38.96 -54.96 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-N 110.799 -2.91 . . . . 0.0 114.365 -158.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 40' ' ' PRO 0.416 0.6 OUTLIER -10.53 -47.26 0.0 OUTLIER 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.746 3.619 . . . . 0.0 113.387 167.657 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -92.44 -29.16 16.41 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.904 2.082 . . . . 0.0 108.682 -166.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.79 -35.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 125.114 1.509 . . . . 0.0 111.776 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.903 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.21 -44.01 45.3 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 125.073 1.32 . . . . 0.0 111.452 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.34 -48.75 6.51 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 125.441 1.497 . . . . 0.0 111.039 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 mmtt -66.11 -62.5 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.328 170.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.6 -50.65 6.93 Favored Glycine 0 C--O 1.267 2.217 0 O-C-N 124.999 1.437 . . . . 0.0 113.259 172.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.903 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 15.9 tt0 -42.23 -51.54 4.7 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 124.639 1.175 . . . . 0.0 111.07 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.12 -2.22 51.34 Favored 'General case' 0 C--O 1.257 1.483 0 C-N-CA 125.759 1.624 . . . . 0.0 110.041 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -83.4 143.97 29.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.645 1.978 . . . . 0.0 111.307 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 53' ' ' VAL . 25.4 t0 -85.84 -35.12 20.82 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.672 2.389 . . . . 0.0 112.062 169.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 75' ' ' PRO . 5.1 t -160.01 151.42 5.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.786 0 C-N-CA 125.564 1.546 . . . . 0.0 109.264 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.001 ' CG1' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.8 140.86 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.984 1.714 . . . . 0.0 107.766 -157.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.79 HD22 HG12 ' A' ' 79' ' ' ILE . 1.2 mt -119.1 151.72 37.78 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 126.252 1.821 . . . . 0.0 111.052 158.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 9' ' ' PHE 0.359 1.8 tp -132.64 116.74 17.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.714 2.006 . . . . 0.0 105.774 164.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -14.44 154.7 0.0 OUTLIER Glycine 0 C--N 1.351 1.366 0 C-N-CA 127.533 2.492 . . . . 0.0 118.499 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 79' ' ' ILE 0.42 11.3 Cg_endo -76.74 -21.41 12.74 Favored 'Trans proline' 0 C--N 1.37 1.689 1 C-N-CA 127.913 5.742 . . . . 0.0 121.648 173.48 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.771 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.5 mt-30 -91.1 -32.32 15.9 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.506 168.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.852 ' O ' HD23 ' A' ' 56' ' ' LEU 0.259 0.1 OUTLIER -91.01 36.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.581 164.777 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -83.62 -10.85 57.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.591 2.356 . . . . 0.0 111.949 -173.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 63' ' ' MET . 23.3 p90 -80.1 -32.45 39.14 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 128.896 2.879 . . . . 0.0 111.63 -162.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.675 ' O ' HG12 ' A' ' 67' ' ' ILE . 16.6 mmm -87.16 4.77 41.03 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.803 -164.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -57.0 -43.03 99.25 Favored Pre-proline 0 C--N 1.354 0.771 0 O-C-N 125.717 1.886 . . . . 0.0 111.016 -168.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.684 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 71.2 Cg_endo -73.7 -32.45 7.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.252 2.635 . . . . 0.0 117.548 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.731 ' OE2' HD13 ' A' ' 70' ' ' LEU . 2.3 tp10 -68.15 -45.98 72.05 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 111.341 -2.663 . . . . 0.0 110.015 162.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.841 ' CG2' HG11 ' A' ' 76' ' ' VAL . 16.6 mm -42.39 -59.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.185 1.394 . . . . 0.0 109.142 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.473 ' OE1' HG22 ' A' ' 67' ' ' ILE . 1.3 mm100 -73.21 -11.73 60.62 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.933 1.693 . . . . 0.0 111.966 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 11.4 mmm180 -78.47 -56.77 4.18 Favored 'General case' 0 C--N 1.372 1.545 0 O-C-N 124.806 1.316 . . . . 0.0 110.751 168.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.844 HD23 ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -92.82 -3.21 55.08 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 129.216 3.006 . . . . 0.0 110.813 -161.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -160.41 98.67 1.41 Allowed Pre-proline 0 C--N 1.371 1.532 0 C-N-CA 125.307 1.443 . . . . 0.0 108.894 155.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -98.34 -18.82 0.16 Allowed 'Trans proline' 0 CA--C 1.555 1.531 1 C-N-CA 126.214 4.61 . . . . 0.0 120.147 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -72.47 -5.35 36.18 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 111.703 -2.498 . . . . 0.0 111.978 -172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.626 ' HE3' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.12 167.22 13.44 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.82 ' O ' HG13 ' A' ' 54' ' ' VAL . 33.1 Cg_endo -85.76 124.76 2.69 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 126.541 4.827 . . . . 0.0 120.214 -169.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.001 HG22 ' CG1' ' A' ' 54' ' ' VAL . 71.3 t -138.65 157.86 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 126.704 2.001 . . . . 0.0 106.443 -164.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -157.12 157.96 35.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.598 -1.637 . . . . 0.0 111.769 176.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.1 p -80.46 165.89 2.63 Favored 'Isoleucine or valine' 0 C--O 1.292 3.298 0 O-C-N 125.06 1.475 . . . . 0.0 108.814 152.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.814 HG22 ' O ' ' A' ' 80' ' ' ASP . 5.0 mt -79.06 163.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 128.031 2.532 . . . . 0.0 111.643 168.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 4.3 m-20 -82.85 163.77 20.96 Favored 'General case' 0 CA--C 1.574 1.882 0 C-N-CA 128.89 2.876 . . . . 0.0 111.182 158.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -102.82 -27.82 12.44 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 112.062 -2.336 . . . . 0.0 110.334 -159.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -73.4 -69.75 0.41 Allowed 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.997 2.119 . . . . 0.0 110.131 161.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.288 7.2 mt -50.26 -47.28 55.31 Favored 'General case' 0 C--N 1.39 2.358 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.93 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.0 t80 -45.64 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.92 23.1 1.76 Allowed Glycine 1 CA--C 1.58 4.134 0 C-N-CA 125.236 1.398 . . . . 0.0 113.782 -157.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -132.9 10.95 4.29 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 112.822 -1.689 . . . . 0.0 114.752 156.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.926 HG11 ' HG ' ' A' ' 18' ' ' LEU 0.253 4.7 t 57.62 69.11 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 C-N-CA 128.678 2.791 . . . . 0.0 110.85 161.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.6 m-20 -115.19 119.52 36.64 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 128.794 2.837 . . . . 0.0 111.01 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -88.94 -34.09 9.22 Favored Glycine 0 C--O 1.283 3.219 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' CA ' ' HG3' ' A' ' 26' ' ' GLN . 1.9 tp -71.95 -39.13 69.61 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 125.855 1.662 . . . . 0.0 108.02 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.22 -24.7 22.95 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 124.026 0.829 . . . . 0.0 115.145 160.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 19' ' ' LEU . 74.7 t -99.82 -52.22 9.01 Favored 'Isoleucine or valine' 0 C--N 1.369 1.43 0 C-N-CA 126.226 1.811 . . . . 0.0 111.295 -170.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.4 tp -43.64 -47.54 7.61 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.593 163.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -77.63 -35.96 52.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 123.715 0.634 . . . . 0.0 111.822 -168.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -57.99 -49.76 75.72 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.255 1.022 . . . . 0.0 111.075 165.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 93' ' ' LEU . . . -36.55 -55.5 0.84 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.604 1.562 . . . . 0.0 111.46 163.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.53 -35.75 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.417 1.087 . . . . 0.0 108.985 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -63.79 -32.79 74.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.611 1.564 . . . . 0.0 111.611 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' ALA . . . -80.64 -22.63 40.35 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 125.368 1.467 . . . . 0.0 110.685 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 mm -76.61 -56.62 7.72 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.231 0 C-N-CA 126.621 1.968 . . . . 0.0 107.734 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.746 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -49.97 -45.46 51.5 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 126.426 2.329 . . . . 0.0 112.969 172.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 -12.38 59.82 Favored 'General case' 0 C--O 1.259 1.563 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.132 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -75.09 -8.65 57.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.987 1.715 . . . . 0.0 110.935 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.28 175.66 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.265 170.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.27 -53.12 2.36 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 125.19 1.556 . . . . 0.0 111.08 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.378 1.824 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.454 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.19 -2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.73 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -93.64 85.85 5.0 Favored 'General case' 0 CA--C 1.573 1.85 0 CA-C-N 111.868 -2.424 . . . . 0.0 109.849 -166.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER 178.5 110.15 0.03 OUTLIER 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 123.921 1.819 . . . . 0.0 111.765 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 52' ' ' ASP 0.466 0.0 OUTLIER -174.86 141.47 0.61 Allowed 'General case' 0 C--N 1.386 2.158 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -161.896 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.73 ' CD2' HG11 ' A' ' 34' ' ' VAL . 3.7 m80 -74.24 117.91 16.59 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 129.055 2.942 . . . . 0.0 114.21 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.961 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 3.8 mt -114.53 113.17 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 C-N-CA 129.766 3.226 . . . . 0.0 109.073 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 40.4 m-85 -112.74 135.93 52.92 Favored 'General case' 0 C--N 1.363 1.186 0 CA-C-O 124.228 1.966 . . . . 0.0 113.499 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.969 HD12 HG23 ' A' ' 20' ' ' VAL . 48.3 mt -110.57 96.47 6.21 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 129.01 2.924 . . . . 0.0 111.255 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 56' ' ' LEU . 95.3 m-85 -101.41 101.87 12.57 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -168.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.66 172.03 11.14 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-O 123.781 1.753 . . . . 0.0 113.265 -145.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -46.39 4.48 Favored 'General case' 0 C--N 1.397 2.671 0 CA-C-N 112.664 -2.062 . . . . 0.0 113.753 -162.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.84 42.35 3.06 Favored 'General case' 0 N--CA 1.419 -1.999 0 C-N-CA 128.119 2.568 . . . . 0.0 116.037 -161.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' MET . . . -8.4 103.91 0.01 OUTLIER Glycine 0 C--O 1.265 2.093 0 C-N-CA 125.991 1.758 . . . . 0.0 115.259 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 1.5 mtt 104.27 12.95 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 128.073 2.549 . . . . 0.0 112.119 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.501 ' O ' HD23 ' A' ' 19' ' ' LEU . 40.0 t -101.01 9.23 42.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.163 1.459 . . . . 0.0 110.73 147.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.677 HG22 ' HB1' ' A' ' 38' ' ' ALA . 11.1 m -119.58 -86.56 0.65 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 129.009 2.924 . . . . 0.0 111.562 -160.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.04 -50.02 2.56 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.229 -1.351 . . . . 0.0 112.282 -160.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -72.95 -18.48 61.37 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.4 2.28 . . . . 0.0 109.028 -173.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.889 ' CD1' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -84.21 -31.84 24.86 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.405 2.282 . . . . 0.0 108.472 179.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD12 ' A' ' 8' ' ' LEU . 1.1 t -63.77 -65.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.078 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.651 ' N ' HG12 ' A' ' 20' ' ' VAL . 54.4 p -56.66 -27.44 58.65 Favored 'General case' 0 CA--C 1.585 2.295 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.212 -158.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.947 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -91.53 -33.51 15.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 126.339 2.275 . . . . 0.0 108.652 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.891 ' CE ' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -53.65 -44.81 69.91 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 124.091 1.9 . . . . 0.0 111.145 168.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.817 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -58.56 -55.28 37.06 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-O 122.828 1.299 . . . . 0.0 111.52 167.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.912 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -35.41 -69.47 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.604 173.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.845 ' OE1' ' HB3' ' A' ' 90' ' ' LEU . 1.6 mp0 -18.8 -72.34 0.01 OUTLIER 'General case' 0 C--O 1.183 -2.407 0 C-N-CA 127.614 2.366 . . . . 0.0 109.014 158.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -56.07 -51.9 66.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 126.624 2.452 . . . . 0.0 111.141 -161.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.93 -19.31 52.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.647 1.579 . . . . 0.0 108.631 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 7.1 ttpt -66.63 -35.38 80.03 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.882 169.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.651 ' HB2' HG23 ' A' ' 32' ' ' VAL . 9.5 m-30 -108.02 -58.65 1.95 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.309 1.844 . . . . 0.0 109.435 -158.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 30' ' ' TYR . 6.9 tp10 105.34 48.91 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.159 -153.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.753 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 t -119.74 69.39 12.58 Favored Pre-proline 0 C--N 1.375 1.717 0 C-N-CA 124.724 1.21 . . . . 0.0 111.16 166.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 31' ' ' GLU 0.52 22.5 Cg_exo -65.68 -160.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.579 1 C-N-CA 130.268 7.312 . . . . 0.0 122.485 -161.845 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.813 HG23 ' C ' ' A' ' 3' ' ' LYS 0.272 14.5 t 29.05 -130.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 127.264 2.225 . . . . 0.0 112.412 -148.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.655 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 mt -115.22 131.86 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 127.188 2.195 . . . . 0.0 109.32 -159.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.961 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -101.57 137.9 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.173 145.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 mm-40 -152.63 146.81 25.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.52 1.528 . . . . 0.0 111.604 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.677 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -109.41 131.28 55.21 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 125.401 1.481 . . . . 0.0 110.487 -165.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.868 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 38.2 m-85 -138.68 143.17 36.79 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.005 2.122 . . . . 0.0 110.078 -156.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 39' ' ' PHE . 21.7 Cg_endo -95.86 59.78 0.17 Allowed 'Trans proline' 0 N--CA 1.506 2.238 1 C-N-CA 125.764 4.309 . . . . 0.0 116.191 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.594 ' CD ' ' HG3' ' A' ' 63' ' ' MET 0.25 5.1 pt-20 36.07 -50.51 0.0 OUTLIER 'General case' 0 C--O 1.274 2.354 0 CA-C-N 110.891 -2.868 . . . . 0.0 115.741 -158.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.936 ' OG1' HD13 ' A' ' 43' ' ' LEU 0.303 0.2 OUTLIER 0.01 -55.61 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 131.169 3.788 . . . . 0.0 112.173 169.501 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' OG1' ' A' ' 42' ' ' THR 0.341 0.0 OUTLIER -123.72 24.98 8.28 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.415 -155.553 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -77.02 -38.1 53.63 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 126.788 2.555 . . . . 0.0 109.613 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.915 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -29.62 -63.59 0.15 Allowed Glycine 0 C--N 1.377 2.809 0 CA-C-N 113.255 -1.793 . . . . 0.0 112.652 164.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 1.9 mp0 -76.12 -42.91 45.5 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 112.98 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -91.44 -47.6 7.35 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 123.522 1.63 . . . . 0.0 111.262 -169.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -42.66 -62.59 2.18 Favored Glycine 0 C--N 1.361 1.949 0 CA-C-N 113.535 -1.666 . . . . 0.0 114.075 160.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.915 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -52.69 -30.1 30.19 Favored 'General case' 0 C--O 1.253 1.266 0 C-N-CA 125.182 1.393 . . . . 0.0 110.889 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 1.1 m120 -93.15 7.42 44.34 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.031 1.332 . . . . 0.0 111.605 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.609 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -85.07 162.94 19.11 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-O 123.038 1.399 . . . . 0.0 110.764 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -91.42 -55.67 3.42 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 126.807 2.043 . . . . 0.0 110.26 149.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -124.49 151.61 29.89 Favored 'Isoleucine or valine' 0 C--N 1.382 1.988 0 CA-C-O 124.373 2.035 . . . . 0.0 112.003 171.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.733 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t -140.16 141.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.369 1.429 0 C-N-CA 127.394 2.278 . . . . 0.0 112.1 -171.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -126.13 152.95 45.23 Favored 'General case' 0 C--O 1.172 -3.007 0 C-N-CA 126.351 1.86 . . . . 0.0 111.914 167.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 67' ' ' ILE . 2.6 mm? -106.61 174.13 6.02 Favored 'General case' 0 C--N 1.39 2.364 0 O-C-N 125.683 1.864 . . . . 0.0 109.702 160.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -78.05 151.98 37.77 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-O 123.08 1.378 . . . . 0.0 111.505 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 47.3 Cg_exo -51.21 -37.44 59.15 Favored 'Trans proline' 0 CA--C 1.585 3.055 0 C-N-CA 124.674 3.583 . . . . 0.0 115.909 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -107.37 -1.15 21.87 Favored 'General case' 0 C--O 1.262 1.742 0 CA-C-N 110.316 -3.129 . . . . 0.0 111.168 -167.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.842 HD13 HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -108.96 17.1 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 124.006 1.86 . . . . 0.0 109.099 162.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' PRO . . . -22.71 -64.22 0.04 OUTLIER 'General case' 0 C--N 1.364 1.196 0 CA-C-N 113.177 -1.829 . . . . 0.0 113.165 155.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -44.98 -31.98 1.48 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.54 2.336 . . . . 0.0 109.405 -167.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.672 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 10.0 mmt -70.83 -11.41 60.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.508 1.923 . . . . 0.0 112.375 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 3.0 tm? -58.17 -40.22 81.53 Favored Pre-proline 0 C--O 1.247 0.936 0 C-N-CA 128.302 2.641 . . . . 0.0 111.759 -171.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.852 ' O ' ' HD3' ' A' ' 69' ' ' ARG 0.285 12.3 Cg_exo -71.11 -23.83 24.35 Favored 'Trans proline' 0 CA--C 1.564 2.004 1 C-N-CA 126.354 4.702 . . . . 0.0 117.928 -170.62 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -88.48 -49.57 6.83 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-N 109.819 -3.355 . . . . 0.0 110.256 170.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -43.94 -38.66 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 125.042 1.337 . . . . 0.0 108.942 171.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.911 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 12.9 mm-40 -99.15 -19.65 17.06 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.081 1.752 . . . . 0.0 109.206 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HD3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -88.85 0.47 56.53 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.388 1.075 . . . . 0.0 109.92 170.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.021 HD23 HD13 ' A' ' 71' ' ' LEU . 8.9 tt -129.21 -58.28 1.13 Allowed 'General case' 0 C--O 1.274 2.376 0 C-N-CA 125.969 1.707 . . . . 0.0 111.028 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD13 HD23 ' A' ' 70' ' ' LEU 0.385 0.0 OUTLIER -90.6 97.17 1.1 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 119.836 -1.79 . . . . 0.0 106.799 148.288 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 74' ' ' LYS 0.302 66.6 Cg_endo -75.71 -108.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.022 1 C-N-CA 126.7 4.933 . . . . 0.0 118.099 171.818 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -17.46 -46.96 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.534 1.533 . . . . 0.0 111.649 164.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -46.59 147.44 2.08 Favored Pre-proline 0 N--CA 1.496 1.869 0 C-N-CA 123.072 0.549 . . . . 0.0 111.602 -171.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.566 ' O ' HG22 ' A' ' 53' ' ' VAL . 68.6 Cg_endo -82.78 51.74 3.81 Favored 'Trans proline' 0 CA--C 1.574 2.508 1 C-N-CA 125.924 4.416 . . . . 0.0 118.62 173.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' VAL . 97.0 t -62.64 158.35 3.39 Favored 'Isoleucine or valine' 0 C--N 1.369 1.447 0 CA-C-N 110.868 -2.878 . . . . 0.0 109.468 162.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.878 ' OE1' ' HB2' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -176.13 135.74 0.28 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.288 164.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.9 p -59.26 141.15 16.52 Favored 'Isoleucine or valine' 0 C--N 1.373 1.601 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.507 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.81 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 mt -79.05 175.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 C-N-CA 126.007 1.723 . . . . 0.0 107.082 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.013 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER -86.89 169.86 12.15 Favored 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 126.248 1.819 . . . . 0.0 107.745 165.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -100.3 -30.38 11.91 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.824 -163.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.755 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -77.98 -61.75 1.9 Allowed 'General case' 0 C--N 1.373 1.591 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.042 170.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 mt -50.13 -51.05 46.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.439 1.896 . . . . 0.0 106.955 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.013 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.6 t80 -40.85 -85.99 0.0 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 126.037 1.735 . . . . 0.0 110.739 168.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.96 1.2 60.01 Favored Glycine 0 N--CA 1.498 2.769 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.96 -164.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 3.6 mttt -110.05 7.4 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 123.04 1.4 . . . . 0.0 110.981 167.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.947 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER 51.9 64.37 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.084 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.344 156.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -104.86 57.63 0.69 Allowed 'General case' 0 C--O 1.253 1.255 0 C-N-CA 130.869 3.667 . . . . 0.0 113.753 -174.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 23' ' ' MET . . . -15.41 -76.2 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 125.46 1.505 . . . . 0.0 111.369 169.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -65.1 -17.12 64.2 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.672 1.589 . . . . 0.0 109.347 -171.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.858 ' N ' HD23 ' A' ' 90' ' ' LEU . . . -83.85 -30.21 29.79 Favored Glycine 0 CA--C 1.554 2.47 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.891 HG12 ' CE ' ' A' ' 23' ' ' MET . 60.9 t -82.3 -46.22 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.169 0.988 . . . . 0.0 109.502 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.691 HD13 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -46.5 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.664 1.986 . . . . 0.0 111.059 161.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -48.15 -34.28 9.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.53 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -60.25 -52.72 64.07 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 125.584 1.554 . . . . 0.0 112.189 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -54.45 -48.21 72.0 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.643 1.977 . . . . 0.0 111.443 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.49 -50.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.336 1.854 . . . . 0.0 110.574 171.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.1 -34.1 71.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.667 1.187 . . . . 0.0 111.37 -170.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.878 ' HB2' ' OE1' ' A' ' 77' ' ' GLU . . . -60.82 -68.32 0.32 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.518 1.127 . . . . 0.0 111.574 170.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -26.42 -57.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 C-N-CA 126.188 1.795 . . . . 0.0 107.245 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 1.3 tmtm? -59.09 -66.53 0.49 Allowed 'General case' 0 C--N 1.36 1.038 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.201 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -27.51 -45.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.773 . . . . 0.0 112.324 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.91 -49.28 50.35 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.234 1.013 . . . . 0.0 112.403 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 105' ' ' ALA . . . -41.87 144.2 0.45 Allowed 'General case' 0 C--N 1.352 0.712 0 CA-C-O 123.584 1.659 . . . . 0.0 112.738 -161.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 104' ' ' ALA . . . 118.31 152.53 0.0 OUTLIER 'General case' 0 C--N 1.381 1.968 0 C-N-CA 124.897 1.279 . . . . 0.0 113.418 161.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 125.07 1.348 . . . . 0.0 110.089 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' HG2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 122.144 0.973 . . . . 0.0 110.693 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' HG2' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 25.74 -107.56 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.043 -178.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 2.4 ptpt -174.81 138.1 0.47 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.953 1.301 . . . . 0.0 111.051 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.9 mttp -130.89 -177.24 4.28 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.514 1.133 . . . . 0.0 112.612 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.654 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 12.1 m170 -116.47 132.52 56.65 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.995 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 60.2 mt -104.52 110.09 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 126.635 1.974 . . . . 0.0 108.298 164.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.668 ' CD2' ' HB3' ' A' ' 47' ' ' LYS . 41.6 m-85 -119.68 124.68 46.86 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 128.144 2.578 . . . . 0.0 111.735 -175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.829 ' CD1' HD23 ' A' ' 55' ' ' LEU . 4.4 mp -116.16 99.64 7.38 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 128.678 2.791 . . . . 0.0 112.953 -164.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.917 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 17.9 m-85 -103.83 92.99 4.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.327 2.251 . . . . 0.0 111.515 -157.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.955 ' HA ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -153.99 -175.11 5.23 Favored 'General case' 0 C--N 1.384 2.077 0 O-C-N 119.298 -2.126 . . . . 0.0 111.674 -145.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.654 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -138.65 29.59 2.36 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 113.538 -1.664 . . . . 0.0 110.968 -151.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB3' ' CE2' ' A' ' 84' ' ' TYR . . . -172.61 82.79 0.05 Allowed 'General case' 0 C--O 1.262 1.733 0 C-N-CA 126.506 1.922 . . . . 0.0 113.009 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -48.45 -19.59 1.27 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.308 1.432 . . . . 0.0 113.906 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.35 29.01 7.94 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.828 1.651 . . . . 0.0 110.496 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 12.5 m -135.2 -3.9 2.42 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.077 1.751 . . . . 0.0 113.772 157.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.026 HG22 ' HB1' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -122.98 -58.83 1.63 Allowed 'General case' 0 C--N 1.367 1.362 0 C-N-CA 130.227 3.411 . . . . 0.0 113.046 -166.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.852 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -52.36 -56.46 14.77 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.883 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -75.99 -6.01 48.98 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -170.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.033 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.18 -34.23 9.35 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.252 1.421 . . . . 0.0 107.323 -174.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' CG2' ' A' ' 36' ' ' ILE . 1.2 t -78.51 -26.66 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 164.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.852 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -96.15 -6.64 37.88 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.18 -175.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.876 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.9 ttmt -98.85 -50.62 4.14 Favored 'General case' 0 CA--C 1.585 2.317 0 CA-C-O 122.712 1.244 . . . . 0.0 108.354 165.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.823 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtp -39.29 -59.33 1.06 Allowed 'General case' 0 C--N 1.388 2.243 0 CA-C-N 111.352 -2.658 . . . . 0.0 111.639 161.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 15.6 mtt-85 -57.34 -49.92 74.59 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.337 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -31.59 -55.69 0.27 Allowed 'General case' 0 C--N 1.38 1.916 0 O-C-N 126.976 2.673 . . . . 0.0 109.501 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.645 ' OE1' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -42.2 -90.31 0.0 OUTLIER 'General case' 0 C--O 1.274 2.358 0 C-N-CA 125.964 1.705 . . . . 0.0 112.604 153.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 36' ' ' ILE . . . -33.1 -37.22 0.03 OUTLIER 'General case' 0 C--O 1.264 1.819 0 C-N-CA 129.764 3.226 . . . . 0.0 117.419 -163.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.35 -44.0 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 124.799 1.24 . . . . 0.0 110.431 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 4.6 ttpt -48.22 -19.48 0.29 Allowed 'General case' 0 N--CA 1.523 3.178 0 CA-C-O 122.241 1.02 . . . . 0.0 109.84 164.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' CB ' HG23 ' A' ' 32' ' ' VAL . 76.8 m-85 -116.82 168.0 10.61 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 161.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.31 23.08 2.63 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.167 172.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 30' ' ' TYR . 10.1 t -45.05 119.94 4.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 124.869 1.355 . . . . 0.0 109.953 173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.0 Cg_endo -85.06 59.85 5.51 Favored 'Trans proline' 0 CA--C 1.552 1.413 1 C-N-CA 126.339 4.693 . . . . 0.0 119.435 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 4' ' ' LYS 0.316 0.4 OUTLIER -161.09 153.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.376 1.721 0 CA-C-N 111.555 -2.566 . . . . 0.0 112.053 169.611 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 1.3 mm -116.39 138.85 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 127.274 2.23 . . . . 0.0 111.432 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.995 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -125.41 124.35 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 127.833 2.453 . . . . 0.0 106.578 -165.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 12.2 mt-10 -155.3 121.69 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 125.552 1.782 . . . . 0.0 109.092 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.026 ' HB1' HG22 ' A' ' 16' ' ' THR . . . -107.73 111.12 23.14 Favored 'General case' 0 C--O 1.206 -1.23 0 C-N-CA 126.098 1.759 . . . . 0.0 112.431 -159.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.917 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 10.0 m-30 -120.1 163.19 29.55 Favored Pre-proline 0 C--O 1.197 -1.692 0 C-N-CA 127.85 2.46 . . . . 0.0 111.574 -155.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -94.79 60.49 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 125.192 3.928 . . . . 0.0 119.465 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG2' ' SD ' ' A' ' 63' ' ' MET 0.482 0.0 OUTLIER 42.97 -35.15 0.0 OUTLIER 'General case' 0 C--O 1.295 3.481 1 N-CA-C 122.044 4.09 . . . . 0.0 122.044 -167.385 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 69.5 p -73.26 5.77 3.33 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 130.084 3.354 . . . . 0.0 110.772 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 39' ' ' PHE 0.279 21.2 mt -122.07 29.08 7.21 Favored 'General case' 0 C--N 1.39 2.328 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.467 156.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -83.44 -44.66 14.51 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.372 1.082 . . . . 0.0 111.461 159.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -30.13 -65.75 0.14 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-N 113.204 -1.817 . . . . 0.0 112.284 159.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.598 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 36.6 tp10 -82.16 -57.72 3.27 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.669 1.187 . . . . 0.0 110.498 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 10.2 mmtm -84.06 -42.14 16.44 Favored 'General case' 0 N--CA 1.531 3.614 0 CA-C-O 122.442 1.115 . . . . 0.0 109.717 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 54' ' ' VAL . . . -62.84 -18.65 59.91 Favored Glycine 0 C--N 1.352 1.459 0 C-N-CA 125.377 1.465 . . . . 0.0 115.928 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.873 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.7 tt0 -66.36 -55.9 13.65 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.147 1.379 . . . . 0.0 113.578 154.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.41 12.1 21.69 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.187 1.795 . . . . 0.0 112.271 -163.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.704 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -75.15 172.17 12.86 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.758 1.623 . . . . 0.0 113.879 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 9.8 t0 -101.52 -51.71 3.4 Favored 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 128.056 2.543 . . . . 0.0 108.484 151.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.867 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.4 t -129.23 154.17 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.051 0 CA-C-N 112.274 -2.239 . . . . 0.0 110.22 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 76' ' ' VAL . 5.7 t -154.95 140.03 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 113.19 -1.823 . . . . 0.0 108.229 -167.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 ' CD1' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -128.32 144.41 51.13 Favored 'General case' 0 C--O 1.257 1.471 0 C-N-CA 127.762 2.425 . . . . 0.0 112.391 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.734 HD23 HD11 ' A' ' 67' ' ' ILE . 2.3 tm? -120.05 123.59 43.79 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 129.95 3.3 . . . . 0.0 110.144 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' CA ' ' OG ' ' A' ' 10' ' ' SER . . . -35.79 154.41 0.01 OUTLIER Glycine 0 N--CA 1.476 1.309 0 C-N-CA 125.304 1.431 . . . . 0.0 112.463 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 79' ' ' ILE 0.316 84.2 Cg_endo -76.07 -5.97 16.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 125.093 3.862 . . . . 0.0 117.868 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.654 ' NE2' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -109.89 -33.09 6.82 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 112.21 -2.268 . . . . 0.0 111.122 -176.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -77.39 -8.35 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 126.574 1.95 . . . . 0.0 108.619 172.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 3.9 -66.75 0.0 OUTLIER 'General case' 0 C--O 1.254 1.295 0 C-N-CA 125.938 1.695 . . . . 0.0 113.434 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.716 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.83 -15.68 13.59 Favored 'General case' 0 C--O 1.281 2.746 0 C-N-CA 126.744 2.018 . . . . 0.0 112.946 -167.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 60' ' ' ILE . 10.5 mtt -72.36 -2.1 17.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.587 2.755 . . . . 0.0 113.659 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 4.8 tp -68.71 -40.65 18.56 Favored Pre-proline 0 C--N 1.367 1.369 0 C-N-CA 127.136 2.174 . . . . 0.0 112.409 -171.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.699 ' O ' ' HG3' ' A' ' 69' ' ' ARG 0.277 3.0 Cg_exo -75.3 -30.44 6.74 Favored 'Trans proline' 0 CA--C 1.584 2.986 1 C-N-CA 126.19 4.593 . . . . 0.0 116.019 179.007 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.95 -46.79 70.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 110.408 -3.087 . . . . 0.0 113.594 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.072 HG21 HG11 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -46.59 -55.29 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 123.575 0.75 . . . . 0.0 109.876 168.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' A' ' 67' ' ' ILE . 1.5 mm100 -74.11 -21.45 59.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 126.719 2.008 . . . . 0.0 112.201 -164.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm105 -78.2 -36.7 46.96 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.71 -61.78 1.67 Allowed 'General case' 0 C--N 1.373 1.607 0 C-N-CA 128.205 2.602 . . . . 0.0 110.245 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mt -127.0 80.39 71.55 Favored Pre-proline 0 C--N 1.363 1.168 0 C-N-CA 127.07 2.148 . . . . 0.0 109.841 -162.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 18.5 Cg_endo -93.4 -3.83 3.1 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 124.857 3.705 . . . . 0.0 118.219 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.46 -31.74 12.66 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.298 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 11.2 mptt -73.84 139.37 76.89 Favored Pre-proline 0 N--CA 1.504 2.263 0 C-N-CA 123.64 0.776 . . . . 0.0 112.751 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 68.7 Cg_endo -81.81 61.89 8.04 Favored 'Trans proline' 0 N--CA 1.491 1.359 1 C-N-CA 125.937 4.425 . . . . 0.0 116.882 169.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 67' ' ' ILE . 3.5 t -57.93 135.66 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 111.472 -2.604 . . . . 0.0 111.61 160.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -121.04 170.7 9.27 Favored 'General case' 0 C--O 1.196 -1.716 0 C-N-CA 127.962 2.505 . . . . 0.0 111.636 162.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.1 p -108.26 141.94 22.21 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 112.147 -2.297 . . . . 0.0 108.425 156.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.5 mt -84.1 171.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 123.407 1.575 . . . . 0.0 110.145 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.981 ' O ' ' HB2' ' A' ' 84' ' ' TYR 0.274 3.4 m-20 -89.14 166.33 13.91 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 129.652 3.181 . . . . 0.0 109.013 161.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.55 -15.59 14.75 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 126.347 2.28 . . . . 0.0 109.944 -161.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.07 -53.69 4.03 Favored 'General case' 0 C--N 1.37 1.496 0 C-N-CA 125.581 1.552 . . . . 0.0 110.142 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -61.44 -39.9 92.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.981 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 3.7 t80 -45.03 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.261 1.667 0 C-N-CA 125.716 1.606 . . . . 0.0 111.708 163.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 15' ' ' SER . . . -73.3 0.47 47.84 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.284 1.897 . . . . 0.0 113.276 -167.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 87' ' ' VAL 0.278 0.0 OUTLIER -113.38 10.13 18.29 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 156.904 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 2.2 m 59.34 37.84 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.011 0 C-N-CA 127.296 2.239 . . . . 0.0 112.841 153.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.935 ' O ' HG23 ' A' ' 92' ' ' VAL . 68.2 t0 -75.29 77.09 2.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.482 3.113 . . . . 0.0 113.202 -167.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA3' ' OE1' ' A' ' 26' ' ' GLN . . . -41.28 -71.81 0.3 Allowed Glycine 0 C--N 1.365 2.191 0 C-N-CA 127.402 2.429 . . . . 0.0 118.406 174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -38.63 -31.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.058 0.943 . . . . 0.0 109.219 -177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . -80.81 -45.52 7.7 Favored Glycine 0 C--N 1.357 1.741 0 C-N-CA 125.97 1.748 . . . . 0.0 115.381 171.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.033 HG11 HD11 ' A' ' 19' ' ' LEU 0.261 2.6 t -71.34 -26.16 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.29 -81.88 0.01 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.165 1.786 . . . . 0.0 112.379 158.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.642 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 20.4 ptmt -55.13 -28.24 51.19 Favored 'General case' 0 N--CA 1.511 2.59 0 O-C-N 120.965 -1.084 . . . . 0.0 109.517 -171.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 94' ' ' LYS . . . -74.94 -37.91 61.88 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.847 1.342 . . . . 0.0 110.698 -172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.867 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -56.78 -53.45 57.64 Favored 'General case' 0 C--N 1.369 1.418 0 CA-C-O 122.048 0.928 . . . . 0.0 111.032 163.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 100' ' ' ILE . 3.1 t -40.76 -61.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 122.926 1.346 . . . . 0.0 109.984 166.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.21 -35.46 59.93 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.446 1.898 . . . . 0.0 110.693 -165.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' HG13 ' A' ' 53' ' ' VAL . . . -66.63 -48.57 69.03 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.008 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.86 HG22 HG21 ' A' ' 53' ' ' VAL 0.257 0.1 OUTLIER -57.5 -23.15 19.09 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.743 0 C-N-CA 125.915 1.686 . . . . 0.0 108.569 -166.511 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -102.19 -22.47 14.18 Favored 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.28 -2.236 . . . . 0.0 115.779 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 3.56 29.25 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 160.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.47 -44.12 15.08 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.611 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 66.86 -161.25 0.24 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.864 1.666 . . . . 0.0 111.076 -165.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 179.23 -54.33 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.302 1.441 . . . . 0.0 110.744 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 6.2 t-20 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 125.555 1.542 . . . . 0.0 109.953 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.806 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 1.2 tp10 61.58 52.02 3.8 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.224 2.21 . . . . 0.0 111.569 160.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HB3' ' C ' ' A' ' 33' ' ' PRO . 12.5 mmmt -96.77 159.7 14.78 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -42.59 136.69 2.4 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.906 1.682 . . . . 0.0 114.905 -163.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 9.2 m170 -85.41 102.95 13.87 Favored 'General case' 0 C--N 1.368 1.388 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.634 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.939 HG22 HG23 ' A' ' 36' ' ' ILE . 33.5 mt -86.53 127.05 40.68 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.114 2.166 . . . . 0.0 112.368 158.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 21.9 m-30 -132.87 138.79 47.14 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.219 2.207 . . . . 0.0 111.947 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.107 HD12 HG22 ' A' ' 20' ' ' VAL . 56.8 mt -120.13 101.79 8.07 Favored 'General case' 0 C--N 1.369 1.436 0 C-N-CA 127.733 2.413 . . . . 0.0 112.768 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.982 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 18.2 m-85 -108.35 70.94 0.77 Allowed 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 127.373 2.269 . . . . 0.0 106.143 -168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.85 ' HA ' HG21 ' A' ' 60' ' ' ILE . 4.3 t -162.71 -171.4 2.71 Favored 'General case' 0 C--N 1.401 2.81 0 CA-C-N 110.682 -2.963 . . . . 0.0 109.691 -167.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.572 ' CB ' ' OH ' ' A' ' 84' ' ' TYR . 23.4 t 116.68 -77.65 0.0 OUTLIER 'General case' 0 C--O 1.248 0.999 0 C-N-CA 125.862 1.665 . . . . 0.0 115.326 146.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 121.96 -88.37 0.0 OUTLIER 'General case' 0 C--N 1.372 1.572 0 C-N-CA 124.587 1.155 . . . . 0.0 112.449 -156.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.66 -93.01 1.83 Allowed Glycine 0 C--O 1.267 2.188 0 O-C-N 125.235 1.584 . . . . 0.0 116.397 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 72.59 1.41 Allowed 'General case' 0 C--N 1.371 1.539 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.88 29.25 4.75 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 127.367 2.267 . . . . 0.0 109.774 146.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -107.14 -63.85 1.25 Allowed 'General case' 0 C--N 1.371 1.531 0 CA-C-N 110.685 -2.962 . . . . 0.0 110.903 156.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.879 ' O ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -58.84 -30.99 68.1 Favored 'General case' 0 C--O 1.267 2.009 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.003 -163.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -92.78 -16.14 25.73 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 127.374 2.27 . . . . 0.0 108.741 178.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -83.75 -37.22 22.93 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 127.339 2.256 . . . . 0.0 109.742 171.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.107 HG22 HD12 ' A' ' 8' ' ' LEU . 88.3 t -63.9 -44.8 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.187 0 O-C-N 119.536 -1.978 . . . . 0.0 106.538 164.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.879 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -82.93 -7.19 59.69 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 111.775 -2.466 . . . . 0.0 113.661 -173.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' A' ' 87' ' ' VAL . 12.1 ttmm -97.62 -32.65 11.68 Favored 'General case' 0 C--N 1.383 2.024 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.323 161.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.871 ' HB3' HD13 ' A' ' 36' ' ' ILE . 14.7 mtp -65.84 -31.69 72.79 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 123.181 1.467 . . . . 0.0 109.005 169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 82.0 mtt180 -69.56 -54.58 13.4 Favored 'General case' 0 C--N 1.362 1.125 0 C-N-CA 124.784 1.234 . . . . 0.0 110.311 171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LYS . . . -34.61 -71.61 0.06 Allowed 'General case' 0 C--O 1.195 -1.802 0 O-C-N 124.498 1.124 . . . . 0.0 110.123 164.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.848 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -17.9 -58.71 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.228 162.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.65 -80.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 125.279 1.612 . . . . 0.0 110.695 -168.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -33.06 -41.84 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.508 0.723 . . . . 0.0 111.722 166.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.848 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 17.3 ttpt -46.46 -54.6 8.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 111.94 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 25.8 m-85 -109.43 -28.4 8.96 Favored 'General case' 0 C--O 1.265 1.886 0 C-N-CA 125.818 1.647 . . . . 0.0 112.754 -161.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 30' ' ' TYR . 1.3 tm-20 89.77 28.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.409 1.484 . . . . 0.0 110.427 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 30' ' ' TYR . 40.8 t -79.92 133.6 57.97 Favored Pre-proline 0 N--CA 1.506 2.346 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' C ' ' HB3' ' A' ' 3' ' ' LYS . 96.8 Cg_endo -84.04 87.27 1.19 Allowed 'Trans proline' 0 CA--C 1.555 1.568 0 C-N-CA 124.335 3.356 . . . . 0.0 118.536 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 4' ' ' LYS 0.26 0.1 OUTLIER -175.79 100.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.6 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.772 166.867 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -41.05 141.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 126.975 2.11 . . . . 0.0 109.228 161.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.939 HG23 HG22 ' A' ' 6' ' ' ILE . 1.4 mt -125.11 140.71 47.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.895 0 C-N-CA 126.89 2.076 . . . . 0.0 109.371 170.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -154.12 151.12 28.89 Favored 'General case' 0 CA--C 1.557 1.231 0 O-C-N 125.27 1.607 . . . . 0.0 110.255 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' C ' ' CD1' ' A' ' 39' ' ' PHE . . . -121.48 156.7 32.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.203 1.801 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -168.55 168.22 5.68 Favored Pre-proline 0 C--O 1.257 1.499 0 C-N-CA 129.591 3.156 . . . . 0.0 110.534 -174.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.713 ' O ' HG23 ' A' ' 42' ' ' THR . 17.7 Cg_endo -100.27 66.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 129.335 6.69 . . . . 0.0 121.532 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 1.5 pp20? 39.41 -47.55 0.0 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 127.6 2.36 . . . . 0.0 116.54 -162.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -21.14 -46.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 126.902 2.081 . . . . 0.0 111.542 167.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -95.03 -20.55 19.24 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 128.174 2.59 . . . . 0.0 109.47 -171.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . . . -34.69 -58.42 0.5 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.3 1.0 . . . . 0.0 110.962 167.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -36.86 -60.22 1.03 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.844 2.164 . . . . 0.0 113.772 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -95.78 -38.42 10.33 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 125.803 1.641 . . . . 0.0 110.016 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 39' ' ' PHE . 3.1 mptt -75.63 -62.32 1.62 Allowed 'General case' 0 C--N 1.371 1.54 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.399 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -37.25 -46.36 1.35 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 124.53 1.062 . . . . 0.0 114.721 162.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.958 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 12.7 tt0 -57.7 -37.53 73.63 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 170.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -95.89 14.85 22.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.129 0.972 . . . . 0.0 112.39 -178.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -97.21 157.78 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.315 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -80.15 -49.69 11.34 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.634 1.974 . . . . 0.0 112.34 153.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 75' ' ' PRO . 42.9 t -133.65 129.58 55.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.455 0 CA-C-O 123.395 1.569 . . . . 0.0 111.663 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.2 t -107.43 95.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.372 1.546 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.512 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.993 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 28.9 tp -107.03 108.45 19.95 Favored 'General case' 0 C--O 1.177 -2.753 0 C-N-CA 126.787 2.035 . . . . 0.0 109.779 -169.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 9' ' ' PHE . 3.6 tt -110.02 170.78 7.85 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.99 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -79.77 163.47 47.87 Favored Glycine 0 C--N 1.361 1.97 0 O-C-N 124.698 1.249 . . . . 0.0 112.711 -160.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.909 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 40.9 Cg_endo -88.24 -32.47 0.15 Allowed 'Trans proline' 0 CA--C 1.565 2.029 1 C-N-CA 125.462 4.108 . . . . 0.0 117.112 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.38 -26.39 64.63 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.764 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -121.01 41.23 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 C-N-CA 127.017 2.127 . . . . 0.0 107.508 -176.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.88 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -94.21 31.86 1.62 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.678 -164.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.662 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 10.0 p90 -113.93 -53.59 2.66 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 127.595 2.358 . . . . 0.0 111.526 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.738 ' CE ' HD11 ' A' ' 60' ' ' ILE . 5.7 mtm -44.92 -21.5 0.06 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 127.021 2.128 . . . . 0.0 115.935 -166.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.782 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -23.82 -50.54 0.11 Allowed Pre-proline 0 C--O 1.27 2.163 0 C-N-CA 128.047 2.539 . . . . 0.0 111.378 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 62' ' ' TYR 0.263 24.2 Cg_exo -64.63 -33.11 56.71 Favored 'Trans proline' 0 CA--C 1.57 2.324 1 C-N-CA 126.138 4.559 . . . . 0.0 115.286 -166.912 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -76.58 -29.65 56.68 Favored 'General case' 0 C--O 1.255 1.372 0 CA-C-N 111.076 -2.784 . . . . 0.0 114.595 167.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.871 HG21 HG21 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -51.12 -66.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.762 2.025 . . . . 0.0 109.369 163.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PRO . 14.5 mm-40 -43.14 -52.4 5.51 Favored 'General case' 0 C--N 1.37 1.467 0 CA-C-N 113.029 -1.896 . . . . 0.0 108.622 176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 3.9 mtm180 -69.71 -20.0 63.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 125.373 1.671 . . . . 0.0 110.407 -169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.38 -45.36 16.21 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.854 2.462 . . . . 0.0 110.152 171.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -136.39 73.64 56.04 Favored Pre-proline 0 C--N 1.363 1.19 0 C-N-CA 127.08 2.152 . . . . 0.0 110.563 -176.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 71' ' ' LEU 0.317 11.8 Cg_exo -70.93 52.84 1.43 Allowed 'Trans proline' 0 CA--C 1.569 2.234 1 C-N-CA 125.817 4.344 . . . . 0.0 118.139 -172.456 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -174.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.136 -2.302 . . . . 0.0 112.447 161.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' H ' ' ND2' ' A' ' 73' ' ' ASN . 7.1 mttm -35.82 138.91 0.41 Allowed Pre-proline 0 N--CA 1.498 1.927 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.633 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' HG13 ' A' ' 53' ' ' VAL 0.391 57.2 Cg_endo -69.26 72.92 1.17 Allowed 'Trans proline' 0 CA--C 1.557 1.674 1 C-N-CA 125.545 4.163 . . . . 0.0 118.921 -179.3 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.871 HG21 HG21 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -88.78 147.86 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 112.18 -2.282 . . . . 0.0 109.31 -174.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.993 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.16 138.48 20.46 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 127.287 2.235 . . . . 0.0 112.461 169.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.99 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.1 p -57.27 161.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 CA-C-O 122.901 1.334 . . . . 0.0 107.914 162.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.909 ' O ' ' HB3' ' A' ' 58' ' ' PRO 0.309 1.5 mt -80.06 158.94 4.41 Favored 'Isoleucine or valine' 0 C--O 1.251 1.18 0 O-C-N 118.885 -2.384 . . . . 0.0 113.566 153.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.828 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 11.6 m-20 -73.28 162.94 28.79 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 129.76 3.224 . . . . 0.0 106.978 160.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -101.8 -24.23 14.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 113.101 -1.863 . . . . 0.0 112.591 -155.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -93.25 -42.13 9.51 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.064 1.746 . . . . 0.0 111.582 168.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.262 9.8 mt -63.98 -50.08 69.95 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.828 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 61.3 t80 -42.83 -81.27 0.01 OUTLIER 'General case' 0 C--N 1.387 2.234 0 C-N-CA 126.3 1.84 . . . . 0.0 111.249 168.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.61 -2.82 81.9 Favored Glycine 0 CA--C 1.546 2.015 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.438 -163.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' A' ' 86' ' ' LYS . 1.2 ptmt -115.88 12.42 15.79 Favored 'General case' 0 CA--C 1.56 1.361 0 O-C-N 124.56 0.8 . . . . 0.0 110.462 161.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 2.9 t 45.65 70.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.076 160.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.7 m-20 -110.06 66.22 0.63 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 129.049 2.939 . . . . 0.0 111.693 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' HA3' ' NE2' ' A' ' 26' ' ' GLN . . . -13.62 -67.12 0.01 OUTLIER Glycine 0 C--N 1.364 2.13 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 170.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.787 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 4.7 tp -50.77 -70.25 0.09 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 127.518 2.327 . . . . 0.0 108.812 -168.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -22.63 -42.97 0.01 OUTLIER Glycine 0 N--CA 1.501 3.031 0 C-N-CA 124.595 1.093 . . . . 0.0 110.641 163.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 23' ' ' MET . 9.4 t -87.91 -27.94 5.56 Favored 'Isoleucine or valine' 0 C--O 1.279 2.652 0 C-N-CA 124.479 1.112 . . . . 0.0 113.018 -169.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -73.87 -47.74 36.05 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 128.442 2.697 . . . . 0.0 107.571 171.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -57.24 -44.42 83.81 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.973 0.892 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -48.88 -67.75 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.152 1.381 . . . . 0.0 111.733 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -38.95 -55.86 1.48 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.904 1.682 . . . . 0.0 111.703 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.19 -41.54 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 124.01 0.924 . . . . 0.0 109.033 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -64.96 -36.72 85.3 Favored 'General case' 0 C--N 1.369 1.444 0 CA-C-O 122.131 0.967 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -44.83 -61.89 1.43 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.726 1.61 . . . . 0.0 111.086 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.679 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -44.75 -71.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 125.33 1.452 . . . . 0.0 109.556 178.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.679 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -41.93 -41.53 2.5 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-N 113.743 -1.572 . . . . 0.0 112.523 -170.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -48.69 78.41 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.773 0.829 . . . . 0.0 111.45 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -37.23 -39.8 0.29 Allowed 'General case' 0 C--N 1.357 0.927 0 C-N-CA 125.66 1.584 . . . . 0.0 111.386 175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -39.55 150.24 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.172 0.989 . . . . 0.0 111.659 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 106' ' ' ASN . . . 163.05 -59.21 0.0 OUTLIER 'General case' 0 C--O 1.247 0.947 0 C-N-CA 125.299 1.44 . . . . 0.0 110.792 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 105' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--O 1.269 2.131 0 C-N-CA 124.518 1.127 . . . . 0.0 110.262 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.512 2.646 0 CA-C-O 123.138 1.447 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 1.9 mt-10 162.18 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.408 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 13.0 mmtm 96.7 123.15 0.02 OUTLIER 'General case' 0 C--O 1.254 1.316 0 C-N-CA 124.232 1.013 . . . . 0.0 113.029 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.575 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 mttp -85.21 165.91 16.99 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.729 174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 6.5 m80 -132.98 113.02 12.34 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.93 1.348 . . . . 0.0 112.123 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 21.0 mt -78.31 89.75 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 126.366 1.866 . . . . 0.0 107.864 155.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 8.9 m-30 -88.8 137.47 32.29 Favored 'General case' 0 C--N 1.371 1.526 0 C-N-CA 127.494 2.317 . . . . 0.0 112.478 163.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.951 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.527 0.3 OUTLIER -156.63 125.19 5.79 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -162.563 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.775 ' HB2' HD22 ' A' ' 56' ' ' LEU . 33.5 m-85 -126.03 107.02 10.03 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.404 -150.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.02 -161.63 1.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 O-C-N 119.489 -2.007 . . . . 0.0 112.276 -161.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -140.52 -63.79 0.47 Allowed 'General case' 0 C--N 1.393 2.48 0 CA-C-N 112.569 -2.105 . . . . 0.0 111.376 -161.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -51.29 83.47 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 129.223 3.009 . . . . 0.0 114.693 -159.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 32.68 -86.44 0.01 OUTLIER Glycine 0 C--N 1.369 2.416 0 N-CA-C 116.172 1.229 . . . . 0.0 116.172 163.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.886 ' HG3' ' O ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -120.57 94.12 4.26 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 126.014 1.726 . . . . 0.0 109.789 169.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.989 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.5 m -172.29 24.04 0.01 OUTLIER 'General case' 0 C--O 1.29 3.232 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.214 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.852 HG22 HD21 ' A' ' 8' ' ' LEU 0.277 0.0 OUTLIER -135.62 -58.22 0.78 Allowed 'General case' 0 C--O 1.249 1.056 1 C-N-CA 132.054 4.142 . . . . 0.0 115.219 -173.786 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -53.31 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.461 1.6 . . . . 0.0 111.084 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.9 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -74.8 11.89 0.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.67 1.588 . . . . 0.0 109.208 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.989 HD12 ' O ' ' A' ' 15' ' ' SER 0.416 0.4 OUTLIER -76.92 -70.51 0.46 Allowed 'General case' 0 CA--C 1.601 2.913 0 C-N-CA 126.914 2.085 . . . . 0.0 107.491 149.983 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -52.61 -24.99 7.3 Favored 'Isoleucine or valine' 0 C--O 1.267 2.005 0 C-N-CA 125.84 1.656 . . . . 0.0 108.754 178.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -100.37 -26.27 13.94 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 125.917 1.687 . . . . 0.0 113.408 -177.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.92 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 37.9 ttmt -79.28 -39.19 33.57 Favored 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.703 170.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.999 ' HE3' HG21 ' A' ' 36' ' ' ILE . 7.2 mtm -53.29 -58.62 6.43 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.838 167.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.727 ' HD3' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -39.4 -36.97 0.4 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 22' ' ' LYS 0.254 . . -63.27 -33.28 75.16 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -178.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.973 ' OE1' ' HA ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -64.59 -65.85 0.62 Allowed 'General case' 0 C--O 1.196 -1.727 0 C-N-CA 125.841 1.656 . . . . 0.0 110.556 156.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' HD11 ' A' ' 93' ' ' LEU . . . -75.7 1.08 15.58 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 126.189 1.796 . . . . 0.0 113.092 -156.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -123.48 -22.61 4.99 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.696 166.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.5 ttpt -47.39 -26.78 1.41 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.206 157.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.618 ' HB2' HG23 ' A' ' 32' ' ' VAL . 35.6 m-85 -109.79 -102.12 0.38 Allowed 'General case' 0 C--O 1.265 1.913 0 C-N-CA 126.344 1.858 . . . . 0.0 113.516 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 24.7 mt-10 -177.78 21.98 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.431 2.293 . . . . 0.0 111.398 -171.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' TYR . 45.2 t -85.5 99.77 1.04 Allowed Pre-proline 0 C--O 1.248 1.017 0 C-N-CA 126.543 1.937 . . . . 0.0 111.236 -163.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.298 66.8 Cg_endo -70.14 31.35 0.2 Allowed 'Trans proline' 0 C--O 1.254 1.288 1 C-N-CA 126.818 5.012 . . . . 0.0 119.987 -167.432 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.636 HG11 HG13 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -96.46 160.38 2.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 124.191 1.948 . . . . 0.0 111.388 164.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.5 mm -110.34 149.82 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 119.965 -1.709 . . . . 0.0 109.498 149.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.999 HG21 ' HE3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -109.9 125.04 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.371 0 C-N-CA 127.066 2.146 . . . . 0.0 107.9 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.8 mt-10 -137.8 157.99 45.3 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.87 1.268 . . . . 0.0 111.541 168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.951 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -147.44 101.08 3.33 Favored 'General case' 0 N--CA 1.511 2.602 0 O-C-N 125.315 1.635 . . . . 0.0 107.675 -152.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.643 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -105.8 -178.55 0.62 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 126.816 2.047 . . . . 0.0 108.81 -164.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.995 ' O ' HG22 ' A' ' 42' ' ' THR . 72.5 Cg_endo -98.53 50.93 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.669 1 C-N-CA 126.614 4.876 . . . . 0.0 118.003 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.637 ' OE1' ' HB ' ' A' ' 60' ' ' ILE . 16.2 pt-20 25.44 38.85 0.0 OUTLIER 'General case' 0 C--N 1.364 1.216 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.544 -166.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -121.01 -7.47 9.45 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 129.127 2.971 . . . . 0.0 111.534 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -130.39 10.03 5.22 Favored 'General case' 0 C--O 1.261 1.71 0 C-N-CA 127.289 2.236 . . . . 0.0 110.495 -173.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -68.48 -37.44 80.13 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 126.125 1.77 . . . . 0.0 110.885 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.775 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -45.71 -64.15 2.51 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.192 165.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 4.8 tp10 -79.98 -55.19 5.14 Favored 'General case' 0 CA--C 1.576 1.965 0 C-N-CA 125.93 1.692 . . . . 0.0 109.585 -170.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 65.8 mmtt -83.49 -29.79 27.69 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.394 1.684 . . . . 0.0 108.878 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.641 ' CA ' HG22 ' A' ' 54' ' ' VAL . . . -75.32 -32.9 54.72 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 125.569 1.556 . . . . 0.0 113.495 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.775 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 pt20 -76.63 -10.04 59.1 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.476 1.51 . . . . 0.0 110.805 166.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -96.45 -23.62 16.5 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.295 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -68.76 176.63 2.92 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.874 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.866 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 5.3 t0 -92.68 -32.88 14.57 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.058 159.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 75' ' ' PRO . 58.8 t -150.06 145.58 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.369 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.641 HG22 ' CA ' ' A' ' 48' ' ' GLY . 54.0 t -126.61 82.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.639 -165.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.955 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.255 1.5 tp -105.91 109.46 21.42 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 127.477 2.311 . . . . 0.0 109.376 -162.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.775 HD22 ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -95.86 132.84 40.72 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 127.323 2.249 . . . . 0.0 107.856 -161.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -24.59 144.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 163.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -89.64 -23.14 0.8 Allowed 'Trans proline' 0 CA--C 1.562 1.888 1 C-N-CA 126.265 4.643 . . . . 0.0 117.501 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -87.83 -11.74 46.98 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 126.348 2.28 . . . . 0.0 112.051 163.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.661 ' CD1' HD13 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.67 10.1 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 C-N-CA 125.499 1.52 . . . . 0.0 109.22 171.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -24.34 -52.46 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 123.783 1.754 . . . . 0.0 111.263 169.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.482 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -45.27 -28.67 0.85 Allowed 'General case' 0 C--N 1.394 2.523 0 CA-C-O 124.917 2.294 . . . . 0.0 111.581 -163.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.479 ' HB2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -69.82 -17.9 63.42 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.612 -1.93 . . . . 0.0 111.578 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt -64.85 -37.15 19.9 Favored Pre-proline 0 C--O 1.259 1.605 0 C-N-CA 129.5 3.12 . . . . 0.0 111.821 -155.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 36.3 Cg_endo -83.14 -23.98 3.37 Favored 'Trans proline' 0 CA--C 1.575 2.532 1 C-N-CA 126.023 4.482 . . . . 0.0 116.69 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.31 -50.79 64.32 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 112.392 -2.185 . . . . 0.0 108.927 156.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.1 mm -56.89 -30.9 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 126.152 1.781 . . . . 0.0 109.65 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -67.69 -49.14 64.24 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.139 1.776 . . . . 0.0 110.394 168.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.02 0.61 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 124.964 1.415 . . . . 0.0 110.518 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' ' HD3' ' A' ' 72' ' ' PRO 0.281 0.0 OUTLIER -96.83 -69.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.319 2.248 . . . . 0.0 107.782 175.877 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.635 HD21 ' N ' ' A' ' 49' ' ' GLN . 7.3 mp -93.9 83.78 0.19 Allowed Pre-proline 0 C--N 1.365 1.272 0 C-N-CA 125.364 1.466 . . . . 0.0 111.763 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -96.62 27.8 0.21 Allowed 'Trans proline' 0 CA--C 1.573 2.459 1 C-N-CA 128.357 6.038 . . . . 0.0 117.563 174.875 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 46.81 0.04 OUTLIER 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.387 2.305 . . . . 0.0 112.398 167.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 mtpp -131.69 149.74 74.29 Favored Pre-proline 0 C--O 1.214 -0.801 0 CA-C-O 123.482 1.61 . . . . 0.0 112.403 170.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.866 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.324 4.2 Cg_exo -48.5 63.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 125.058 3.839 . . . . 0.0 119.065 168.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 21.5 t -87.76 103.92 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-N 111.474 -2.603 . . . . 0.0 109.994 168.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.955 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.99 122.49 24.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.572 1.949 . . . . 0.0 111.341 172.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.93 158.72 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 124.499 1.119 . . . . 0.0 111.223 173.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 55' ' ' LEU 0.321 0.0 OUTLIER -74.79 172.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.275 171.19 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -104.42 126.25 51.35 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.091 2.556 . . . . 0.0 109.362 157.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 t -74.09 -10.89 60.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 125.929 1.692 . . . . 0.0 110.541 -160.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD12 HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.57 -54.62 3.07 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 126.361 1.864 . . . . 0.0 106.641 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD22 ' OD2' ' A' ' 88' ' ' ASP 0.265 0.4 OUTLIER -59.67 -41.19 90.06 Favored 'General case' 0 C--N 1.381 1.972 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 172.947 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.736 ' HA ' HD11 ' A' ' 19' ' ' LEU . 43.5 t80 -44.56 -73.22 0.05 OUTLIER 'General case' 0 C--O 1.252 1.201 0 C-N-CA 128.227 2.611 . . . . 0.0 111.696 171.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.799 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -86.63 -3.24 84.01 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.458 -1.246 . . . . 0.0 114.38 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.532 ' C ' HG22 ' A' ' 87' ' ' VAL . 28.8 mttt -111.24 17.38 20.32 Favored 'General case' 0 C--N 1.366 1.3 0 CA-C-O 121.721 0.772 . . . . 0.0 111.54 163.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 18' ' ' LEU . 12.0 m 52.88 49.82 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.171 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.413 150.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.648 ' OD2' HD22 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -70.76 24.84 0.04 OUTLIER 'General case' 0 C--O 1.251 1.142 0 C-N-CA 131.346 3.858 . . . . 0.0 113.283 -163.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 90' ' ' LEU . . . -3.36 73.11 0.0 OUTLIER Glycine 0 C--N 1.352 1.418 0 C-N-CA 124.538 1.066 . . . . 0.0 115.06 150.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 145.81 -29.26 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 128.745 2.818 . . . . 0.0 107.933 166.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -92.77 -21.03 32.22 Favored Glycine 0 CA--C 1.57 3.486 0 O-C-N 125.361 1.663 . . . . 0.0 109.956 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.959 HG11 HD22 ' A' ' 19' ' ' LEU . 85.0 t -84.39 -34.78 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 127.477 2.516 . . . . 0.0 109.134 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.913 HD22 ' HG3' ' A' ' 26' ' ' GLN . 4.1 tp -62.71 -66.35 0.55 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.678 165.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.94 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.6 -53.89 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.265 0.938 . . . . 0.0 113.375 163.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -55.75 -28.46 56.06 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.936 0.895 . . . . 0.0 112.004 -170.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.692 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -69.79 -63.91 0.98 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.645 1.178 . . . . 0.0 111.042 161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 94' ' ' LYS . 1.1 m -33.33 -60.19 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 113.212 -1.813 . . . . 0.0 108.145 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.872 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -71.22 -20.99 62.19 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.791 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -61.17 -41.1 96.18 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 127.2 2.2 . . . . 0.0 110.57 160.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -66.58 -67.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 125.809 1.943 . . . . 0.0 108.919 -173.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 100' ' ' ILE . 9.0 ttpt -39.0 -53.31 1.77 Allowed 'General case' 0 C--N 1.368 1.395 0 CA-C-N 113.485 -1.689 . . . . 0.0 112.273 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.872 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -58.5 -25.4 62.33 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.222 -169.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.34 -20.51 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.603 1.561 . . . . 0.0 110.302 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.28 87.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.41 1.484 . . . . 0.0 110.988 168.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.42 107.54 5.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.884 1.674 . . . . 0.0 112.159 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 126.638 1.975 . . . . 0.0 111.011 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtm . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 122.072 0.939 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 1.4 tt0 75.91 46.37 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.562 1.145 . . . . 0.0 110.494 -171.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.836 ' C ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER 60.77 117.07 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.37 -177.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 34' ' ' VAL 0.342 0.0 OUTLIER -165.07 132.8 3.12 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 125.894 2.759 . . . . 0.0 113.712 -164.527 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.638 ' CB ' ' CE2' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -70.77 147.42 48.99 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 119.333 -2.105 . . . . 0.0 114.69 -175.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.807 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 83.0 mt -118.5 151.01 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 142.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' HB3' ' A' ' 47' ' ' LYS . 53.2 m-85 -138.21 141.68 39.99 Favored 'General case' 0 C--O 1.267 2.015 0 C-N-CA 127.64 2.376 . . . . 0.0 111.285 177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD11 HD11 ' A' ' 19' ' ' LEU 0.278 1.0 OUTLIER -109.19 152.25 25.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.633 1.973 . . . . 0.0 109.469 173.145 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.847 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 22.7 m-85 -137.05 110.07 7.71 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 127.255 2.222 . . . . 0.0 111.649 -171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 11' ' ' SER . 31.1 t -44.84 174.53 0.0 OUTLIER 'General case' 0 C--N 1.38 1.899 0 N-CA-C 119.566 3.173 . . . . 0.0 119.566 -153.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.643 ' OG ' ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER 149.21 67.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.204 -156.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . . . 138.28 31.16 0.0 OUTLIER 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.737 2.015 . . . . 0.0 111.66 157.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.884 ' O ' ' HB3' ' A' ' 14' ' ' MET . . . 17.31 51.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 126.778 2.132 . . . . 0.0 113.775 -164.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.884 ' HB3' ' O ' ' A' ' 13' ' ' GLY 0.259 3.0 ttm 126.32 166.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.998 0.904 . . . . 0.0 109.052 156.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.928 ' O ' HG22 ' A' ' 87' ' ' VAL . 28.7 p 97.07 -8.66 0.07 Allowed 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 113.556 -1.656 . . . . 0.0 108.334 -149.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.893 HG23 ' OH ' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -64.11 -90.23 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 O-C-N 125.944 2.028 . . . . 0.0 108.954 162.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -26.6 -57.6 0.08 Allowed 'General case' 0 C--O 1.253 1.245 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.963 -159.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.759 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -78.9 -7.53 58.04 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.269 1.828 . . . . 0.0 110.551 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -93.76 -33.94 13.4 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.132 1.373 . . . . 0.0 109.055 176.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -58.2 -61.07 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 163.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.51 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -77.27 -6.12 51.94 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.83 1.331 . . . . 0.0 112.353 -171.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.782 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 1.1 mttm -80.47 -54.02 6.06 Favored 'General case' 0 C--O 1.171 -3.072 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 159.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.815 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -49.38 -51.11 37.04 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 111.448 -2.615 . . . . 0.0 113.01 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' N ' HD13 ' A' ' 36' ' ' ILE . 5.5 mtt85 -43.46 -68.83 0.16 Allowed 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 154.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -30.26 -67.59 0.09 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 123.664 0.786 . . . . 0.0 110.586 169.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -28.4 -61.82 0.11 Allowed 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 125.795 1.638 . . . . 0.0 110.126 163.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -74.1 -14.78 61.03 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.445 -171.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 24' ' ' ARG . 1.0 OUTLIER -87.88 -44.53 11.0 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 126.122 1.769 . . . . 0.0 109.888 170.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -36.24 -61.27 0.51 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 113.589 -1.641 . . . . 0.0 112.319 159.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 32.7 m-85 -100.43 -19.11 16.4 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 126.574 1.95 . . . . 0.0 110.692 -157.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 36.4 tp10 86.08 33.07 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.469 1.508 . . . . 0.0 108.429 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.624 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 28.2 t -82.09 97.46 0.37 Allowed Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 126.103 1.761 . . . . 0.0 110.395 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 11.2 Cg_exo -46.62 169.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.569 2.26 1 C-N-CA 125.818 4.345 . . . . 0.0 116.577 -165.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 3' ' ' LYS 0.35 64.6 t 34.48 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 C-N-CA 128.115 2.566 . . . . 0.0 114.529 -164.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.789 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -121.29 170.14 11.74 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.04 0 C-N-CA 127.737 2.415 . . . . 0.0 112.583 -156.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.8 mp -143.07 100.5 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.116 0 C-N-CA 126.475 1.91 . . . . 0.0 109.358 150.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 35' ' ' ILE . 3.6 mm-40 -109.92 140.0 44.38 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 126.237 1.815 . . . . 0.0 110.33 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' N ' HG21 ' A' ' 20' ' ' VAL . . . -102.19 138.89 38.53 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 125.768 1.917 . . . . 0.0 113.771 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.847 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 26.3 m-85 -146.85 161.83 35.83 Favored Pre-proline 0 C--O 1.261 1.677 0 C-N-CA 127.863 2.465 . . . . 0.0 113.742 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.892 ' O ' HG23 ' A' ' 42' ' ' THR . 44.9 Cg_endo -91.77 66.37 1.03 Allowed 'Trans proline' 0 N--CA 1.485 0.994 1 C-N-CA 127.306 5.337 . . . . 0.0 119.756 -177.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.728 ' HG3' ' O ' ' A' ' 40' ' ' PRO . 1.3 pp20? 43.31 -54.78 0.0 OUTLIER 'General case' 0 C--O 1.265 1.882 0 C-N-CA 128.969 2.908 . . . . 0.0 118.171 -169.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -18.35 -44.49 0.0 OUTLIER 'General case' 0 C--N 1.353 0.754 0 C-N-CA 128.3 2.64 . . . . 0.0 114.503 163.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.264 0.8 OUTLIER -102.41 3.1 37.44 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 127.856 2.462 . . . . 0.0 110.06 -158.605 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -72.81 -46.1 54.95 Favored 'General case' 0 C--O 1.188 -2.138 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 1.036 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -31.87 -42.93 0.12 Allowed Glycine 0 N--CA 1.507 3.392 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.552 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.775 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -100.38 -43.22 6.32 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.827 1.651 . . . . 0.0 112.604 -165.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 28.5 mmtt -82.21 -60.15 2.31 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.602 1.192 . . . . 0.0 109.838 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -20.22 -81.88 0.01 OUTLIER Glycine 0 C--N 1.368 2.328 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.76 152.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -43.79 -56.81 3.6 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.144 0.978 . . . . 0.0 110.826 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.775 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -58.6 -28.19 65.36 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -65.51 171.67 3.88 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.272 1.429 . . . . 0.0 109.514 -163.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.83 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 26.8 t0 -104.7 -30.12 10.14 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 128.309 2.644 . . . . 0.0 113.912 156.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.3 t -144.32 154.16 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.742 2.017 . . . . 0.0 110.413 166.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -147.87 146.12 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 C-N-CA 125.173 1.389 . . . . 0.0 108.58 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.964 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -125.2 139.6 53.6 Favored 'General case' 0 C--N 1.377 1.771 0 N-CA-C 117.554 2.428 . . . . 0.0 117.554 168.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -102.96 138.17 40.19 Favored 'General case' 0 C--N 1.381 1.973 0 C-N-CA 128.659 2.783 . . . . 0.0 109.081 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.54 122.95 21.18 Favored Glycine 1 N--CA 1.535 5.255 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 169.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.619 ' HG3' ' O ' ' A' ' 79' ' ' ILE . 9.9 Cg_exo -28.79 -38.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 0 C-N-CA 123.593 2.862 . . . . 0.0 115.172 172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 12' ' ' ALA 0.258 2.5 pt20 -101.59 24.56 9.58 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 110.613 -2.994 . . . . 0.0 110.86 -171.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' O ' ' HD1' ' A' ' 62' ' ' TYR . 1.2 tt -98.65 -57.73 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 144.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.819 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . 46.33 -64.08 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.953 2.501 . . . . 0.0 115.424 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.803 ' HD1' ' O ' ' A' ' 60' ' ' ILE . 34.7 p90 -62.3 -16.27 52.97 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 125.609 1.563 . . . . 0.0 107.185 -159.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.611 ' HG2' ' CE2' ' A' ' 62' ' ' TYR . 4.0 mmt -92.25 -21.32 20.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.123 1.769 . . . . 0.0 112.29 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.819 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -50.63 -27.66 1.62 Allowed Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 126.943 2.097 . . . . 0.0 110.339 174.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 64' ' ' LEU . 80.1 Cg_exo -62.25 -47.48 9.93 Favored 'Trans proline' 0 CA--C 1.581 2.858 1 C-N-CA 127.39 5.393 . . . . 0.0 116.374 162.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.94 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 42.9 mt-10 -82.07 -19.57 39.97 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 110.696 -2.956 . . . . 0.0 112.747 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.489 HG21 HG11 ' A' ' 76' ' ' VAL . 5.7 mm -67.76 -51.48 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 C-N-CA 127.272 2.229 . . . . 0.0 107.702 163.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.813 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 6.1 mm-40 -90.23 -3.3 57.91 Favored 'General case' 0 C--O 1.26 1.617 0 C-N-CA 128.186 2.595 . . . . 0.0 114.081 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -121.12 -26.02 5.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.102 1.761 . . . . 0.0 111.893 175.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.94 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -60.61 -61.62 2.46 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 125.686 1.594 . . . . 0.0 110.415 156.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -126.11 78.79 70.29 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 127.84 2.456 . . . . 0.0 107.306 -169.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 2.5 Cg_endo -109.32 56.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.639 1 C-N-CA 126.351 4.701 . . . . 0.0 118.254 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 3.5 m-20 -140.85 25.02 2.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 125.216 1.572 . . . . 0.0 111.839 170.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.876 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -135.96 159.51 70.82 Favored Pre-proline 0 C--O 1.212 -0.902 0 CA-C-O 122.789 1.28 . . . . 0.0 114.086 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.83 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.296 94.4 Cg_endo -76.26 68.76 6.68 Favored 'Trans proline' 0 C--N 1.365 1.441 1 C-N-CA 125.692 4.261 . . . . 0.0 119.303 167.344 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.968 HG13 HG12 ' A' ' 54' ' ' VAL . 6.8 t -76.3 153.39 5.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 126.876 2.07 . . . . 0.0 111.743 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.964 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 6.0 mt-10 -161.04 145.7 13.8 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.642 1.977 . . . . 0.0 112.94 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -66.22 128.63 29.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 124.967 1.307 . . . . 0.0 111.329 153.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.619 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 2.0 mt -57.69 178.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.284 2.896 0 C-N-CA 126.301 1.84 . . . . 0.0 109.707 168.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.7 m-20 -97.06 134.83 39.89 Favored 'General case' 0 C--O 1.18 -2.58 0 C-N-CA 130.509 3.523 . . . . 0.0 109.571 158.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -81.05 -16.76 52.35 Favored 'General case' 0 C--O 1.268 2.069 0 CA-C-N 112.067 -2.333 . . . . 0.0 113.891 -160.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.65 -46.23 6.08 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 128.141 2.576 . . . . 0.0 109.242 175.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.59 -51.94 67.76 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.893 ' OH ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -37.7 -81.09 0.01 OUTLIER 'General case' 0 C--N 1.386 2.168 0 C-N-CA 125.201 1.4 . . . . 0.0 111.401 164.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.24 64.51 Favored Glycine 0 C--N 1.378 2.884 0 CA-C-N 111.966 -2.379 . . . . 0.0 112.76 -164.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 5.1 mttm -87.57 3.8 46.17 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.593 1.187 . . . . 0.0 113.71 168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 15' ' ' SER 0.335 57.3 t 52.68 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 128.686 2.794 . . . . 0.0 111.445 166.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -111.26 116.12 30.49 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 129.222 3.009 . . . . 0.0 115.595 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.651 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -52.98 -67.9 1.88 Allowed Glycine 0 N--CA 1.486 2.015 0 CA-C-O 123.064 1.369 . . . . 0.0 114.473 163.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.46 -37.56 3.53 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 126.786 2.034 . . . . 0.0 109.854 -155.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.656 ' O ' ' HB3' ' A' ' 94' ' ' LYS . . . -64.72 -59.5 8.08 Favored Glycine 0 C--O 1.268 2.276 0 O-C-N 121.801 -0.562 . . . . 0.0 113.106 170.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 19' ' ' LEU . 6.3 m -67.18 -17.13 22.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.149 0 C-N-CA 127.403 2.281 . . . . 0.0 113.076 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -72.91 -40.73 65.26 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 124.324 1.05 . . . . 0.0 109.014 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.821 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 32.8 ttmt -56.04 -75.0 0.04 OUTLIER 'General case' 0 C--N 1.367 1.352 0 CA-C-O 121.64 0.733 . . . . 0.0 112.176 168.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -37.98 -41.69 0.57 Allowed 'General case' 0 C--N 1.369 1.435 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.839 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -48.83 -58.01 5.49 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 126.102 1.761 . . . . 0.0 110.935 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 94' ' ' LYS . 2.5 t -38.16 -59.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.424 0 C-N-CA 124.535 1.134 . . . . 0.0 110.032 167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 95' ' ' ALA . . . -43.02 -44.44 4.72 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.304 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.04 -67.62 0.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.841 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -45.35 -58.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 123.445 1.593 . . . . 0.0 107.805 -174.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.633 ' HZ3' ' N ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -67.02 -21.36 65.94 Favored 'General case' 0 C--N 1.371 1.535 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.566 -168.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.633 ' N ' ' HZ3' ' A' ' 101' ' ' LYS . 4.5 tttt -69.24 -31.94 70.82 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.021 167.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.07 -2.86 39.35 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 126.704 2.001 . . . . 0.0 111.455 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 101' ' ' LYS . . . -25.62 -92.49 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.644 1.577 . . . . 0.0 111.47 -170.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.13 -177.95 0.95 Allowed 'General case' 0 C--N 1.358 0.952 0 C-N-CA 126.21 1.804 . . . . 0.0 113.235 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 C--N 1.375 1.706 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 -175.259 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 11.0 ptm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 121.213 0.53 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 1' ' ' MET . 4.5 mt-10 -141.6 66.39 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.077 0.951 . . . . 0.0 110.689 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 66.32 116.76 0.03 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 124.207 1.003 . . . . 0.0 113.591 162.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.93 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 13.7 mttm -92.16 174.95 7.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 113.441 168.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.604 ' CA ' HG23 ' A' ' 34' ' ' VAL . 6.1 m80 -136.49 125.2 23.86 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.467 1.507 . . . . 0.0 114.406 -172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.903 HG22 HG23 ' A' ' 36' ' ' ILE . 8.1 mt -97.12 96.26 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 125.919 1.688 . . . . 0.0 109.423 157.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.0 m-30 -98.17 133.78 42.14 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 128.211 2.604 . . . . 0.0 110.024 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.967 HD12 HD12 ' A' ' 55' ' ' LEU 0.46 0.7 OUTLIER -149.21 107.06 3.68 Favored 'General case' 1 N--CA 1.549 4.519 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -155.731 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.714 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 27.1 m-85 -113.32 83.67 1.88 Allowed 'General case' 0 C--O 1.251 1.156 0 C-N-CA 128.019 2.528 . . . . 0.0 112.719 -150.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 t 55.2 160.75 0.01 OUTLIER 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.054 -2.279 . . . . 0.0 115.834 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.844 ' OG ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -178.77 39.13 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.851 0 CA-C-N 113.239 -1.8 . . . . 0.0 108.232 170.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 11' ' ' SER . . . 109.96 13.76 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 126.015 1.726 . . . . 0.0 110.341 170.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 -100.98 2.43 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.671 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 71.28 0.4 Allowed 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.702 1.239 . . . . 0.0 112.232 -170.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 14.6 t -167.45 16.9 0.03 OUTLIER 'General case' 0 C--O 1.267 2.014 0 CA-C-N 112.872 -1.967 . . . . 0.0 112.985 159.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.56 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 12.0 m -126.31 -72.66 0.64 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 130.812 3.645 . . . . 0.0 112.552 -165.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.3 OUTLIER -57.67 -31.3 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.968 -166.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.72 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -88.48 -8.38 54.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.385 1.874 . . . . 0.0 110.434 -173.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.056 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -102.84 -24.39 13.7 Favored 'General case' 0 C--N 1.376 1.742 0 C-N-CA 125.337 1.455 . . . . 0.0 109.102 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.979 ' CG2' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -83.1 -39.7 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.443 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 17' ' ' SER . 3.6 m -72.91 -29.95 63.53 Favored 'General case' 0 C--O 1.278 2.571 0 O-C-N 127.147 2.78 . . . . 0.0 113.927 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -90.75 -39.89 12.14 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.192 1.472 . . . . 0.0 111.318 171.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.997 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -48.05 -50.68 27.14 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.28 1.99 . . . . 0.0 110.11 166.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.3 mtt180 -46.55 -43.84 17.42 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 111.54 -2.573 . . . . 0.0 110.536 164.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.01 ' O ' ' HB2' ' A' ' 29' ' ' LYS 0.337 . . -54.39 -25.25 23.51 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 166.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.904 ' HG3' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.74 9.48 22.71 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.967 2.507 . . . . 0.0 113.526 165.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 23' ' ' MET . . . -102.82 -5.26 23.81 Favored 'General case' 0 C--O 1.26 1.616 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 152.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.815 ' HG3' ' O ' ' A' ' 24' ' ' ARG . 7.5 mt-10 -119.4 -29.82 5.04 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 129.087 2.955 . . . . 0.0 114.063 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.01 ' HB2' ' O ' ' A' ' 25' ' ' ALA 0.346 0.0 OUTLIER -49.23 -41.7 38.17 Favored 'General case' 0 C--O 1.172 -3.0 0 CA-C-O 123.972 1.844 . . . . 0.0 110.306 155.765 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' HD2' ' O ' ' A' ' 26' ' ' GLN 0.323 35.3 m-85 -129.62 114.84 16.54 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 108.649 -3.887 . . . . 0.0 106.8 -176.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -52.9 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.718 154.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 30' ' ' TYR . 5.4 t -96.86 88.99 0.58 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 162.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.337 53.8 Cg_endo -61.63 69.17 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.449 3.433 . . . . 0.0 118.259 -165.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -138.8 124.58 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 127.055 2.142 . . . . 0.0 109.633 162.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' HIS . 12.6 mm -68.29 118.07 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 110.281 167.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.979 HG22 ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -89.16 102.93 13.51 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 127.446 2.298 . . . . 0.0 110.73 162.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 4.2 mt-10 -115.93 130.78 56.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.313 1.445 . . . . 0.0 112.794 168.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -106.96 129.49 54.76 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.494 1.918 . . . . 0.0 110.284 176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 2.9 m-85 -130.78 169.51 13.48 Favored Pre-proline 0 C--O 1.289 3.149 0 O-C-N 125.273 1.608 . . . . 0.0 110.966 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.987 ' O ' HG23 ' A' ' 42' ' ' THR . 10.8 Cg_endo -86.2 94.98 0.55 Allowed 'Trans proline' 0 CA--C 1.58 2.788 1 C-N-CA 125.708 4.272 . . . . 0.0 116.656 164.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.712 ' HB2' HD21 ' A' ' 56' ' ' LEU 0.31 0.0 OUTLIER 15.16 -57.45 0.0 OUTLIER 'General case' 0 C--O 1.288 3.13 0 N-CA-C 121.054 3.724 . . . . 0.0 121.054 -178.968 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -14.02 -43.38 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 130.525 3.53 . . . . 0.0 111.569 161.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HD2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -85.46 -27.1 25.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 126.263 1.825 . . . . 0.0 108.483 -171.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.909 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -42.74 -31.04 0.43 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.315 1.446 . . . . 0.0 113.149 -172.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -78.29 -34.59 36.19 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 126.076 2.11 . . . . 0.0 112.538 -177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -53.34 3.79 Favored 'General case' 0 C--O 1.253 1.256 0 C-N-CA 126.99 2.116 . . . . 0.0 113.281 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -67.21 -53.93 25.7 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.791 0.805 . . . . 0.0 111.123 171.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.909 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -38.86 -57.48 1.98 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-N 114.201 -1.363 . . . . 0.0 114.215 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.967 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 1.3 tt0 -60.75 -25.71 66.68 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 123.817 0.847 . . . . 0.0 112.574 176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -93.75 14.1 20.3 Favored 'General case' 0 C--O 1.266 1.973 0 C-N-CA 124.216 1.006 . . . . 0.0 113.389 169.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -86.92 162.67 17.57 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 126.531 1.933 . . . . 0.0 111.061 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 26.0 t70 -98.24 -41.47 7.86 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 128.126 2.57 . . . . 0.0 112.395 154.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 75' ' ' PRO . 43.0 t -127.24 136.59 60.24 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.029 162.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.941 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 t -98.58 140.23 18.76 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 C-N-CA 125.106 1.363 . . . . 0.0 109.445 164.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.976 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 7.3 mt -124.75 134.45 52.8 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 127.846 2.458 . . . . 0.0 111.011 159.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.85 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -114.83 137.34 52.07 Favored 'General case' 0 C--N 1.372 1.556 0 C-N-CA 129.012 2.925 . . . . 0.0 110.701 165.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.844 ' HA3' ' OG ' ' A' ' 11' ' ' SER . . . -40.16 150.5 0.12 Allowed Glycine 0 CA--C 1.549 2.201 0 C-N-CA 126.325 1.917 . . . . 0.0 113.208 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -47.84 -25.82 6.43 Favored 'Trans proline' 0 CA--C 1.569 2.229 0 C-N-CA 124.362 3.375 . . . . 0.0 116.654 163.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 6.2 mp0 -71.97 -59.09 2.92 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 110.462 -3.063 . . . . 0.0 115.104 162.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG1' HD22 ' A' ' 56' ' ' LEU . 5.9 tp -94.47 39.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 127.886 2.474 . . . . 0.0 108.572 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.99 ' CB ' HG21 ' A' ' 78' ' ' VAL . . . -85.15 -31.42 23.28 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 113.314 -1.766 . . . . 0.0 110.174 171.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.747 ' CE2' HD12 ' A' ' 60' ' ' ILE . 51.1 p90 -61.17 -23.49 65.61 Favored 'General case' 0 N--CA 1.528 3.464 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.576 ' CG ' ' CE1' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -95.24 -14.9 23.63 Favored 'General case' 0 C--O 1.251 1.147 0 C-N-CA 125.548 1.539 . . . . 0.0 114.349 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.064 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -38.06 -45.8 2.38 Favored Pre-proline 0 N--CA 1.495 1.798 0 C-N-CA 125.324 1.449 . . . . 0.0 109.129 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 55.6 Cg_endo -76.53 -36.72 1.57 Allowed 'Trans proline' 0 CA--C 1.554 1.512 1 C-N-CA 125.348 4.032 . . . . 0.0 119.697 175.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.93 -47.37 21.68 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 111.301 -2.681 . . . . 0.0 108.171 163.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.064 ' HB ' ' O ' ' A' ' 64' ' ' LEU . 2.3 mm -37.53 -75.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.803 0 C-N-CA 125.683 1.593 . . . . 0.0 110.729 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.882 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -81.62 16.86 1.59 Allowed 'General case' 0 C--O 1.25 1.118 0 C-N-CA 126.432 1.893 . . . . 0.0 111.111 -156.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -58.66 1.91 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.031 -1.668 . . . . 0.0 109.786 152.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 18.9 tp -50.48 -67.28 0.27 Allowed 'General case' 0 C--N 1.362 1.119 0 C-N-CA 126.349 1.86 . . . . 0.0 110.689 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.57 92.31 1.07 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 125.543 1.537 . . . . 0.0 108.716 168.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HG2' ' ND2' ' A' ' 73' ' ' ASN 0.305 66.2 Cg_endo -73.78 -98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 1 C-N-CA 127.255 5.303 . . . . 0.0 121.707 -179.761 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.669 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -22.23 -43.56 0.01 OUTLIER 'General case' 0 C--O 1.266 1.941 0 C-N-CA 128.031 2.533 . . . . 0.0 115.476 174.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.967 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -85.01 152.0 58.21 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 122.118 0.961 . . . . 0.0 111.542 -173.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HB2' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -34.14 139.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 124.428 3.418 . . . . 0.0 118.536 160.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG22 HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -160.85 135.86 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 126.362 1.865 . . . . 0.0 112.999 163.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -143.82 162.45 36.02 Favored 'General case' 0 C--O 1.162 -3.543 0 C-N-CA 126.381 1.872 . . . . 0.0 109.878 176.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.99 HG21 ' CB ' ' A' ' 61' ' ' ALA . 7.0 t -86.67 167.03 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.463 0 CA-C-N 111.419 -2.628 . . . . 0.0 110.718 161.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.75 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt -79.87 177.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 125.451 1.5 . . . . 0.0 108.954 169.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.034 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.8 OUTLIER -92.86 159.73 15.24 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 154.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.4 t -102.69 -25.15 13.65 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 126.389 2.306 . . . . 0.0 110.435 -154.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -88.68 -44.19 10.77 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.632 2.773 . . . . 0.0 112.191 170.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 88' ' ' ASP 0.269 0.1 OUTLIER -66.73 -38.1 86.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 173.415 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.034 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 2.4 t80 -47.61 -83.62 0.01 OUTLIER 'General case' 0 C--O 1.267 2.024 0 C-N-CA 125.998 1.719 . . . . 0.0 113.066 166.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -77.14 1.79 63.11 Favored Glycine 0 CA--C 1.563 3.08 0 C-N-CA 125.774 1.654 . . . . 0.0 112.275 -162.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -129.78 20.61 5.51 Favored 'General case' 0 C--O 1.188 -2.158 0 O-C-N 124.84 0.965 . . . . 0.0 110.717 163.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.896 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 44.67 70.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.611 0 CA-C-N 113.04 -1.891 . . . . 0.0 109.798 153.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 83' ' ' LEU . 7.1 t0 -39.94 -68.2 0.19 Allowed 'General case' 0 CA--C 1.595 2.698 0 C-N-CA 128.801 2.84 . . . . 0.0 109.378 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.997 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . 91.98 -72.6 1.61 Allowed Glycine 0 N--CA 1.492 2.418 0 O-C-N 127.89 3.244 . . . . 0.0 110.12 -166.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.685 ' HB2' ' OE1' ' A' ' 26' ' ' GLN . 17.4 tp -78.36 -44.93 23.76 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 125.998 1.719 . . . . 0.0 111.436 -168.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -71.58 -13.43 74.51 Favored Glycine 0 C--N 1.36 1.878 0 C-N-CA 126.755 2.121 . . . . 0.0 114.771 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.056 HG11 HD11 ' A' ' 19' ' ' LEU . 65.1 t -90.16 -31.75 5.31 Favored 'Isoleucine or valine' 0 C--N 1.391 2.398 0 C-N-CA 125.647 1.579 . . . . 0.0 113.443 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.904 HD12 ' HG3' ' A' ' 26' ' ' GLN 0.259 7.2 mt -65.72 -38.92 90.52 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.955 163.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 23.8 ttmt -48.25 -61.08 2.17 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 156.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 92' ' ' VAL . . . -58.77 -45.03 90.72 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.223 1.009 . . . . 0.0 111.532 -171.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -41.15 -58.61 1.73 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.049 1.34 . . . . 0.0 110.596 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 100' ' ' ILE . 24.6 t -49.14 -46.81 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.706 1.602 . . . . 0.0 109.829 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -65.24 -22.24 66.84 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.527 1.931 . . . . 0.0 113.21 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.447 ' CB ' ' HG3' ' A' ' 77' ' ' GLU . . . -82.54 -60.41 2.2 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.486 1.514 . . . . 0.0 113.821 166.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 97' ' ' VAL . 0.4 OUTLIER -33.92 -31.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.678 1.591 . . . . 0.0 109.865 165.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -44.08 12.13 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 124.655 1.182 . . . . 0.0 113.525 170.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.595 ' HD2' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.49 -17.3 53.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -97.88 1.53 48.24 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.901 2.08 . . . . 0.0 114.513 -173.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . 93.0 127.94 0.02 OUTLIER 'General case' 0 C--O 1.253 1.251 0 C-N-CA 126.149 1.78 . . . . 0.0 112.004 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' O ' ' ND2' ' A' ' 106' ' ' ASN . . . 177.33 155.95 0.31 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.14 1.776 . . . . 0.0 111.874 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.377 2.271 . . . . 0.0 110.476 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.978 0.418 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -150.9 51.34 0.86 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 125.379 1.471 . . . . 0.0 113.252 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.792 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 93.12 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.434 1.112 . . . . 0.0 112.138 160.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.867 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 4.5 mtmm -130.48 174.79 9.54 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.036 1.335 . . . . 0.0 111.785 172.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . 32.5 m170 -121.16 110.52 16.29 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.579 1.8 . . . . 0.0 112.204 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 88.7 mt -97.51 110.14 24.74 Favored 'Isoleucine or valine' 0 C--O 1.263 1.794 0 C-N-CA 127.733 2.413 . . . . 0.0 112.372 168.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 m-30 -126.47 132.12 51.51 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 126.316 1.846 . . . . 0.0 109.119 -159.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 79' ' ' ILE 0.354 19.0 mt -129.55 97.81 4.65 Favored 'General case' 0 N--CA 1.513 2.723 0 CA-C-N 112.781 -2.009 . . . . 0.0 106.804 -156.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.787 ' O ' HD22 ' A' ' 56' ' ' LEU . 22.2 m-85 -111.79 104.88 13.23 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 128.262 2.625 . . . . 0.0 110.668 -152.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.659 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -126.59 -176.94 3.82 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 124.481 2.086 . . . . 0.0 112.598 -147.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.14 -3.11 6.35 Favored 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 112.582 -2.099 . . . . 0.0 110.64 170.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.52 -80.7 0.02 OUTLIER 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.922 2.014 . . . . 0.0 112.232 -163.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.8 -31.12 8.94 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 124.267 0.937 . . . . 0.0 113.99 -155.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 167.73 79.41 0.0 OUTLIER 'General case' 0 C--N 1.356 0.882 0 CA-C-O 124.122 1.915 . . . . 0.0 111.258 174.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.78 32.14 1.15 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.585 155.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.98 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -141.49 -68.8 0.38 Allowed 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.816 2.046 . . . . 0.0 110.108 -161.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.998 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.0 t -32.25 -38.16 0.03 OUTLIER 'General case' 0 C--O 1.252 1.209 0 C-N-CA 125.685 1.594 . . . . 0.0 114.657 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 4.1 mp -91.0 -19.27 23.39 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.267 1.827 . . . . 0.0 108.873 -168.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.98 HD12 ' HA ' ' A' ' 16' ' ' THR 0.311 28.2 mt -62.7 -50.37 71.38 Favored 'General case' 0 CA--C 1.611 3.304 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 167.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.998 HG22 ' O ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -53.37 -74.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 128.542 3.651 . . . . 0.0 106.881 170.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.59 ' H ' HG22 ' A' ' 20' ' ' VAL . 16.7 m -54.76 -12.43 0.78 Allowed 'General case' 0 C--O 1.249 1.042 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.549 -172.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.771 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 7.2 ttmm -91.93 -59.77 2.03 Favored 'General case' 0 CA--C 1.6 2.885 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 171.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.844 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.4 mtp -35.81 -67.39 0.16 Allowed 'General case' 0 N--CA 1.509 2.509 1 O-C-N 129.335 4.147 . . . . 0.0 108.777 175.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 9.3 mtt180 -23.65 -72.68 0.02 OUTLIER 'General case' 0 C--N 1.366 1.304 0 C-N-CA 125.738 1.615 . . . . 0.0 111.507 158.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LYS . . . -49.1 -55.45 12.19 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.718 1.607 . . . . 0.0 114.399 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.824 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 5.1 pp0? -70.78 -48.62 53.31 Favored 'General case' 0 C--O 1.265 1.87 0 C-N-CA 129.03 2.932 . . . . 0.0 112.106 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.721 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . . . -68.57 -33.73 74.58 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.701 1.2 . . . . 0.0 112.474 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 24' ' ' ARG . 7.7 mt-10 -74.81 -53.1 9.76 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 124.089 1.899 . . . . 0.0 111.354 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HG2' ' CD1' ' A' ' 30' ' ' TYR . 1.5 ttpt -27.18 -65.35 0.07 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.91 -1.119 . . . . 0.0 112.515 159.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.695 ' CD1' ' HG2' ' A' ' 29' ' ' LYS . 22.5 m-85 -91.05 13.67 16.14 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.724 2.01 . . . . 0.0 110.531 -167.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.792 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.5 OUTLIER 65.58 15.8 10.21 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.448 167.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG11 HD21 ' A' ' 93' ' ' LEU . 2.6 t -64.15 98.64 0.15 Allowed Pre-proline 0 C--O 1.256 1.403 0 C-N-CA 123.5 0.72 . . . . 0.0 109.288 157.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.792 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 4.5 Cg_endo -91.59 96.12 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.647 1 C-N-CA 127.065 5.176 . . . . 0.0 117.179 -169.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.867 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -163.34 179.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.119 0 CA-C-N 111.308 -2.678 . . . . 0.0 108.153 -163.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 37' ' ' GLU . 1.2 mt -121.12 139.44 48.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.213 161.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.844 HD13 ' HB3' ' A' ' 23' ' ' MET . 4.4 mt -115.76 115.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.386 2.19 0 C-N-CA 126.28 1.832 . . . . 0.0 110.258 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 5.0 mt-10 -135.38 145.59 47.49 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.248 1.592 . . . . 0.0 110.771 -173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -130.06 109.26 10.71 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 126.124 1.77 . . . . 0.0 112.938 -167.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.682 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -102.16 -178.78 0.69 Allowed Pre-proline 0 C--N 1.358 0.954 0 C-N-CA 129.099 2.96 . . . . 0.0 111.06 -164.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' HG23 ' A' ' 42' ' ' THR . 19.4 Cg_endo -102.84 32.8 0.07 OUTLIER 'Trans proline' 0 C--O 1.184 -2.191 1 C-N-CA 128.809 6.339 . . . . 0.0 117.455 169.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 2.7 pt-20 55.85 -35.0 0.03 OUTLIER 'General case' 0 C--O 1.269 2.095 0 CA-C-N 110.291 -3.14 . . . . 0.0 117.4 -166.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.873 HG23 ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -15.15 -57.96 0.01 OUTLIER 'General case' 0 C--O 1.25 1.126 0 C-N-CA 129.445 3.098 . . . . 0.0 113.008 160.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 47' ' ' LYS 0.275 0.0 OUTLIER -108.74 16.19 23.02 Favored 'General case' 0 CA--C 1.592 2.582 0 C-N-CA 127.437 2.295 . . . . 0.0 106.04 -172.397 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -71.79 -53.93 11.78 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.99 1.431 . . . . 0.0 109.3 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.777 ' O ' HD11 ' A' ' 71' ' ' LEU . . . -44.25 -51.12 7.65 Favored Glycine 0 CA--C 1.557 2.665 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.1 mt-10 -85.38 -41.53 15.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 125.843 1.555 . . . . 0.0 109.613 -167.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.943 ' HG2' ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -96.47 -44.73 7.05 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.647 1.689 . . . . 0.0 110.238 -168.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -43.36 -41.65 5.26 Favored Glycine 0 N--CA 1.5 2.922 0 CA-C-N 111.422 -2.627 . . . . 0.0 112.815 159.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.923 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 5.5 tt0 -42.94 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.378 1.821 0 C-N-CA 124.215 1.006 . . . . 0.0 113.548 152.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -35.11 -33.18 0.02 OUTLIER 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.765 1.226 . . . . 0.0 111.085 174.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -43.75 170.48 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.205 1.566 . . . . 0.0 108.47 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.684 ' OD1' ' HD3' ' A' ' 4' ' ' LYS . 38.4 t70 -100.96 -20.65 15.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.765 2.026 . . . . 0.0 110.42 149.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 1.3 p -166.15 135.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.35 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.74 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' HE2' ' A' ' 9' ' ' PHE . 3.8 t -104.65 135.66 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.79 1.636 . . . . 0.0 108.194 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 77' ' ' GLU 0.251 3.7 mt -123.47 131.63 53.7 Favored 'General case' 0 C--N 1.372 1.586 0 C-N-CA 126.0 1.72 . . . . 0.0 108.801 168.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' VAL 0.257 2.3 tm? -123.24 140.18 53.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.338 1.855 . . . . 0.0 107.99 -177.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.713 ' N ' HD13 ' A' ' 56' ' ' LEU . . . -54.39 158.13 5.95 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 122.006 0.781 . . . . 0.0 111.47 -169.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 10.4 Cg_endo -89.59 6.07 4.5 Favored 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 126.731 4.954 . . . . 0.0 121.63 169.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.1 -29.71 13.46 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 111.684 -2.507 . . . . 0.0 108.117 157.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.744 HG13 ' O ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER -105.51 16.66 6.23 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 126.947 2.099 . . . . 0.0 111.308 -170.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.62 -20.24 60.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.77 2.028 . . . . 0.0 112.011 -161.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE2' ' HG2' ' A' ' 63' ' ' MET . 32.7 p90 -74.92 -27.96 60.42 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.385 1.874 . . . . 0.0 109.168 -165.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.619 ' O ' HG12 ' A' ' 67' ' ' ILE . 2.3 mmt -82.96 -6.58 59.54 Favored 'General case' 0 C--N 1.371 1.522 0 C-N-CA 126.814 2.046 . . . . 0.0 113.62 -167.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.9 mt -31.6 -54.69 0.47 Allowed Pre-proline 0 C--N 1.372 1.587 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 64' ' ' LEU . 61.4 Cg_exo -65.04 -32.56 53.23 Favored 'Trans proline' 0 CA--C 1.581 2.862 0 C-N-CA 123.712 2.941 . . . . 0.0 115.36 -157.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 13.6 mt-10 -96.57 -6.07 37.75 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 110.673 -2.967 . . . . 0.0 111.681 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 63' ' ' MET . 1.1 mm -68.81 -29.46 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.428 0 CA-C-O 122.703 1.239 . . . . 0.0 108.3 157.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.606 ' NE2' ' HB ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -120.16 5.31 10.8 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.569 2.348 . . . . 0.0 110.46 -166.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -90.72 -44.01 9.75 Favored 'General case' 0 CA--C 1.582 2.186 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.394 153.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -54.34 -87.33 0.0 OUTLIER 'General case' 0 C--O 1.27 2.167 0 O-C-N 126.058 2.099 . . . . 0.0 109.675 167.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -93.71 93.43 0.84 Allowed Pre-proline 0 N--CA 1.506 2.337 0 C-N-CA 126.317 1.847 . . . . 0.0 109.114 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.81 -2.2 6.46 Favored 'Trans proline' 0 C--O 1.254 1.321 1 C-N-CA 126.278 4.652 . . . . 0.0 120.784 164.166 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -113.9 -18.48 11.76 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 126.772 2.029 . . . . 0.0 111.685 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 75' ' ' PRO . 4.8 mttm -102.85 -177.82 0.58 Allowed Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 123.177 0.591 . . . . 0.0 110.368 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HG2' ' HB ' ' A' ' 53' ' ' VAL 0.269 33.0 Cg_endo -89.43 147.75 5.21 Favored 'Trans proline' 0 CA--C 1.561 1.857 1 C-N-CA 127.36 5.373 . . . . 0.0 117.994 173.037 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 54' ' ' VAL . 15.3 t -156.14 125.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 110.896 -2.865 . . . . 0.0 108.39 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.92 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -154.17 108.47 3.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 124.492 1.12 . . . . 0.0 109.85 -174.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 96.8 t -49.68 165.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 165.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 8' ' ' LEU . 1.1 mt -95.33 166.98 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 124.289 1.995 . . . . 0.0 110.472 166.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.774 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -79.53 141.36 36.74 Favored 'General case' 0 C--N 1.387 2.21 0 C-N-CA 126.607 1.963 . . . . 0.0 109.876 156.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 58' ' ' PRO . 2.2 t -82.16 -18.54 42.43 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 126.526 1.93 . . . . 0.0 112.22 -155.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.98 ' O ' HD12 ' A' ' 82' ' ' LEU 0.296 0.1 OUTLIER -106.35 -39.95 5.75 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.847 3.659 . . . . 0.0 108.851 177.316 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -63.28 -43.71 97.13 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 8.0 t80 -38.43 -73.49 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.74 1.616 . . . . 0.0 110.305 159.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.48 -22.25 73.29 Favored Glycine 0 C--N 1.357 1.724 0 C-N-CA 124.945 1.259 . . . . 0.0 112.946 -165.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 86' ' ' LYS 0.256 0.0 OUTLIER -106.17 24.13 12.96 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.628 1.571 . . . . 0.0 108.024 172.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.758 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 t 53.17 77.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 152.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.601 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -110.3 130.51 55.53 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.924 2.89 . . . . 0.0 113.765 162.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.771 ' N ' ' HD2' ' A' ' 22' ' ' LYS . . . -123.9 -47.75 0.24 Allowed Glycine 0 N--CA 1.503 3.124 0 C-N-CA 125.533 1.54 . . . . 0.0 111.168 -166.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.91 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 44.5 tp -61.63 -65.83 0.63 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 124.341 1.057 . . . . 0.0 109.715 161.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA3' ' OD2' ' A' ' 88' ' ' ASP . . . -48.05 -30.33 7.31 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 172.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.605 ' CG1' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -74.85 -47.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.971 1.309 . . . . 0.0 109.568 176.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB3' ' O ' ' A' ' 90' ' ' LEU . 1.1 tm? -43.41 -59.65 2.04 Favored 'General case' 0 C--N 1.379 1.855 0 C-N-CA 124.924 1.289 . . . . 0.0 108.197 165.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.789 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -49.34 -52.64 26.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.762 1.289 . . . . 0.0 113.356 -171.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.13 -36.75 68.59 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.666 1.986 . . . . 0.0 112.392 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -56.01 -59.95 4.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.666 1.186 . . . . 0.0 110.772 173.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 100' ' ' ILE . 2.4 t -49.12 -36.97 9.31 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 C-N-CA 125.088 1.355 . . . . 0.0 109.34 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.79 83.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.768 1.627 . . . . 0.0 110.002 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.56 -44.08 62.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 111.674 168.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.808 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.89 -63.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 126.7 2.0 . . . . 0.0 109.012 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 2.7 ttpm? -23.85 -86.85 0.0 OUTLIER 'General case' 0 C--O 1.254 1.309 0 CA-C-N 113.344 -1.753 . . . . 0.0 113.972 172.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -21.63 65.99 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.794 -1.191 . . . . 0.0 114.079 -172.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -49.87 -34.27 19.6 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 124.299 1.04 . . . . 0.0 111.325 161.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' LYS . . . -60.7 81.71 0.01 OUTLIER 'General case' 0 C--N 1.352 0.68 0 C-N-CA 126.26 1.824 . . . . 0.0 112.546 171.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 65.38 -174.75 0.18 Allowed 'General case' 0 C--O 1.249 1.042 0 C-N-CA 125.124 1.37 . . . . 0.0 111.902 164.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 127.074 2.15 . . . . 0.0 110.518 175.447 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 123.197 1.475 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 33' ' ' PRO . 21.2 mt-10 81.79 12.64 0.64 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.306 1.442 . . . . 0.0 112.621 -173.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -102.07 135.03 44.35 Favored 'General case' 0 C--N 1.368 1.392 0 CA-C-O 122.797 1.284 . . . . 0.0 112.685 -175.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.8 mtmm -127.49 165.56 19.63 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.174 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.573 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 14.7 m170 -140.35 118.88 12.25 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.633 1.573 . . . . 0.0 110.544 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.84 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 39.8 mt -98.98 99.68 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 124.244 1.973 . . . . 0.0 111.765 159.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.297 3.4 m-85 -89.35 151.99 21.77 Favored 'General case' 0 C--N 1.39 2.353 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD23 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -131.95 140.82 49.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.553 2.341 . . . . 0.0 106.642 -173.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 22.8 m-30 -143.36 81.8 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.909 2.083 . . . . 0.0 107.502 -158.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.76 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.1 t -172.7 171.23 4.51 Favored 'General case' 0 C--N 1.384 2.098 0 C-N-CA 124.663 1.185 . . . . 0.0 111.632 -151.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' A' ' 84' ' ' TYR . 27.1 t 83.24 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.22 . . . . 0.0 111.764 155.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.71 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 C-N-CA 127.012 2.125 . . . . 0.0 113.272 161.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 11' ' ' SER . . . 153.69 80.46 0.03 OUTLIER Glycine 0 C--O 1.263 1.938 0 C-N-CA 125.595 1.569 . . . . 0.0 115.144 156.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 14' ' ' MET 0.252 0.0 OUTLIER 161.2 -104.47 0.0 OUTLIER 'General case' 0 C--O 1.256 1.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.904 153.42 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 11' ' ' SER . 6.7 t -22.9 136.61 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 126.241 2.213 . . . . 0.0 109.042 172.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.891 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 91.0 m 108.15 -74.68 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.795 2.038 . . . . 0.0 111.447 -151.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.947 ' O ' HG12 ' A' ' 20' ' ' VAL . 1.6 p -46.75 -51.79 15.46 Favored 'General case' 0 C--N 1.36 1.046 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.35 -159.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.07 55.38 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.34 1.856 . . . . 0.0 110.285 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.909 HD22 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -76.99 -33.54 57.58 Favored 'General case' 0 C--O 1.27 2.163 0 C-N-CA 126.867 2.067 . . . . 0.0 111.888 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.947 HG12 ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -63.83 -46.59 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.46 0 O-C-N 118.33 -2.731 . . . . 0.0 105.719 163.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -79.96 -4.68 53.5 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 126.007 2.067 . . . . 0.0 115.54 -171.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG2' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -103.04 -35.66 8.46 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.024 -1.047 . . . . 0.0 111.381 162.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.913 ' HB3' HD13 ' A' ' 36' ' ' ILE . 54.2 mtp -50.12 -39.12 42.0 Favored 'General case' 0 N--CA 1.519 2.99 0 O-C-N 125.043 1.464 . . . . 0.0 108.909 165.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 22.1 mtt180 -70.81 -43.2 69.11 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.13 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -40.0 -69.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.463 162.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.956 ' OE1' ' HG2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -29.39 -82.1 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 126.352 1.861 . . . . 0.0 110.726 159.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.1 -36.83 6.16 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.199 -162.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -96.12 -27.07 15.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.125 1.37 . . . . 0.0 109.447 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 5.2 ttpt -54.14 -25.31 21.61 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.61 1.195 . . . . 0.0 109.244 165.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.601 ' CE2' ' HA ' ' A' ' 26' ' ' GLN . 18.0 m-85 -106.94 -83.63 0.53 Allowed 'General case' 0 C--O 1.284 2.899 0 C-N-CA 126.81 2.044 . . . . 0.0 113.185 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 3.0 mt-10 134.9 16.78 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.573 2.349 . . . . 0.0 115.937 -164.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.705 HG12 ' CG1' ' A' ' 34' ' ' VAL . 3.0 t -67.02 116.68 38.2 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.197 1.799 . . . . 0.0 112.197 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 32' ' ' VAL 0.335 66.7 Cg_endo -65.47 61.65 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 125.936 4.424 . . . . 0.0 119.793 -179.752 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.869 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -154.98 167.4 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 111.661 -2.518 . . . . 0.0 109.71 -171.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 mt -140.83 116.13 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 125.55 1.54 . . . . 0.0 111.68 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.913 HD13 ' HB3' ' A' ' 23' ' ' MET . 3.2 mt -97.44 113.04 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.302 2.241 . . . . 0.0 111.271 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -139.99 122.36 16.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.524 2.329 . . . . 0.0 112.089 -171.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.891 ' HB1' ' CG2' ' A' ' 16' ' ' THR . . . -129.43 128.99 44.09 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.636 1.207 . . . . 0.0 109.805 -158.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 1.3 m-30 -147.31 177.36 1.8 Allowed Pre-proline 0 C--O 1.199 -1.603 0 C-N-CA 129.698 3.199 . . . . 0.0 108.369 -152.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.8 ' O ' HG23 ' A' ' 42' ' ' THR . 93.6 Cg_endo -105.4 69.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 127.533 5.488 . . . . 0.0 120.478 173.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HG3' ' C ' ' A' ' 40' ' ' PRO . 2.4 pp20? 41.54 -46.38 0.0 OUTLIER 'General case' 0 C--O 1.273 2.311 0 C-N-CA 127.667 2.387 . . . . 0.0 117.329 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -12.33 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 128.244 2.617 . . . . 0.0 110.009 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.807 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -100.81 8.25 43.31 Favored 'General case' 0 CA--C 1.582 2.187 0 C-N-CA 127.124 2.17 . . . . 0.0 108.867 -158.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.69 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -74.97 -49.5 19.82 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 127.07 2.731 . . . . 0.0 105.595 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.836 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -26.23 -70.21 0.04 OUTLIER Glycine 0 CA--C 1.551 2.332 0 O-C-N 126.216 2.198 . . . . 0.0 110.011 168.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 47' ' ' LYS . 1.7 mt-10 -72.33 -41.45 66.49 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.828 1.651 . . . . 0.0 111.692 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 3.0 mmtm -99.4 -63.54 1.12 Allowed 'General case' 0 C--O 1.174 -2.895 0 CA-C-O 123.08 1.419 . . . . 0.0 108.867 -165.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -27.12 -46.81 0.04 OUTLIER Glycine 0 C--N 1.382 3.104 0 CA-C-N 110.654 -2.976 . . . . 0.0 114.361 158.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.836 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.1 tt0 -72.58 -37.35 68.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.467 2.307 . . . . 0.0 113.371 170.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m120 -83.81 13.04 5.16 Favored 'General case' 0 C--O 1.26 1.623 0 C-N-CA 124.582 1.153 . . . . 0.0 112.889 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.89 173.78 7.12 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.486 -1.384 . . . . 0.0 110.937 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 4' ' ' LYS . 3.9 m-20 -100.31 -32.84 10.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 129.854 3.262 . . . . 0.0 113.359 156.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 75' ' ' PRO . 53.1 t -144.48 136.07 21.47 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.35 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.887 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.5 t -99.36 144.5 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 C-N-CA 124.95 1.3 . . . . 0.0 107.597 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 54' ' ' VAL . 9.6 mt -127.13 149.0 50.15 Favored 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 127.025 2.13 . . . . 0.0 111.929 158.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 9' ' ' PHE 0.252 52.5 mt -109.95 161.83 15.11 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 125.795 1.638 . . . . 0.0 108.114 155.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.654 ' HA3' ' OG ' ' A' ' 10' ' ' SER . . . -66.37 171.25 29.26 Favored Glycine 0 N--CA 1.484 1.847 0 O-C-N 125.796 1.935 . . . . 0.0 111.212 165.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HG3' ' O ' ' A' ' 80' ' ' ASP 0.27 88.6 Cg_endo -85.74 6.98 5.29 Favored 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 125.848 4.365 . . . . 0.0 119.174 172.366 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -38.51 8.07 Favored 'General case' 0 C--N 1.391 2.378 0 CA-C-N 110.894 -2.866 . . . . 0.0 111.993 155.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.07 14.86 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 125.28 1.432 . . . . 0.0 108.414 -164.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -65.17 -35.89 82.51 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -48.63 -23.91 1.17 Allowed 'General case' 0 C--O 1.264 1.846 0 C-N-CA 127.656 2.382 . . . . 0.0 113.054 -169.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 62' ' ' TYR . 5.4 mmm -77.84 -7.58 56.85 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-O 123.592 1.663 . . . . 0.0 110.235 -170.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -48.77 -40.94 46.65 Favored Pre-proline 0 C--N 1.369 1.447 0 C-N-CA 126.412 1.885 . . . . 0.0 110.086 -166.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 71.2 Cg_exo -57.44 -39.98 84.87 Favored 'Trans proline' 0 CA--C 1.587 3.131 1 C-N-CA 127.489 5.46 . . . . 0.0 115.557 173.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.814 ' O ' ' HB2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -56.42 -64.58 0.82 Allowed 'General case' 0 C--N 1.357 0.901 0 CA-C-N 108.672 -3.876 . . . . 0.0 111.575 166.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.716 HG23 HD12 ' A' ' 71' ' ' LEU 0.256 3.5 mm -41.33 -63.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 127.846 2.459 . . . . 0.0 111.182 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.688 ' OE1' HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -56.84 -33.88 67.22 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.095 -1.866 . . . . 0.0 108.761 -172.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.814 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 46.7 mtt-85 -49.74 -89.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.253 1.421 . . . . 0.0 110.318 172.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.51 8.6 1.73 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.167 1.787 . . . . 0.0 111.586 -176.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 67' ' ' ILE . 47.1 mt -145.19 77.9 12.64 Favored Pre-proline 0 C--N 1.372 1.584 0 C-N-CA 128.186 2.594 . . . . 0.0 109.68 164.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -97.46 38.89 0.11 Allowed 'Trans proline' 0 N--CA 1.501 1.932 1 C-N-CA 126.599 4.866 . . . . 0.0 116.975 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -148.29 -51.88 0.18 Allowed 'General case' 0 C--O 1.261 1.681 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.444 -173.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HG2' ' OD1' ' A' ' 73' ' ' ASN . 8.5 mmtm -68.45 159.03 83.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 123.869 0.868 . . . . 0.0 112.31 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' O ' HG13 ' A' ' 53' ' ' VAL . 94.2 Cg_endo -86.52 77.52 2.25 Favored 'Trans proline' 0 CA--C 1.56 1.803 1 C-N-CA 126.691 4.927 . . . . 0.0 117.521 164.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 ' OE1' ' A' ' 68' ' ' GLN . 1.2 p -67.1 148.89 11.87 Favored 'Isoleucine or valine' 0 C--N 1.363 1.195 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.866 163.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 2.4 pp20? -164.45 142.37 6.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.481 2.313 . . . . 0.0 112.929 160.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -83.23 167.28 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 122.493 1.139 . . . . 0.0 109.825 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.623 HD11 HD23 ' A' ' 8' ' ' LEU . 4.5 mt -101.27 169.46 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.368 0 C-N-CA 128.234 2.614 . . . . 0.0 111.312 -167.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 58' ' ' PRO . 1.3 m-20 -78.92 178.79 7.71 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 129.085 2.954 . . . . 0.0 108.263 158.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 t -106.35 -37.94 6.37 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 127.136 2.772 . . . . 0.0 108.274 -152.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -116.71 11.37 14.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 128.063 2.545 . . . . 0.0 112.222 172.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 83' ' ' LEU 0.281 0.3 OUTLIER -88.44 -44.12 10.97 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 151.495 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' A' ' 11' ' ' SER . 3.2 t80 -53.61 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.805 159.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -38.6 -56.58 2.0 Allowed Glycine 0 CA--C 1.563 3.073 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -100.06 23.76 9.49 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 124.9 2.286 . . . . 0.0 109.225 -162.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.798 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 59.21 58.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.967 0 O-C-N 119.819 -1.801 . . . . 0.0 109.275 151.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.909 ' OD2' HD22 ' A' ' 19' ' ' LEU . 5.7 p30 -16.56 -129.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 130.197 3.399 . . . . 0.0 112.073 151.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . . . 81.23 116.72 0.4 Allowed Glycine 0 N--CA 1.507 3.415 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -162.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 84.32 -48.54 0.11 Allowed 'General case' 0 C--O 1.192 -1.97 0 C-N-CA 128.016 2.526 . . . . 0.0 107.907 -169.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -36.87 -67.69 0.4 Allowed Glycine 0 C--N 1.369 2.379 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.962 158.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.728 HG21 ' OD2' ' A' ' 88' ' ' ASP . 16.1 t -88.83 -19.38 7.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 C-N-CA 126.016 1.726 . . . . 0.0 112.039 -165.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -63.97 -54.93 26.71 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.594 1.558 . . . . 0.0 111.984 151.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -45.86 -67.02 0.32 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 169.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -64.89 -27.58 68.96 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 126.776 2.03 . . . . 0.0 113.285 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -58.23 -42.55 86.55 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.243 1.417 . . . . 0.0 111.387 164.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 93' ' ' LEU . 74.0 t -79.3 -34.57 16.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 C-N-CA 125.003 1.321 . . . . 0.0 109.271 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.81 -19.04 31.28 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.648 1.579 . . . . 0.0 111.453 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -51.18 -61.48 2.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.21 1.404 . . . . 0.0 111.569 158.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.02 -59.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 126.756 2.022 . . . . 0.0 107.869 179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.0 tttm -63.36 -20.99 66.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.906 -1.497 . . . . 0.0 114.597 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 4.7 tttp -91.67 -6.04 52.76 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -62.93 -34.39 77.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 111.245 166.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . 104.21 74.93 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.926 1.69 . . . . 0.0 112.248 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.17 -157.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.648 1.179 . . . . 0.0 111.098 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 124.373 1.069 . . . . 0.0 110.557 167.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' C ' ' HG2' ' A' ' 2' ' ' GLU . 1.5 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.649 0.261 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 1' ' ' MET . 4.8 mm-40 73.8 136.81 0.05 Allowed 'General case' 0 C--O 1.253 1.286 0 C-N-CA 124.642 1.177 . . . . 0.0 110.869 161.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -123.65 111.23 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.72 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 13.4 mmtm -123.9 149.99 45.2 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 121.374 0.607 . . . . 0.0 111.823 -159.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.963 ' NE2' HD12 ' A' ' 35' ' ' ILE . 10.8 m170 -97.11 122.49 40.17 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 113.699 -1.592 . . . . 0.0 113.549 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 4.9 mt -87.77 96.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.018 2.127 . . . . 0.0 111.186 155.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 10.4 m-30 -87.2 144.11 26.98 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.008 2.923 . . . . 0.0 112.889 160.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.079 ' CD2' HG22 ' A' ' 16' ' ' THR 0.323 0.1 OUTLIER -148.47 131.33 16.11 Favored 'General case' 0 C--N 1.375 1.704 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.735 -175.074 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.797 ' HB2' HD13 ' A' ' 56' ' ' LEU . 97.3 m-85 -118.11 105.23 11.62 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 127.323 2.249 . . . . 0.0 112.027 -159.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.712 ' O ' ' HB2' ' A' ' 11' ' ' SER . 47.4 t -36.74 -99.77 0.0 OUTLIER 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.077 -2.264 . . . . 0.0 114.351 -149.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' SER . 3.5 t 127.86 -22.2 0.01 OUTLIER 'General case' 0 C--N 1.363 1.154 0 C-N-CA 126.09 1.756 . . . . 0.0 113.769 -165.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.49 60.39 0.04 OUTLIER 'General case' 0 C--O 1.243 0.76 0 C-N-CA 128.153 2.581 . . . . 0.0 112.399 172.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.39 -99.95 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.089 0.852 . . . . 0.0 112.577 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 mtm -97.36 69.06 2.23 Favored 'General case' 0 C--N 1.366 1.316 0 C-N-CA 124.815 1.246 . . . . 0.0 113.594 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 28.5 t -137.36 18.9 2.93 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.198 1.399 . . . . 0.0 110.748 154.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.079 HG22 ' CD2' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -104.44 -80.26 0.54 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 128.151 2.58 . . . . 0.0 111.188 -172.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 21' ' ' SER . 8.7 p -47.84 -42.86 27.45 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.961 -1.472 . . . . 0.0 113.372 -160.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -79.34 -12.83 59.92 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 125.954 1.702 . . . . 0.0 109.126 -174.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD11 HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -90.71 -32.28 16.24 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.359 2.264 . . . . 0.0 107.899 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.123 ' CG2' ' HB2' ' A' ' 38' ' ' ALA . 2.3 t -87.04 -11.4 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 128.161 2.584 . . . . 0.0 109.482 170.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -101.28 -31.3 11.05 Favored 'General case' 0 C--N 1.386 2.182 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.316 -170.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.865 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.4 OUTLIER -82.6 -39.77 21.75 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.045 165.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -44.67 -50.24 9.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.979 1.312 . . . . 0.0 111.46 164.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.1 mtt180 -56.02 -46.46 78.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.969 1.418 . . . . 0.0 111.211 167.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.865 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -45.34 -49.73 12.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.468 1.507 . . . . 0.0 111.827 169.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 1.008 ' HB2' ' O ' ' A' ' 23' ' ' MET . 1.4 mp0 -49.27 -66.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.709 0 O-C-N 124.872 1.357 . . . . 0.0 107.998 160.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 24' ' ' ARG . . . -57.93 -24.32 57.38 Favored 'General case' 0 C--O 1.277 2.532 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.269 -166.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.316 31.6 tp10 -102.71 -28.94 11.81 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 129.496 3.119 . . . . 0.0 111.094 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 11.3 ttpt -52.57 -43.21 65.11 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.788 161.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.744 ' HB2' HG23 ' A' ' 32' ' ' VAL . 18.8 m-85 -105.1 -52.63 2.81 Favored 'General case' 0 CA--C 1.58 2.105 0 O-C-N 126.195 2.184 . . . . 0.0 105.599 -160.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 4.8 tt0 100.92 13.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 126.686 2.491 . . . . 0.0 111.949 -174.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 30' ' ' TYR . 67.8 t -51.13 107.1 0.74 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.166 1.787 . . . . 0.0 109.567 -171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -40.61 57.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.263 1.741 1 C-N-CA 125.706 4.271 . . . . 0.0 121.376 169.38 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 35.7 m -148.05 173.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 125.142 1.377 . . . . 0.0 110.799 165.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.963 HD12 ' NE2' ' A' ' 5' ' ' HIS . 0.9 OUTLIER -131.09 107.55 13.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 C-N-CA 127.188 2.195 . . . . 0.0 111.092 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.2 mp -81.51 114.91 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 128.973 2.909 . . . . 0.0 109.137 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 6.7 mm-40 -124.71 133.72 53.09 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.654 1.182 . . . . 0.0 113.103 166.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.123 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . . . -117.75 112.16 20.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.241 1.816 . . . . 0.0 112.574 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.606 ' CE2' ' HG3' ' A' ' 47' ' ' LYS . 15.8 m-85 -114.19 171.33 4.5 Favored Pre-proline 0 C--O 1.171 -3.048 0 C-N-CA 129.586 3.155 . . . . 0.0 111.51 -155.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 42' ' ' THR . 91.1 Cg_endo -93.81 114.98 0.24 Allowed 'Trans proline' 0 CA--C 1.597 3.634 0 C-N-CA 122.236 1.957 . . . . 0.0 111.731 153.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.738 ' O ' HG22 ' A' ' 42' ' ' THR . 15.6 tt0 -33.82 82.91 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 O-C-N 127.97 3.294 . . . . 0.0 110.39 162.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 178.76 -29.7 0.01 OUTLIER 'General case' 0 C--O 1.265 1.894 0 C-N-CA 126.956 2.102 . . . . 0.0 112.228 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' PRO . 7.8 mp -95.3 -11.56 27.67 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 126.367 1.867 . . . . 0.0 106.979 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 9' ' ' PHE . . . -59.89 -45.35 92.78 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -165.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.984 ' HA3' HD21 ' A' ' 70' ' ' LEU . . . -39.92 -57.65 2.42 Favored Glycine 0 N--CA 1.507 3.407 0 O-C-N 126.943 2.652 . . . . 0.0 109.329 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -68.22 -32.76 73.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.786 1.634 . . . . 0.0 110.544 178.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -90.24 -81.49 0.3 Allowed 'General case' 0 C--O 1.194 -1.827 0 CA-C-O 122.137 0.97 . . . . 0.0 111.274 -167.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.839 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -26.96 -33.08 0.01 OUTLIER Glycine 0 C--N 1.368 2.338 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.592 160.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 1.2 tt0 -64.78 -70.09 0.25 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 122.919 0.488 . . . . 0.0 110.113 162.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 47' ' ' LYS . 3.7 m-80 -40.51 -40.47 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.485 1.514 . . . . 0.0 111.231 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -178.09 0.01 OUTLIER 'General case' 0 C--N 1.366 1.311 0 CA-C-O 122.533 1.158 . . . . 0.0 110.82 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 4' ' ' LYS . 16.1 t0 -100.64 -27.42 13.4 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.79 2.036 . . . . 0.0 111.723 161.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' PRO . 7.4 p -155.18 149.29 12.2 Favored 'Isoleucine or valine' 0 C--O 1.268 2.066 0 C-N-CA 125.725 1.61 . . . . 0.0 110.735 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.839 HG22 ' HA2' ' A' ' 48' ' ' GLY . 64.7 t -125.73 133.7 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 126.572 1.949 . . . . 0.0 108.794 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.037 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -114.91 134.6 55.02 Favored 'General case' 0 C--N 1.367 1.368 0 C-N-CA 127.772 2.429 . . . . 0.0 111.271 166.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.8 mm? -125.2 114.53 19.11 Favored 'General case' 0 C--O 1.205 -1.28 0 C-N-CA 127.551 2.34 . . . . 0.0 110.931 170.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.826 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -46.35 177.23 0.01 OUTLIER Glycine 0 C--N 1.395 3.812 0 O-C-N 120.412 -1.43 . . . . 0.0 113.486 -161.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 20.6 Cg_endo -93.67 6.45 2.75 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.877 3.051 . . . . 0.0 116.512 -164.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.497 ' HB2' ' OG ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -98.34 -20.34 17.24 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 111.422 -2.626 . . . . 0.0 108.652 152.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.765 ' O ' ' HB3' ' A' ' 56' ' ' LEU 0.358 0.2 OUTLIER -118.75 38.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 127.718 2.407 . . . . 0.0 109.926 -166.601 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 78' ' ' VAL . . . -100.33 -0.7 37.85 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 126.463 1.905 . . . . 0.0 110.29 -170.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' CD1' HD13 ' A' ' 60' ' ' ILE . 23.6 p90 -100.7 -24.38 14.43 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 126.137 1.775 . . . . 0.0 110.105 -164.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -78.03 4.78 11.39 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 125.421 1.488 . . . . 0.0 113.272 -174.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -46.23 -38.83 11.18 Favored Pre-proline 0 C--N 1.361 1.09 0 C-N-CA 127.651 2.38 . . . . 0.0 111.762 177.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.74 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 2.8 Cg_exo -77.27 -34.29 2.16 Favored 'Trans proline' 0 CA--C 1.566 2.084 1 C-N-CA 125.425 4.084 . . . . 0.0 116.277 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.73 -28.54 15.88 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 111.767 -2.469 . . . . 0.0 113.319 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.88 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -56.98 -40.66 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 122.959 1.361 . . . . 0.0 108.544 161.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.754 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -64.62 -49.49 70.85 Favored 'General case' 0 C--O 1.263 1.792 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.737 176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -66.15 -30.68 71.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.971 2.108 . . . . 0.0 110.282 -169.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.984 HD21 ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -112.72 -14.5 13.12 Favored 'General case' 0 C--O 1.26 1.65 0 C-N-CA 126.887 2.075 . . . . 0.0 109.293 -172.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.88 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -153.66 93.55 3.03 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 126.543 1.937 . . . . 0.0 107.569 168.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 68' ' ' GLN 0.38 94.4 Cg_endo -65.98 -116.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 1 C-N-CA 126.451 4.768 . . . . 0.0 121.023 -160.812 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -0.3 1.44 Allowed 'General case' 0 C--N 1.378 1.813 0 C-N-CA 126.365 1.866 . . . . 0.0 113.139 -161.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.711 ' HE2' ' O ' ' A' ' 49' ' ' GLN . 1.5 mmmt -57.81 156.49 18.26 Favored Pre-proline 0 N--CA 1.504 2.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 172.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 53' ' ' VAL . 56.1 Cg_endo -81.61 75.51 4.83 Favored 'Trans proline' 0 N--CA 1.483 0.861 1 C-N-CA 125.759 4.306 . . . . 0.0 119.527 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 54' ' ' VAL . 96.2 t -73.7 149.72 7.91 Favored 'Isoleucine or valine' 0 C--N 1.375 1.689 0 CA-C-N 112.262 -2.244 . . . . 0.0 112.735 168.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.037 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -168.74 139.23 2.43 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 126.551 1.941 . . . . 0.0 111.29 164.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 61' ' ' ALA . 14.6 p -34.9 165.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-O 122.194 0.997 . . . . 0.0 111.321 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.3 mt -81.55 163.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 O-C-N 119.651 -1.905 . . . . 0.0 109.702 150.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.035 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -89.38 164.61 14.8 Favored 'General case' 0 CA--C 1.582 2.205 0 C-N-CA 126.764 2.026 . . . . 0.0 107.539 158.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 58' ' ' PRO . 4.7 t -110.5 -16.25 13.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 127.579 3.05 . . . . 0.0 110.355 -157.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 86' ' ' LYS 0.32 2.8 mp -105.22 -34.22 7.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 127.552 2.341 . . . . 0.0 109.116 177.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 83' ' ' LEU . 1.6 mt -71.38 -47.42 56.29 Favored 'General case' 0 C--N 1.381 1.947 0 O-C-N 121.304 -0.872 . . . . 0.0 108.953 164.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.035 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.3 t80 -40.68 -85.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 123.465 1.603 . . . . 0.0 109.817 168.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.53 -19.08 72.48 Favored Glycine 0 N--CA 1.497 2.748 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.339 -163.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.7 mtpt -109.55 22.8 15.29 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.284 1.04 . . . . 0.0 109.476 172.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER 39.08 65.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.49 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.436 154.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 92' ' ' VAL . 3.3 t0 -80.51 67.22 6.29 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 127.578 2.351 . . . . 0.0 114.268 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -23.07 -82.84 0.01 OUTLIER Glycine 0 CA--C 1.55 2.227 0 C-N-CA 125.519 1.533 . . . . 0.0 111.756 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -75.61 -13.48 60.34 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.759 2.024 . . . . 0.0 110.287 -171.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 90' ' ' LEU . . . -72.8 -51.25 11.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.567 1.556 . . . . 0.0 112.001 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 19' ' ' LEU . 16.9 t -81.66 -27.34 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.683 0.793 . . . . 0.0 109.926 -167.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 97' ' ' VAL . 5.3 tp -67.0 -48.01 69.73 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.005 1.322 . . . . 0.0 109.76 167.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.87 -72.58 0.06 Allowed 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.285 -0.884 . . . . 0.0 113.166 162.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.01 -33.61 18.6 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.884 1.674 . . . . 0.0 111.538 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -80.22 -34.61 37.16 Favored 'General case' 0 C--N 1.375 1.688 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.626 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' LEU . 25.4 t -72.91 -26.03 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.265 1.426 . . . . 0.0 109.731 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.7 -37.82 65.05 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.315 1.046 . . . . 0.0 110.794 169.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 96' ' ' ALA . . . -56.45 -33.49 65.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.414 1.486 . . . . 0.0 111.257 170.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.69 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 mm -71.58 -47.97 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 127.273 2.229 . . . . 0.0 108.249 178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -56.62 -44.83 81.57 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.74 170.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -57.73 -30.73 65.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.035 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -59.43 -75.27 0.06 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.597 1.559 . . . . 0.0 112.353 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -130.09 -75.89 0.54 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.651 1.58 . . . . 0.0 111.632 -169.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 104' ' ' ALA . . . 99.84 149.27 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.981 1.712 . . . . 0.0 110.792 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.174 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 122.816 1.293 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.95 -161.52 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.218 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 53.81 111.56 0.01 OUTLIER 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.329 1.052 . . . . 0.0 113.108 -154.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.739 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 8.8 mtmm -114.27 160.15 19.37 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -161.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.3 m170 -110.74 106.56 15.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.492 3.117 . . . . 0.0 113.027 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 36' ' ' ILE . 8.5 mt -101.65 72.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.597 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.6 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.847 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 24.0 m-85 -82.16 148.06 28.69 Favored 'General case' 0 C--N 1.387 2.218 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.943 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.481 0.2 OUTLIER -158.69 132.13 7.43 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -168.953 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.933 ' HB2' HD12 ' A' ' 56' ' ' LEU . 32.6 m-85 -129.83 91.08 3.08 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.505 1.522 . . . . 0.0 108.546 -146.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' SER . 17.7 t 38.55 -133.32 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.282 -0.886 . . . . 0.0 110.951 169.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.925 ' HB3' HG22 ' A' ' 60' ' ' ILE . 17.2 p 92.35 -49.06 0.01 OUTLIER 'General case' 0 C--O 1.268 2.059 0 C-N-CA 124.15 0.98 . . . . 0.0 109.486 -151.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -163.7 37.64 0.09 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 127.188 2.195 . . . . 0.0 112.975 -173.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 35.74 -76.26 0.0 OUTLIER Glycine 0 C--O 1.285 3.312 0 C-N-CA 126.358 1.932 . . . . 0.0 114.838 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.79 -16.48 2.62 Favored 'General case' 0 C--O 1.258 1.531 0 C-N-CA 128.127 2.571 . . . . 0.0 114.097 -167.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.854 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.87 8.45 17.3 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.556 1.942 . . . . 0.0 112.815 -173.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 8' ' ' LEU . 82.3 p -69.99 -76.09 0.1 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 129.683 3.193 . . . . 0.0 110.603 154.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.97 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.9 OUTLIER -49.65 -34.99 19.89 Favored 'General case' 0 C--O 1.259 1.594 0 CA-C-N 111.47 -2.605 . . . . 0.0 110.137 -156.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -99.34 -8.49 24.8 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 126.586 1.954 . . . . 0.0 110.434 -166.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 15' ' ' SER 0.329 0.3 OUTLIER -70.35 -62.44 1.39 Allowed 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 127.135 2.174 . . . . 0.0 108.662 152.223 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 38' ' ' ALA . 2.6 t -60.02 -32.3 49.84 Favored 'Isoleucine or valine' 0 C--N 1.373 1.611 0 C-N-CA 125.671 1.588 . . . . 0.0 109.624 -176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.97 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -94.6 -27.05 16.11 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.497 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.898 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 11.2 ttmm -78.07 -44.49 26.15 Favored 'General case' 0 C--O 1.166 -3.325 0 O-C-N 125.45 1.719 . . . . 0.0 106.972 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 1.083 ' SD ' HG12 ' A' ' 92' ' ' VAL . 4.1 mtm -54.9 -66.32 0.42 Allowed 'General case' 0 C--O 1.19 -2.07 0 O-C-N 128.542 3.651 . . . . 0.0 108.421 172.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.71 ' HA ' HD12 ' A' ' 36' ' ' ILE . 2.5 mtt180 -37.67 -46.29 0.87 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.711 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -36.06 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 125.254 1.596 . . . . 0.0 111.341 161.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.782 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -21.63 -62.35 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.985 0 C-N-CA 126.478 1.911 . . . . 0.0 109.498 173.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.64 -12.49 45.36 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 126.66 1.984 . . . . 0.0 115.283 -160.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -92.6 -60.67 1.77 Allowed 'General case' 0 C--O 1.261 1.709 0 C-N-CA 125.494 1.518 . . . . 0.0 111.543 156.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 19.7 ttpt -30.94 -44.72 0.06 Allowed 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 124.616 1.166 . . . . 0.0 109.847 166.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.1 m-85 -122.08 122.97 40.49 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 128.453 2.701 . . . . 0.0 108.65 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -35.81 -40.21 0.18 Allowed 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 125.562 1.545 . . . . 0.0 108.784 -170.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 30' ' ' TYR . 21.7 t -4.04 73.05 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 126.94 2.096 . . . . 0.0 111.244 -165.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.803 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -43.12 77.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 1 C-N-CA 125.95 4.433 . . . . 0.0 117.857 -169.186 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -162.62 164.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 112.166 -2.288 . . . . 0.0 113.196 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.84 162.53 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 129.091 2.956 . . . . 0.0 109.875 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG23 HG22 ' A' ' 6' ' ' ILE . 2.2 mt -142.09 137.28 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 127.387 2.275 . . . . 0.0 110.49 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 mm-40 -151.77 157.04 41.43 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 128.053 2.541 . . . . 0.0 111.886 161.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' O ' ' A' ' 8' ' ' LEU 0.255 . . -142.61 110.88 6.05 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.676 -156.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 37' ' ' GLU . 12.2 m-85 -120.61 169.42 8.78 Favored Pre-proline 0 C--N 1.363 1.166 0 C-N-CA 126.288 1.835 . . . . 0.0 114.326 -157.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' THR . 11.3 Cg_endo -85.31 57.32 4.61 Favored 'Trans proline' 0 C--N 1.369 1.646 1 C-N-CA 126.593 4.862 . . . . 0.0 120.129 172.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 60' ' ' ILE . 1.8 pm0 39.81 -54.77 0.0 OUTLIER 'General case' 0 C--O 1.29 3.227 0 C-N-CA 128.022 2.529 . . . . 0.0 115.78 -163.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 40' ' ' PRO 0.288 0.5 OUTLIER 1.59 -53.23 0.0 OUTLIER 'General case' 0 C--O 1.246 0.884 0 C-N-CA 131.421 3.888 . . . . 0.0 115.665 173.807 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -128.14 33.78 4.68 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 129.761 3.224 . . . . 0.0 114.835 -167.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.842 ' O ' HD22 ' A' ' 71' ' ' LEU . . . -69.16 -36.77 77.74 Favored 'General case' 0 N--CA 1.525 3.278 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 158.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' CD2' ' A' ' 70' ' ' LEU . . . -42.87 -61.53 2.58 Favored Glycine 0 C--O 1.263 1.951 0 O-C-N 124.77 1.294 . . . . 0.0 112.198 159.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -92.01 -42.26 10.08 Favored 'General case' 0 C--O 1.268 2.028 0 C-N-CA 127.555 2.342 . . . . 0.0 115.273 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 19.0 mmtt -76.34 -50.17 14.98 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 123.054 1.407 . . . . 0.0 110.97 170.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.801 ' HA3' ' O ' ' A' ' 44' ' ' ALA . . . -41.49 -38.16 2.02 Favored Glycine 0 C--N 1.371 2.484 0 CA-C-N 112.998 -1.91 . . . . 0.0 113.212 164.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 3.1 tt0 -52.65 -56.73 13.34 Favored 'General case' 0 C--O 1.276 2.474 0 C-N-CA 124.483 1.113 . . . . 0.0 111.089 164.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -70.88 14.48 0.14 Allowed 'General case' 0 C--O 1.249 1.065 0 C-N-CA 127.759 2.423 . . . . 0.0 115.12 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 48' ' ' GLY . . . -90.55 167.24 12.72 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.892 1.277 . . . . 0.0 110.385 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.911 ' OD1' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.19 -32.66 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 126.131 2.144 . . . . 0.0 109.511 152.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 75' ' ' PRO 0.268 0.8 OUTLIER -149.75 141.11 17.12 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 CA-C-O 123.547 1.641 . . . . 0.0 112.786 170.399 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.811 HG13 ' CE1' ' A' ' 9' ' ' PHE . 15.4 t -124.3 145.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 127.222 2.209 . . . . 0.0 105.433 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -129.04 137.45 51.3 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.966 1.706 . . . . 0.0 109.811 159.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.947 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -113.93 126.18 54.87 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.784 2.034 . . . . 0.0 108.03 167.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' CA ' ' HB3' ' A' ' 11' ' ' SER . . . -70.45 -174.21 15.08 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 125.297 1.427 . . . . 0.0 112.027 -154.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.777 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 41.3 Cg_endo -91.49 4.67 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.104 1 C-N-CA 128.004 5.802 . . . . 0.0 119.199 -162.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.429 ' OE1' ' C ' ' A' ' 11' ' ' SER . 14.9 mp0 -86.82 -52.19 5.64 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.364 145.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HB3' ' A' ' 11' ' ' SER . 0.6 OUTLIER -83.53 55.29 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.933 0 CA-C-O 123.236 1.493 . . . . 0.0 109.057 -176.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -90.38 -32.26 16.53 Favored 'General case' 0 C--O 1.289 3.183 0 C-N-CA 128.392 2.677 . . . . 0.0 116.347 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.575 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 30.5 p90 -54.39 -46.64 73.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 109.006 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.881 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -39.87 -37.83 0.61 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 131.254 3.822 . . . . 0.0 117.797 -171.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -40.88 -33.49 0.41 Allowed Pre-proline 0 C--O 1.275 2.412 0 C-N-CA 125.911 1.685 . . . . 0.0 112.615 -162.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.808 ' O ' ' HB3' ' A' ' 69' ' ' ARG . 53.1 Cg_exo -61.52 -40.66 45.8 Favored 'Trans proline' 0 CA--C 1.584 3.001 1 C-N-CA 125.761 4.308 . . . . 0.0 116.239 174.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 3.1 tp10 -71.69 -49.46 39.39 Favored 'General case' 0 C--O 1.263 1.777 0 CA-C-N 109.895 -3.32 . . . . 0.0 114.099 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 76' ' ' VAL . 2.7 mm -50.18 -65.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.799 1.639 . . . . 0.0 108.989 165.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.845 ' O ' ' HA ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -52.49 -39.77 61.62 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.212 2.205 . . . . 0.0 110.364 -176.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -81.96 -9.29 59.62 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.181 1.792 . . . . 0.0 109.701 -174.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 4.7 tp -101.48 -60.47 1.52 Allowed 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.165 1.386 . . . . 0.0 108.696 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.842 HD22 ' O ' ' A' ' 44' ' ' ALA 0.38 1.4 tp -121.32 66.73 17.2 Favored Pre-proline 0 N--CA 1.505 2.295 0 C-N-CA 126.83 2.052 . . . . 0.0 106.756 -171.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.845 ' HA ' ' O ' ' A' ' 68' ' ' GLN . 7.7 Cg_exo -31.64 -62.24 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.857 4.371 . . . . 0.0 118.768 -159.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.46 31.28 3.45 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 111.268 -2.697 . . . . 0.0 113.257 -156.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.57 ' CG ' HD11 ' A' ' 71' ' ' LEU . 10.1 mttm -81.69 165.94 40.74 Favored Pre-proline 0 N--CA 1.511 2.623 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.759 151.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.978 ' O ' HG23 ' A' ' 53' ' ' VAL 0.275 1.2 Cg_endo -82.87 64.9 8.07 Favored 'Trans proline' 0 CA--C 1.56 1.802 1 C-N-CA 126.165 4.577 . . . . 0.0 118.394 -171.906 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 67' ' ' ILE . 21.5 t -79.92 133.36 29.86 Favored 'Isoleucine or valine' 0 C--O 1.261 1.664 0 CA-C-N 111.532 -2.576 . . . . 0.0 108.338 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm-40 -142.05 128.25 19.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.059 1.743 . . . . 0.0 111.902 167.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.947 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 3.3 t -45.86 149.42 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 164.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.777 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 34.7 mt -93.2 167.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.707 2.403 . . . . 0.0 109.974 172.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 1.033 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER -89.11 159.43 17.53 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 128.68 2.792 . . . . 0.0 109.851 164.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . 0.25 10.6 t -109.34 -14.75 14.39 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 126.225 2.203 . . . . 0.0 109.794 -156.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.805 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -102.87 -35.36 8.64 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 128.86 2.864 . . . . 0.0 110.666 175.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 88' ' ' ASP 0.288 9.1 mt -71.98 -41.42 67.68 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 126.959 2.104 . . . . 0.0 106.886 169.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.033 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 1.8 t80 -47.83 -90.4 0.0 OUTLIER 'General case' 0 C--O 1.281 2.722 0 C-N-CA 126.451 1.901 . . . . 0.0 110.61 166.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.85 -5.17 44.92 Favored Glycine 0 C--O 1.263 1.93 0 O-C-N 120.745 -1.222 . . . . 0.0 113.803 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 2.0 mttp -112.02 4.97 18.44 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.655 1.182 . . . . 0.0 111.87 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 24.6 m 55.69 70.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.401 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.022 154.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 92' ' ' VAL . 19.7 p-10 -102.53 71.38 1.19 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 130.654 3.582 . . . . 0.0 114.574 171.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.677 ' O ' ' HG2' ' A' ' 23' ' ' MET . . . -53.14 -46.28 62.5 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 126.485 1.993 . . . . 0.0 114.26 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mt -37.62 -73.59 0.05 OUTLIER 'General case' 0 C--N 1.369 1.422 0 C-N-CA 126.958 2.103 . . . . 0.0 109.966 165.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . -53.85 -25.05 28.82 Favored Glycine 0 C--N 1.362 2.004 0 O-C-N 121.119 -0.988 . . . . 0.0 114.012 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.083 HG12 ' SD ' ' A' ' 23' ' ' MET . 42.6 t -86.71 -33.15 6.86 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.702 1.601 . . . . 0.0 110.249 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.995 ' O ' HG13 ' A' ' 97' ' ' VAL . 3.5 tp -65.79 -57.29 8.31 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.378 1.071 . . . . 0.0 109.846 167.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 97' ' ' VAL . 11.9 ttmt -75.26 -14.38 60.51 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.999 1.319 . . . . 0.0 113.396 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 91' ' ' GLY . . . -63.93 -50.34 69.05 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.657 1.183 . . . . 0.0 112.3 158.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 99' ' ' ALA . . . -63.5 -44.99 92.75 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.81 1.244 . . . . 0.0 109.695 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 93' ' ' LEU . 3.5 m -52.43 -57.62 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 125.676 1.59 . . . . 0.0 108.851 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.509 ' N ' ' CG2' ' A' ' 97' ' ' VAL . . . -57.06 -30.64 64.45 Favored 'General case' 0 C--O 1.179 -2.615 0 CA-C-O 123.771 1.748 . . . . 0.0 110.61 -173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 53' ' ' VAL . . . -67.07 -58.22 5.33 Favored 'General case' 0 C--N 1.378 1.835 0 CA-C-N 113.011 -1.904 . . . . 0.0 111.927 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.624 HD11 ' OD1' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -34.44 -57.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.488 0 C-N-CA 125.998 1.719 . . . . 0.0 109.851 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 100' ' ' ILE . 11.4 tttt -81.68 -14.3 56.78 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.516 1.126 . . . . 0.0 112.125 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 102' ' ' LYS . 13.0 tmtt? -89.72 8.42 31.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 125.101 1.501 . . . . 0.0 112.036 167.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -96.73 -45.21 6.77 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.938 1.295 . . . . 0.0 111.412 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -142.41 102.44 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.955 2.102 . . . . 0.0 113.143 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . 158.64 -169.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.291 1.436 . . . . 0.0 112.12 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 C-N-CA 125.459 1.504 . . . . 0.0 110.105 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.478 1.132 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.893 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 7.4 mm-40 -57.9 139.92 53.17 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.492 1.117 . . . . 0.0 110.551 159.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.893 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 12.2 mttt 108.11 128.84 0.0 OUTLIER 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.933 1.293 . . . . 0.0 114.463 -164.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 3' ' ' LYS 0.294 0.0 OUTLIER 163.81 157.38 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 173.33 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.817 ' CD2' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -67.65 135.63 53.12 Favored 'General case' 0 C--N 1.382 1.997 0 O-C-N 120.117 -1.615 . . . . 0.0 114.901 -172.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 94.5 mt -115.69 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.499 0 C-N-CA 127.673 2.389 . . . . 0.0 110.105 155.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.752 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 20.1 m-85 -88.98 154.76 19.96 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 128.374 2.67 . . . . 0.0 108.684 169.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.977 ' O ' ' HA ' ' A' ' 38' ' ' ALA 0.505 1.2 tt -162.97 143.01 9.15 Favored 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 109.409 -3.542 . . . . 0.0 104.897 -169.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.726 ' N ' HD23 ' A' ' 8' ' ' LEU . 24.4 m-85 -142.18 105.13 4.57 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.385 -151.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 169.84 17.47 Favored 'General case' 0 C--N 1.372 1.556 0 CA-C-O 122.88 1.324 . . . . 0.0 114.058 -154.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 60' ' ' ILE . 1.2 t -86.09 -29.34 23.43 Favored 'General case' 0 C--N 1.378 1.807 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.429 -152.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 13' ' ' GLY . . . -146.25 76.14 1.44 Allowed 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.916 1.385 . . . . 0.0 110.251 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 12' ' ' ALA . . . 15.67 -83.1 0.0 OUTLIER Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.08 -1.418 . . . . 0.0 113.586 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.51 23.31 1.14 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 127.476 2.31 . . . . 0.0 110.698 -167.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' CE1' ' A' ' 84' ' ' TYR . 77.9 p -94.66 -2.21 51.71 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.29 149.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.864 ' O ' ' HB2' ' A' ' 19' ' ' LEU 0.407 9.9 t -126.49 -41.81 1.85 Allowed 'General case' 0 C--N 1.399 2.721 0 C-N-CA 129.39 3.076 . . . . 0.0 119.015 163.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' THR . 5.5 p -35.78 -38.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 124.539 2.114 . . . . 0.0 108.253 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' HB3' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.79 -19.76 24.32 Favored 'General case' 0 C--N 1.392 2.452 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.0 -174.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD22 HG11 ' A' ' 92' ' ' VAL 0.327 12.2 mt -60.26 -60.33 3.98 Favored 'General case' 0 C--O 1.162 -3.549 0 C-N-CA 128.49 2.716 . . . . 0.0 105.32 160.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 HG22 ' A' ' 36' ' ' ILE . 1.4 t -62.33 -27.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.387 2.212 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.353 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -19.6 19.64 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 125.346 1.458 . . . . 0.0 111.477 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.881 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 18.2 ttmm -94.73 -44.98 7.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 124.801 1.241 . . . . 0.0 108.778 176.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 36' ' ' ILE . 1.8 mtm -48.48 -59.75 3.24 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.073 161.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.816 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.3 mtt-85 -37.72 -52.49 1.26 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 124.983 1.313 . . . . 0.0 110.092 174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -76.78 0.02 OUTLIER 'General case' 0 C--O 1.187 -2.203 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.894 163.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.908 ' HB2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -27.17 -74.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.723 169.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.017 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -60.36 -32.06 70.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.924 2.49 . . . . 0.0 113.023 -156.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.13 -28.81 12.84 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.72 1.608 . . . . 0.0 109.012 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 3.6 ttpt -49.53 -38.54 31.08 Favored 'General case' 0 N--CA 1.511 2.595 0 C-N-CA 123.969 0.908 . . . . 0.0 110.434 160.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.771 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 17.8 m-85 -98.77 -72.05 0.67 Allowed 'General case' 0 C--O 1.276 2.453 0 C-N-CA 126.128 1.771 . . . . 0.0 110.827 -174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.954 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 128.53 19.44 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.664 1.986 . . . . 0.0 110.085 -158.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.017 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 2.6 t -80.41 77.89 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 48.2 Cg_endo -90.75 -176.79 1.04 Allowed 'Trans proline' 0 CA--C 1.549 1.258 1 C-N-CA 127.021 5.148 . . . . 0.0 119.038 -157.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.817 HG11 ' CD2' ' A' ' 5' ' ' HIS . 39.0 t 81.61 -98.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 C-N-CA 130.47 3.508 . . . . 0.0 109.277 -164.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' N ' HG12 ' A' ' 34' ' ' VAL . 1.1 mm -145.87 155.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 124.886 2.279 . . . . 0.0 110.099 -168.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG22 HG22 ' A' ' 20' ' ' VAL . 3.3 mt -118.19 133.35 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 125.785 1.634 . . . . 0.0 107.913 144.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 7.1 mm-40 -145.42 126.32 14.47 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.952 -1.477 . . . . 0.0 111.688 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.977 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -84.61 144.15 28.8 Favored 'General case' 0 C--O 1.269 2.087 0 C-N-CA 125.184 1.393 . . . . 0.0 110.717 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -139.8 160.4 61.07 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 129.114 2.965 . . . . 0.0 112.242 175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.689 ' HD2' HD12 ' A' ' 43' ' ' LEU 0.299 33.5 Cg_endo -79.4 45.13 1.85 Allowed 'Trans proline' 0 CA--C 1.544 1.009 1 C-N-CA 125.545 4.163 . . . . 0.0 118.397 -174.911 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 13.0 pt-20 23.74 37.33 0.0 OUTLIER 'General case' 0 C--O 1.254 1.294 0 CA-C-N 110.365 -3.107 . . . . 0.0 114.782 -165.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.18 -31.05 10.32 Favored 'General case' 0 C--O 1.259 1.604 0 C-N-CA 129.52 3.128 . . . . 0.0 111.108 162.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.955 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 5.9 mt -99.54 9.31 43.43 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.25 1.82 . . . . 0.0 108.265 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.801 ' O ' HD21 ' A' ' 71' ' ' LEU . . . -53.6 -47.23 70.36 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.093 0.949 . . . . 0.0 110.337 157.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . -48.82 -60.34 6.06 Favored Glycine 0 C--O 1.276 2.773 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.546 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.76 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 25.3 mt-10 -91.46 -52.26 4.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.586 1.554 . . . . 0.0 110.919 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.955 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.96 -55.39 14.71 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 123.97 0.794 . . . . 0.0 110.754 177.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -50.04 -44.84 42.16 Favored Glycine 0 C--O 1.282 3.112 0 C-N-CA 124.849 1.214 . . . . 0.0 114.799 170.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.584 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -59.7 -35.75 75.13 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.605 1.562 . . . . 0.0 110.209 167.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.76 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -99.6 10.24 41.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.841 1.338 . . . . 0.0 108.923 -168.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . . . -95.51 163.88 13.03 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 6.0 t0 -69.79 -53.65 17.28 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.221 1.809 . . . . 0.0 108.832 156.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' CG ' ' A' ' 75' ' ' PRO . 15.3 t -150.81 151.87 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-N 112.929 -1.942 . . . . 0.0 107.549 -173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.974 HG11 HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -129.61 161.12 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 123.911 1.815 . . . . 0.0 109.489 -163.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.2 mt -143.29 138.67 29.72 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.147 175.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.985 HD12 HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -125.24 124.89 42.67 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.341 1.456 . . . . 0.0 107.656 178.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -48.13 163.73 0.31 Allowed Glycine 0 N--CA 1.487 2.038 0 C-N-CA 126.503 2.001 . . . . 0.0 111.504 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -91.03 3.82 4.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 1 C-N-CA 127.957 5.771 . . . . 0.0 121.429 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 2.8 mt-30 -109.67 -19.84 13.04 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.351 -2.204 . . . . 0.0 109.808 168.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.985 HD13 HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -95.92 3.22 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.853 1.661 . . . . 0.0 109.449 -175.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -36.38 -48.78 0.68 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 126.972 2.109 . . . . 0.0 111.454 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.638 ' CZ ' ' CG ' ' A' ' 63' ' ' MET . 13.5 p90 -46.67 -34.31 4.98 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 126.341 1.856 . . . . 0.0 109.916 -161.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.638 ' CG ' ' CZ ' ' A' ' 62' ' ' TYR . 41.1 mmm -75.9 -21.63 56.93 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 126.425 1.89 . . . . 0.0 113.421 -172.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -39.35 -44.45 3.09 Favored Pre-proline 0 C--N 1.378 1.805 0 C-N-CA 126.907 2.083 . . . . 0.0 111.841 -176.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 64' ' ' LEU 0.254 4.3 Cg_endo -73.4 -36.36 4.07 Favored 'Trans proline' 0 CA--C 1.575 2.535 1 C-N-CA 125.807 4.338 . . . . 0.0 116.688 -178.977 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 2.9 tt0 -67.92 -49.96 58.85 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 111.139 -2.755 . . . . 0.0 109.868 167.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.497 HD12 HD21 ' A' ' 56' ' ' LEU . 4.6 mm -49.43 -53.67 8.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 127.2 2.2 . . . . 0.0 111.328 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 64' ' ' LEU . 15.8 mm100 -74.43 -24.22 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.862 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -86.37 -1.71 57.78 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.739 1.216 . . . . 0.0 111.293 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.632 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.32 -73.27 0.62 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 109.132 160.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' O ' ' A' ' 44' ' ' ALA 0.255 0.1 OUTLIER -86.29 88.39 0.14 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 127.582 2.353 . . . . 0.0 109.446 166.068 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' HG2' ' ND2' ' A' ' 73' ' ' ASN . 12.1 Cg_endo -87.79 -16.28 3.0 Favored 'Trans proline' 0 CA--C 1.556 1.619 0 C-N-CA 125.284 3.99 . . . . 0.0 118.392 165.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.558 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 2.3 p30 -126.09 26.7 6.46 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 112.174 -2.285 . . . . 0.0 110.664 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.4 tptp -124.63 136.18 27.56 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.946 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.769 ' HG2' ' O ' ' A' ' 52' ' ' ASP 0.373 1.8 Cg_endo -54.21 46.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 1 C-N-CA 126.088 4.525 . . . . 0.0 120.47 -178.101 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.974 HG22 HG11 ' A' ' 54' ' ' VAL . 15.4 t -83.08 123.87 39.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.211 0 CA-C-N 112.081 -2.327 . . . . 0.0 110.583 -174.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 13.7 mm-40 -151.92 144.91 24.49 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.759 1.224 . . . . 0.0 110.665 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.921 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 5.1 p -81.18 154.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 CA-C-N 112.742 -2.027 . . . . 0.0 110.276 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 8' ' ' LEU 0.27 2.4 mt -86.66 171.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.89 2.076 . . . . 0.0 111.336 -176.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.854 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 1.5 m-20 -95.46 130.44 42.27 Favored 'General case' 0 CA--C 1.576 1.977 0 C-N-CA 129.183 2.993 . . . . 0.0 107.835 163.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.809 ' O ' ' HB3' ' A' ' 84' ' ' TYR . 8.4 t -73.95 -32.72 63.62 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 112.714 -2.039 . . . . 0.0 110.371 -162.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.886 ' O ' ' HD3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -80.43 -53.89 6.19 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.87 2.068 . . . . 0.0 107.084 178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.852 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mt -60.8 -29.34 69.4 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.854 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 6.4 t80 -53.48 -75.34 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.354 2.262 . . . . 0.0 108.428 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.64 -6.71 72.79 Favored Glycine 0 C--N 1.361 1.945 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.395 -162.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.886 ' HD3' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -91.51 8.52 36.1 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.343 2.021 . . . . 0.0 111.244 154.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER 56.44 36.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.164 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 150.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -71.89 59.19 0.35 Allowed 'General case' 0 C--N 1.368 1.405 0 C-N-CA 128.623 2.769 . . . . 0.0 113.475 -161.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 92' ' ' VAL . . . -9.78 -50.71 0.01 OUTLIER Glycine 0 C--O 1.273 2.538 0 C-N-CA 125.238 1.399 . . . . 0.0 116.477 176.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mp -73.69 -54.51 7.94 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.418 2.687 . . . . 0.0 109.197 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -49.59 -44.68 37.91 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.897 HG11 HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -74.61 -56.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.225 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -167.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 26' ' ' GLN . 3.0 tm? -31.18 -59.92 0.22 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.78 1.232 . . . . 0.0 108.214 162.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 94' ' ' LYS . 12.5 ttpt -70.22 -27.17 64.27 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 123.75 0.656 . . . . 0.0 112.196 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.04 -23.18 31.01 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.928 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.23 -52.63 38.59 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 124.732 1.213 . . . . 0.0 112.119 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.58 -44.2 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 125.288 1.435 . . . . 0.0 108.507 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -70.01 -25.09 63.42 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.624 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' A' ' 77' ' ' GLU . . . -94.95 -36.03 11.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.912 1.685 . . . . 0.0 110.809 -172.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.741 ' CG1' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -42.61 -64.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.71 -45.37 78.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 126.551 2.407 . . . . 0.0 113.145 -176.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -67.73 -4.1 11.26 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.921 178.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 100' ' ' ILE . . . -54.22 -39.38 66.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.019 1.727 . . . . 0.0 112.112 165.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' ALA . . . 157.94 150.34 0.01 OUTLIER 'General case' 0 C--N 1.374 1.633 0 C-N-CA 125.401 1.48 . . . . 0.0 112.458 167.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.31 -168.45 1.65 Allowed 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 125.69 1.596 . . . . 0.0 110.296 171.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.262 1.741 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.861 168.211 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.814 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 3.2 tpt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.589 0.233 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.536 ' HA ' ' OE1' ' A' ' 2' ' ' GLU . 5.0 mm-40 -55.75 -74.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.385 1.474 . . . . 0.0 108.917 -166.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.856 ' C ' HG23 ' A' ' 34' ' ' VAL . 14.5 mmmt 85.62 122.06 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.197 0 O-C-N 125.812 1.945 . . . . 0.0 111.465 170.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.888 ' N ' HG23 ' A' ' 34' ' ' VAL . 9.6 mttp -150.86 137.75 19.06 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 125.355 2.503 . . . . 0.0 114.544 -174.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 64.1 m170 -79.75 138.2 37.23 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.76 -1.837 . . . . 0.0 113.83 166.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG22 HG23 ' A' ' 36' ' ' ILE 0.254 33.4 mt -123.04 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 124.609 2.147 . . . . 0.0 108.959 162.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.905 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.3 m-30 -100.61 155.97 17.57 Favored 'General case' 0 CA--C 1.573 1.862 0 C-N-CA 128.828 2.851 . . . . 0.0 110.886 -169.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.907 ' CD2' ' HB2' ' A' ' 38' ' ' ALA 0.312 4.1 tp -159.42 138.42 11.05 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 111.127 -2.761 . . . . 0.0 107.045 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' PHE 0.272 1.6 m-85 -134.4 74.61 1.54 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 128.245 2.618 . . . . 0.0 113.006 -166.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 11' ' ' SER . 1.2 t -79.05 175.89 10.16 Favored 'General case' 0 C--O 1.277 2.537 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -99.4 -45.84 5.7 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.886 1.274 . . . . 0.0 111.856 153.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.649 ' HB3' ' HE2' ' A' ' 84' ' ' TYR . . . -84.14 93.74 8.21 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.005 -1.907 . . . . 0.0 110.435 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.07 57.32 0.01 OUTLIER Glycine 0 CA--C 1.553 2.428 0 C-N-CA 126.69 2.091 . . . . 0.0 110.448 158.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.73 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 125.757 1.623 . . . . 0.0 109.835 166.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.806 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.9 m 160.84 -61.8 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.111 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.241 -168.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.04 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.96 -55.94 24.26 Favored 'General case' 0 C--N 1.367 1.332 0 O-C-N 126.202 2.189 . . . . 0.0 112.611 -171.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -57.52 -69.42 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.601 1.667 . . . . 0.0 110.022 -163.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' CG2' ' A' ' 87' ' ' VAL 0.275 0.0 OUTLIER -30.22 -49.21 0.11 Allowed 'General case' 0 C--N 1.374 1.661 0 C-N-CA 126.67 1.988 . . . . 0.0 115.509 159.497 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.04 ' HB2' ' O ' ' A' ' 16' ' ' THR 0.314 2.5 mt -49.91 -61.34 2.19 Favored 'General case' 0 C--O 1.17 -3.082 0 O-C-N 118.565 -2.584 . . . . 0.0 106.538 178.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -55.77 -50.06 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.447 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -167.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.1 -25.31 68.3 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.508 -170.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.969 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -108.39 -29.46 8.82 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.363 1.04 . . . . 0.0 111.352 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -50.07 -50.01 49.45 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.554 1.645 . . . . 0.0 110.938 159.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -46.83 -61.11 2.0 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 113.326 -1.761 . . . . 0.0 115.108 157.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.969 ' HB3' ' O ' ' A' ' 22' ' ' LYS . . . -32.56 -70.85 0.06 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.329 169.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.77 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.78 -66.8 0.33 Allowed 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 126.156 1.782 . . . . 0.0 109.472 173.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB3' HD11 ' A' ' 36' ' ' ILE . . . -81.41 6.23 15.16 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 125.658 1.583 . . . . 0.0 112.531 -164.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 24' ' ' ARG . 44.1 mt-10 -111.42 -49.8 2.98 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 125.635 1.574 . . . . 0.0 112.73 162.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.925 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -17.41 -56.63 0.01 OUTLIER 'General case' 0 C--O 1.185 -2.316 0 C-N-CA 125.622 1.569 . . . . 0.0 111.704 154.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.789 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 23.3 m-85 -112.02 -12.03 13.77 Favored 'General case' 0 C--O 1.261 1.703 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.86 -156.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 30' ' ' TYR . 15.7 mt-10 96.15 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.832 1.653 . . . . 0.0 110.058 169.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 30' ' ' TYR . 27.4 t -57.7 95.5 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 124.901 1.376 . . . . 0.0 108.794 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 31' ' ' GLU 0.348 7.1 Cg_endo -39.49 169.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.202 -1.313 1 C-N-CA 126.37 4.714 . . . . 0.0 117.803 -160.034 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 ' N ' ' A' ' 4' ' ' LYS 0.437 9.5 t 29.63 -125.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 126.989 2.116 . . . . 0.0 113.217 -166.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -115.94 162.77 13.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 1 C-N-CA 133.474 4.709 . . . . 0.0 110.137 -158.315 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -105.94 135.81 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 126.212 1.805 . . . . 0.0 107.6 147.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.903 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 1.3 mm-40 -141.57 130.15 22.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.436 1.894 . . . . 0.0 111.748 172.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -97.39 169.96 9.39 Favored 'General case' 0 C--N 1.369 1.453 0 CA-C-O 123.082 1.42 . . . . 0.0 114.814 157.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 84.6 m-85 -169.06 161.66 7.89 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 127.027 2.131 . . . . 0.0 105.732 -159.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HD2' HD13 ' A' ' 43' ' ' LEU . 83.1 Cg_endo -99.48 94.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 127.144 5.229 . . . . 0.0 117.789 174.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.882 ' OE1' HG23 ' A' ' 42' ' ' THR 0.383 0.0 OUTLIER 27.06 -59.7 0.0 OUTLIER 'General case' 0 C--O 1.286 3.003 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 178.57 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.882 HG23 ' OE1' ' A' ' 41' ' ' GLU . 1.4 p -42.96 -35.66 1.29 Allowed 'General case' 0 CA--C 1.571 1.768 1 C-N-CA 131.861 4.064 . . . . 0.0 111.252 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 40' ' ' PRO 0.308 0.2 OUTLIER -104.31 -9.38 18.58 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-N 111.875 -2.421 . . . . 0.0 109.452 -149.65 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -54.69 -47.68 73.36 Favored 'General case' 0 C--O 1.266 1.929 0 C-N-CA 127.858 2.463 . . . . 0.0 115.402 166.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.7 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -29.25 -62.18 0.15 Allowed Glycine 0 CA--C 1.569 3.451 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.9 mt-10 -77.7 -59.96 2.57 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 125.427 1.31 . . . . 0.0 112.942 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -69.46 -48.69 59.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.082 0.944 . . . . 0.0 110.762 -172.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.96 -40.87 99.04 Favored Glycine 0 C--O 1.273 2.553 0 C-N-CA 126.976 2.226 . . . . 0.0 117.391 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -61.22 -25.18 66.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 161.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.9 m120 -90.68 1.86 56.45 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 127.128 2.171 . . . . 0.0 112.047 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB3' HG23 ' A' ' 54' ' ' VAL . . . -102.97 161.37 13.81 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 125.347 1.459 . . . . 0.0 112.585 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.62 ' OD2' ' HD3' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -98.74 -24.04 15.19 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 129.086 2.954 . . . . 0.0 113.249 170.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.081 HG11 ' HB1' ' A' ' 96' ' ' ALA . 51.5 t -150.31 146.09 16.76 Favored 'Isoleucine or valine' 0 C--N 1.369 1.418 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 1.9 t -149.09 116.0 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.668 -160.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -123.72 112.39 17.3 Favored 'General case' 0 C--N 1.377 1.769 0 C-N-CA 126.846 2.058 . . . . 0.0 111.771 -172.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.872 HD22 HD12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -115.03 146.88 40.81 Favored 'General case' 0 C--N 1.371 1.537 0 C-N-CA 126.885 2.074 . . . . 0.0 108.415 -168.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.817 ' HA3' HG22 ' A' ' 60' ' ' ILE . . . -51.05 164.37 0.91 Allowed Glycine 0 C--O 1.251 1.218 0 C-N-CA 126.652 2.072 . . . . 0.0 114.19 -151.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.869 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 16.0 Cg_endo -100.29 -14.25 0.18 Allowed 'Trans proline' 0 CA--C 1.567 2.156 1 C-N-CA 127.69 5.593 . . . . 0.0 119.874 173.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 2.7 pt20 -105.87 5.17 30.43 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 126.729 2.518 . . . . 0.0 108.622 155.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.817 HG22 ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -134.28 23.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 126.15 2.156 . . . . 0.0 109.438 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -51.97 -43.56 63.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.214 1.806 . . . . 0.0 112.16 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.722 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -40.67 -31.78 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.719 2.007 . . . . 0.0 111.754 -168.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.647 ' SD ' ' CE2' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -66.46 -21.21 66.19 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.938 -167.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -45.98 -34.82 3.29 Favored Pre-proline 0 C--O 1.263 1.784 0 C-N-CA 128.329 2.652 . . . . 0.0 113.488 -166.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.722 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 42.9 Cg_endo -80.92 -27.8 2.87 Favored 'Trans proline' 0 C--N 1.362 1.272 1 C-N-CA 126.731 4.954 . . . . 0.0 119.01 172.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -53.68 20.73 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.924 161.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.872 HD12 HD22 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -54.19 -58.58 3.36 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.754 0 CA-C-O 124.42 2.057 . . . . 0.0 111.057 -176.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.72 2.84 47.42 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 111.796 -2.457 . . . . 0.0 110.029 -160.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.622 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -89.69 -23.57 21.81 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 158.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 6.7 tp -79.86 -62.72 1.6 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.568 1.947 . . . . 0.0 109.429 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 71' ' ' LEU 0.254 0.4 OUTLIER -90.23 91.36 0.35 Allowed Pre-proline 0 C--O 1.255 1.373 0 C-N-CA 127.269 2.228 . . . . 0.0 109.269 163.147 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 40.9 Cg_endo -85.77 -10.21 7.37 Favored 'Trans proline' 0 CA--C 1.551 1.367 1 C-N-CA 126.559 4.839 . . . . 0.0 119.433 169.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -101.45 -21.12 14.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.22 -163.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.4 mttm -127.04 161.62 52.71 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 122.919 1.343 . . . . 0.0 112.365 -162.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 53' ' ' VAL 0.341 63.1 Cg_endo -71.66 63.47 3.03 Favored 'Trans proline' 0 C--N 1.373 1.818 1 C-N-CA 126.52 4.813 . . . . 0.0 120.53 -178.139 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.805 HG13 HG12 ' A' ' 54' ' ' VAL . 12.5 t -71.61 146.4 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 111.159 -2.746 . . . . 0.0 109.892 171.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.949 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 66.1 mm-40 -163.15 156.53 19.49 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 127.052 2.141 . . . . 0.0 112.102 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 33.3 m -111.69 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.981 1.425 . . . . 0.0 107.206 172.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.869 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 1.7 mt -80.2 162.54 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 C-N-CA 125.452 1.501 . . . . 0.0 108.145 -168.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -74.04 154.33 39.29 Favored 'General case' 0 CA--C 1.577 1.981 0 C-N-CA 128.045 2.538 . . . . 0.0 109.563 155.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 t -103.29 -14.99 16.1 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 125.619 1.824 . . . . 0.0 112.763 -159.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' TYR 0.268 0.1 OUTLIER -75.7 -75.69 0.17 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.809 1.644 . . . . 0.0 108.91 151.709 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 80' ' ' ASP . 41.2 mt -39.97 -33.22 0.2 Allowed 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -169.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.756 ' HB2' ' O ' ' A' ' 80' ' ' ASP . 29.8 t80 -71.49 -75.19 0.13 Allowed 'General case' 0 C--N 1.377 1.78 0 C-N-CA 127.413 2.285 . . . . 0.0 110.763 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA2' ' OG ' ' A' ' 15' ' ' SER . . . -84.38 5.62 80.01 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.337 1.922 . . . . 0.0 111.412 -172.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.81 -5.44 9.65 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 123.769 1.747 . . . . 0.0 113.372 168.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.752 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.5 OUTLIER 66.42 80.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 125.03 2.347 . . . . 0.0 109.218 154.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 92' ' ' VAL . 1.4 m-20 -122.84 89.19 3.06 Favored 'General case' 0 C--N 1.378 1.84 0 C-N-CA 127.955 2.502 . . . . 0.0 113.824 164.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' VAL . . . -24.18 -75.29 0.01 OUTLIER Glycine 0 C--N 1.372 2.552 0 O-C-N 120.734 -1.229 . . . . 0.0 113.653 160.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -43.67 -59.03 2.38 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.707 1.603 . . . . 0.0 110.67 -170.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.37 -44.32 1.65 Allowed Glycine 0 N--CA 1.499 2.837 0 O-C-N 125.363 1.664 . . . . 0.0 112.352 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 88' ' ' ASP . 27.8 t -67.15 -43.09 88.77 Favored 'Isoleucine or valine' 0 C--O 1.288 3.098 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HB2' ' CE ' ' A' ' 23' ' ' MET . 0.1 OUTLIER -65.41 -56.2 13.83 Favored 'General case' 0 C--O 1.253 1.252 0 C-N-CA 127.656 2.383 . . . . 0.0 109.013 172.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' A' ' 93' ' ' LEU . 2.4 mmtm -47.41 -58.7 3.86 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.607 0.639 . . . . 0.0 111.695 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 98' ' ' ALA . . . -44.41 -53.66 6.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.653 1.181 . . . . 0.0 112.468 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 1.081 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -60.33 -30.99 69.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.712 1.605 . . . . 0.0 111.984 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 93' ' ' LEU . 62.7 t -67.23 -46.4 84.15 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 C-N-CA 126.242 1.817 . . . . 0.0 109.753 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -56.72 -43.03 80.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.94 1.296 . . . . 0.0 112.051 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.88 42.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.67 1.588 . . . . 0.0 111.707 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -53.22 -71.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.54 -174.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 3.2 tmtt? -68.2 -4.02 12.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.317 -1.765 . . . . 0.0 112.643 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 19.1 ttpt -86.63 -31.46 21.11 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.481 1.113 . . . . 0.0 112.693 168.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . -47.84 -49.45 29.27 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.744 1.618 . . . . 0.0 112.158 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 103' ' ' ALA . . . 155.27 162.4 0.01 OUTLIER 'General case' 0 C--N 1.367 1.368 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.455 -175.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 82.49 90.74 0.04 OUTLIER 'General case' 0 C--N 1.37 1.483 0 C-N-CA 125.162 1.385 . . . . 0.0 112.29 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 126.224 1.809 . . . . 0.0 110.49 172.153 . . . . . . . . 1 1 . 1 stop_ save_